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Bacteria have been the causative agents of major infectious disease pandemics 
throughout human history.  Over the past 4 decades, a combination of changing 
medical practices, industrialization, and globalisation have led to a number of 
emergences and re-emergences of bacterial pathogens.  The design of rational control 
programs and bespoke therapies will require an enhanced understanding of the 
dynamics underpinning the emergence and transmission of pathogenic clones.  The 
recent development of new technologies for sequencing bacterial genomes rapidly 
and economically has led to a greatly enhanced understanding of the diversity of 
bacterial populations.   
 
This thesis describes the application of whole genome sequencing of 2 bacterial 
pathogens, Staphylococcus aureus and Legionella pneumophila, in order to 
understand the dynamics of bacterial infections on different temporal and spatial 
scales. The first study involves the examination of S. aureus evolution during a 
chronic infection of a single patient over a period of 26 months revealing differences 
in antibiotic resistance profiles and virulence factor expression over time.  The 
genetic variation identified correlated with differences in growth rate, haemolytic 
activity, and antibiotic sensitivity, implying a profound effect on the ecology of S. 
aureus.  Importantly, polymorphisms were identified in global regulators of 
virulence, with a high frequency of polymorphisms within the SigB locus identified, 
suggesting this region may be under selection in this patient.  The identification of 
genes under diversifying selection during long-term infection may inform the design 
of novel therapeutics for the control of refractory chronic infections. 
 
Secondly, the emergence and transmission of 3 pandemic lineages derived from S. 
aureus clonal complex 30 (CC30) were investigated.  Independent origins for each 
pandemic lineage were identified, with striking molecular correlates of hospital- or 
community-associated pandemics represented by mobile genetic elements, such as 
bacteriophage and Staphylococcal pathogenicity islands, and non-synonymous 
mutations affecting antibiotic resistance and virulence.  Hospitals in large cities were 
identified as hubs for the transmission of MRSA to regional health care centres. In 
addition, comparison of whole genome sequences revealed that at least 3 
 3 
independent acquisitions of TSST-1 have occurred in CC30, but a single distinct 
clade of diverse community-associated CC30 strains was responsible for the TSS 
epidemic of the late 1970s, and for subsequent cases of TSS in the UK and USA.   
 
Finally, whole genome sequencing was used as a tool for investigating a recent 
outbreak of legionellosis in Edinburgh.  An unexpectedly high level of genomic 
diversity was identified among the outbreak strains, with respect to core genome 
polymorphisms, and accessory genome content.  The data indicate that affected 
individuals may be infected with heterogeneous strains.  The findings highlight the 
complexities in identifying environmental sources and suggest possible differences 
in pathogenic potential among isolates from a single outbreak.  
 
Taken together, the findings demonstrate applications of bacterial genome 
sequencing leading to enhanced understanding of bacterial pathogen evolution, 








1.1. Bacterial diseases of humans 
Bacteria have been the causative agents of some of the most widespread and fatal 
epidemics throughout human history.  At the beginning of the 20th century, 
pneumonia, tuberculosis, and enteritis were the 3 leading causes of death in the 
United States, and along with diphtheria accounted for one third of all deaths (CDC, 
1999).  A century later, the mortality rate attributed to bacterial pathogens has 
significantly declined, with the theory of epidemiologic transition attributing the 
decline to a combination of socioeconomic factors (increased standards of living, 
hygiene practices, nutrition), and medical and public health interventions (antibiotic 
therapies, vaccination strategies, water sanitation) (Omran, 1971). 
Despite the decline of the bacterial disease burden in developed nation populations, 
there have been numerous examples in the past 4 decades of the emergence of novel 
bacterial pathogens, and re-emergences of known bacteria with an increased capacity 
to cause disease (Table 1.1).  Faced with the growing problem of antibiotic resistant 
bacteria (Davies et al., 2010; Kumarasamy et al., 2010), and the lack of development 
of new antibiotic therapies, it seems unlikely that the factors contributing to the 
decline in bacterial disease in the 20th century will have the same impact again.  
Consequently, an increased understanding of the processes that lead to the 
emergence of virulence, antibiotic resistance and the drivers of pathogen spread may 
help inform control programs through targeted interventions. 
 
This thesis will explore the evolution and epidemiology of bacterial pathogens 
through the application of whole genome sequencing (WGS) of populations of 
Staphylococcus aureus and Legionella pneumophila. 
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Table 1.1 Selected emerging or re-emerging bacterial pathogens of humans. 
 
Bacterium Disease Year first described Reference 
 
Bartonella henselae Bartonellosis 1992 (Regnery et al., 1992) 
Borrelia burgdorferi Lyme disease 1982 (Burgdorfer et al., 1982) 
Clostridium difficile Pseudomembranous colitis 1978 (Larson et al., 1978) 
Escherichia coli O157:H7 Haemorrhagic colitis 1982 (Riley et al., 1983) 
Helicobacter pylori Gastric Ulcer 1982 (Marshall et al., 1984) 
Legionella pneumophila Legionellosis 1977 (McDade et al., 1977) 
Listeria monocytogenes Listeriosis 1981 (Schlech et al., 1983) 
Staphylococcus aureus Toxic shock syndrome 1982 (Altemeier et al., 1982) 
Streptococcus pyogenes Streptococcal toxic shock syndrome 1989 (Stevens et al., 1989) 
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1.2. Staphylococcus aureus 
The Gram-positive bacterium S. aureus is an important human pathogen responsible 
for an array of diseases (Lowy, 1998).  The microorganism is commonly isolated as a 
commensal from the anterior nares and skin, with nasal carriage being a major risk 
factor for subsequent invasive disease (Davis et al., 2004; Wertheim et al., 2004).  A 
review of cross-sectional studies showed the mean prevalence of S. aureus nasal 
carriage to be 37.2 % in the general population (Kluytmans et al., 1997).  
Longitudinal studies have demonstrated that approximately 20 % to 30 % of 
individuals are persistent nasal carriers of S. aureus, with 30 % carrying S. aureus 
intermittently, and the remainder of the population being non-carriers (Frank et al., 
2010).  However, an important recent study found that after experimental nasal 
colonisation with S. aureus, the elimination kinetics and antibody responses of 
individuals identified as either intermittent- or non-carriers were highly similar (Van 
Belkum et al., 2009).  Swabs from individuals classed as persistent carriers yielded 
significantly higher CFU per sample, and were culture positive for longer than swabs 
from intermittent- or non-carriers.  Taken together, these data suggest that human S. 
aureus nasal carriers fall into one of two classes, those who are persistently 
colonised, and others who may carry S. aureus given particular selective pressures 
(Van Belkum et al., 2009). 
 
Invasive disease occurs when the protective barriers of the skin or mucosal 
membranes are compromised, typically at surgical or vascular access sites in the 
hospital setting.  Infection is often localised to the lesion site, but can develop into 
systemic disease, particularly if the host is immunosuppressed (Lindsay, 2008; 
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Mourvillier et al., 2004).  Clinical presentation ranges from relatively minor skin and 
soft tissue infections, to potentially fatal bacteraemia, infective endocarditis, toxic 
shock syndrome and necrotising pneumonia (Altemeier et al., 1982; Gillet et al., 
2008; Mourvillier et al., 2004; Stryjewski et al., 2008; Wertheim et al., 2004).  
 
1.2.1. Organisation and evolution of the S. aureus genome 
At the time of writing there are 33 finished genome sequences of S. aureus available 
from the Genomes Online Database (GOLD) (Pagani et al., 2012), with over 8000 
additional sequences identified in the NCBI sequence read archive (SRA) (SRA 
Handbook, 2010).   
 
The S. aureus genome consists of a single chromosome with a GC % of 
approximately 33 %, ranging in size from 2.7 Mb encoding 2,545 CDSs (Sass et al., 
2012) to 3.1 Mb encoding 2,977 CDSs (Holden et al., 2010).  A comparative 
genomic analysis of 17 strains identified 2,266 conserved CDSs (approximately 75 
% of CDSs) that make up the core genome of S. aureus, and 899 CDSs that were 
variably present and represent the accessory genome (Boissy et al., 2011).  There is a 
high level of synteny maintained across the core genome of the S. aureus species 
(Lindsay et al., 2006) and, with the exception of strains from clonal complex 75, 
orthologous genes in the core genome typically display less than 2 % divergence in 
their nucleotide sequence (Holt et al., 2011). 
 
Unlike bacterial genera such as the Streptococci and the Neisseriaceae, S. aureus is a 
clonal organism and genetic variation evolves primarily by point mutation, rather 
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than recombination (Feil et al., 2003).  However, recombination is known to play an 
important role in the long term evolution of S. aureus (Robinson et al., 2004).  The 
MRSA ST239 clone is prevalent in hospitals globally (Aires de Sousa et al., 1998, 
2001; Alp et al., 2009; Feil et al., 2008) and has arisen as a result of a large scale 
chromosomal recombination event between genomes from the unrelated clonal 
complexes (CC) CC30 and CC8 (Robinson et al., 2004).  In addition, recombination 
is known to impact on the diversification of a number of virulence determinants, 
including agr (Robinson et al., 2005b), staphylocoagulase (Watanabe et al., 2009), 
and staphylococcal enterotoxin-like toxin X (Wilson et al., 2011). 
 
The accessory genome consists of a diverse collection of non-essential genes that can 
confer selective advantages in specific niches and can comprise approximately 20 % 
of a S. aureus genome (Fitzgerald et al., 2001).  Within lineages, frequent horizontal 
transfer of mobile genetic elements (MGE) has been reported (Lindsay et al., 2006; 
McCarthy et al., 2010).  Strikingly, the majority of staphylococcal toxins causing 
toxinoses are carried on MGEs.  MGEs integrated into the S. aureus chromosome 
include bacteriophages, staphylococcal pathogenicity islands (SaPI), plasmids, 




1.2.1.1. Staphylococcal pathogenicity islands 
SaPIs are a family of MGEs with 6 defined integration sites in the S. aureus genome, 
and are typically between 14 and 17 kb in size (Novick et al., 2007).  SaPIs do not 
encode the capacity for horizontal transfer within their genome, and are closely 
associated with specific phage that mediate their excision from the S. aureus genome 
and replication (Tormo-Más et al., 2010).  SaPIs maintain a core genome for the 
control of their replication cycle, including an integrase that determines the 
chromosomal attachment site, and a number of replication regulators (Novick et al., 
2010).  Importantly, many SaPIs encode superantigens, with toxic shock syndrome 
toxin (TSST-1) and enterotoxins B and C, superantigens associated with toxic shock 
syndrome (TSS) and food poisoning, being found exclusively on pathogenicity 
islands (Novick, 2003). 
 
1.2.1.2. Bacteriophages 
Bacterial prophages play an important role in the evolution of the S. aureus genome, 
and have the ability to disrupt host genes, while mediating the horizontal transfer of 
genes encoding virulence factors by transduction.  Phage genomes are typically 
highly mosaic, with recombination between phage a common occurrence (Kwan et 
al., 2005).  Phage can carry factors beneficial for survival in a novel host (Lowder et 
al., 2009), virulence factors for establishing and maintaining infection (Coleman et 





1.2.1.3. Staphylococcal cassette chromosomes 
Staphylococcal cassette chromosomes that carry the mecA or mecC gene (SCCmec) 
are large mobile elements that encode PBP2a, a penicillin binding protein with low 
affinity for β-lactam antibiotics (Ubukata et al., 1989).  SCCmec elements integrate 
into the S. aureus chromosome downstream of the orfX locus, and can be subtyped 
based on the nucleotide sequence of the mec gene complex, and of the ccr genes 
(Hanssen et al., 2006).  The ccr loci encode site-specific chromosomal recombinases 
that mediate transfer of SCCmec by controlling the excision and insertion of the 
SCCmec element (Hanssen et al., 2006).  To date, 11 SCCmec types conferring 
resistance to different classes of antibiotics have been described (García-Álvarez et 
al., 2011).  SCCmec types are defined by the combination of the mec gene complex 
and the ccr gene complex carried by the element, and can be further subtyped based 
on the flanking nucleotide sequence of the mec and ccr complexes (Zhang et al., 
2005).  SCCmec I, II and III range in size between 34 – 67 kb and are predominantly 
associated with the nosocomial environment, in part because they encode resistance 
to multiple classes of antibiotics (Chambers et al., 2009; Collins et al., 2010).  
SCCmec types IV and V are smaller, approximately 21 – 28 kb, and are not restricted 
to the hospital environment, and are carried by S. aureus strains that are capable of 
causing disease in the community (Holden et al., 2013; Ma et al., 2002).  It has been 
demonstrated that strains carrying the type II SCCmec have reduced levels of 
virulence factor expression and fitness relative to strains harbouring type IV SCCmec 
(Collins et al., 2010; Rudkin et al., 2012). 
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Understanding the composition of the core and accessory genome is essential in 
order to identify the evolutionary processes that may lead to the emergence of S. 
aureus with phenotypic traits that may cause an increased burden on public health, 
such as antibiotic resistance and increased virulence.  
 
1.2.2. Antibiotic resistant S. aureus 
The growing prevalence of resistance to all classes of antimicrobials is a major 
public health concern, complicating efforts to prevent and treat infections (Aires de 
Sousa et al., 2003; Begier et al., 2004; DeLeo et al., 2011; Harris et al., 2010; Holden 
et al., 2013).  S. aureus readily acquires antimicrobial resistance via gene mutation or 
by the horizontal acquisition of resistance determinants from other bacteria (Holden 
et al., 2004).  For example, single nucleotide polymorphisms in fusA, rpoB, dfrB and 
gyrA mediate resistance to fusidic acid, rifampin, trimethoprim and fluoroquinolones, 
respectively (Besier et al., 2003; Tanaka et al., 2000; Vickers et al., 2009; 
Wichelhaus et al., 2002). 
 
The first methicillin resistant S. aureus (MRSA) strains were described in 1961, 6 
months after the introduction of methicillin as an anti-staphylococcal agent (Jevons, 
1961), but the incidence was low and these strains did not become endemic in 
Europe or the United States (Bran et al. 1972, Rosdahl et al., 1991; Rosendal et al., 
1977).  A second wave of MRSA clones emerged globally throughout the 1980s and 
1990s and spread rapidly between hospitals, with reports of multidrug resistant 
strains in the UK, Ireland, Australia and the United States (Ayliffe, 1997; Cox et al., 
1995; Marples et al., 1992).  Currently, MRSA is disseminated on a global scale in 
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both nosocomial and community settings, with methicillin resistance being recorded 
in 40 % to 60 % of hospital-acquired S. aureus infections from Europe, Japan, and 
the United States (Grundmann et al., 2006; Tiemersma et al., 2004).  Resistance is 
mediated by the expression of a penicillin-binding protein with low affinity for β-
lactam antibiotics (PBP2a) (Fischetti et al., 2006), encoded by the mecA gene carried 
on the staphylococcal cassette chromosome mec (SCCmec), a large (21-67 kb) 
mobile genetic element (Hanssen et al., 2006). 
 
Multidrug resistant strains can be treated using vancomycin as a last resort, although 
vancomycin resistant strains have been sporadically reported since the late 1990s 
(Hiramatsu et al., 1997).  High-level resistance to vancomycin is mediated through 
expression of the VanA operon, carried on the Tn1546 transposon, which was 
acquired through horizontal transfer from enterococci (Kos et al., 2012; Sievert et al., 
2008).  Intermediate resistance to vancomycin has been linked to variants of 
numerous loci, including vraSR, a 2-component system that controls the expression 
of a number of genes involved in peptidoglycan cross-linking, and thickening of the 
bacterial cell wall (Gardete et al., 2006; Mwangi et al., 2007). 
 
S. aureus is capable of causing disease in both hospital and community niches, and 
emerging strains are increasingly capable of causing infections in both environments 
(Espadinha et al., 2013).  An understanding of the factors driving the emergence and 




1.2.3. Hospital-associated MRSA 
Hospital-associated MRSA (HA-MRSA) is a leading cause of nosocomial infection, 
and significantly increases morbidity and mortality rates of affected inpatients.  Since 
the 1990s, multidrug-resistant MRSA has been endemic in UK hospitals, resulting in 
government interventions to increase hygiene standards and bring the prevalence of 
MRSA infections down.  Throughout the late 1990s and early 2000s S. aureus was 
the most common cause of nosocomial-acquired infection, with 2 % of all new 
hospital admissions in the United States resulted in the patient suffering an MRSA 
infection (Jones, 2003), while this figure was 1.3 % in the United Kingdom (Smyth 
et al., 2008).  Although HA-MRSA rates have fallen, the cost of MRSA to the 
European economy is estimated to be €380,000,000 per year (Köck et al., 2010).  
Estimates from the United States attribute 477,927 hospitalisations to S. aureus, 
resulting in death in over 11,000 cases in the years 1999-2005 (Klein et al., 2007).  
More recent figures from the United Kingdom for 2010/11 report the rate of MRSA 
bacteraemia as 3.2/100,000 bed days, while the rate of methicillin sensitive S. aureus 
(MSSA) bacteraemia is 24.6/100,000 bed days (Health Protection Agency, 2012a).  
S. aureus is the second most common cause of post-operative infection in the United 
Kingdom, accounting for 27 % of surgical site infections in 2010/11 (Health 
Protection Agency, 2012b).  Globally, prevalence of HA-MRSA has been reported at 
over 70 % in regions of Asia, over 50 % in the Americas and regions of Europe, 
while rates in Northern Europe can be as low as 5 % (Stefani et al., 2012).   
 
Among HA-MRSA, 6 clonal complexes (CC5, 8, 22, 30, 45 and 239) dominate the 
population, with differences in prevalence associated with geographic location 
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(Chambers et al., 2009; Lindsay, 2013).  CC5 with SCCmec types II and IV, and 
SCCmec type IV ST8 strains predominate in the USA, in southeast Asia and South 
America, the dominant clone is ST239.  Within Europe, there are a number of HA-
MRSA lineages, with CC5 predominating in central regions (Schulte et al., 2012).  In 
the UK, the epidemic clones EMRSA-15 and EMRSA-16 predominate among the 
circulating strains and have been responsible for over 95 % of cases of HA-MRSA 
since the mid-1990s, although the prevalence of EMRSA-16 has been rapidly 
declining (Ellington et al., 2010; Johnson et al., 2005; Murchan et al., 2004; Wyllie 
et al., 2011).  The decline in rates of EMRSA-16 have been hypothesised to be due to 
changes in hygiene management, antibiotic prescription patterns, and phage 
epidemics (Ellington et al., 2010; Knight et al., 2012; Wyllie et al., 2011) 
 
1.2.4. Community-associated MRSA 
In contrast to HA-MRSA, which primarily affects individuals predisposed to 
infection, community-acquired infections (CA-MRSA) commonly occur in otherwise 
healthy individuals (Herold et al., 1998; Söderquist et al., 2006).  Outbreaks of the 
community-associated USA300 clone have been reported in athletics teams, inmates 
at correctional facilities, military recruits, and men who have sex with men (Diep et 
al., 2008; Maree et al., 2007).  CA-MRSA lineages typically demonstrate increased 
virulence in comparison to HA-MRSA, and although commonly associated with 
severe skin and soft tissue infections, can occasionally cause life-threatening 
necrotising pneumonia, and other severe infections (Boyle-Vavra et al., 2007; 
Collins et al., 2010).  Colonisation sites include the throat, axilla, groin, perirectal 
 17 
area and non-intact skin sites, but nasal colonisation does not appear to be a risk 
factor for CA-MRSA infection (DeLeo et al., 2010).  
 
Epidemics of multidrug resistant strains, and the emergence of new pathogenic 
clones in the community, highlight the importance of understanding the molecular 
basis for resistance phenotypes and the evolutionary events that lead to their 
emergence.  Increasingly, the boundaries between the hospital and the community 
are becoming blurred, with virulent CA-MRSA lineages causing severe infections 
within a healthcare setting, and HA-MRSA circulating in community settings 
(Espadinha et al., 2013; Sherwood et al., 2013; Torres-Sangiao et al., 2011).  By 
understanding the dynamics of transmission between hospital and community 
settings, risk factors may be identified leading to the rational design of infection 
control strategies. 
 
1.2.5. S. aureus CC30 is a clone of global health importance  
Of the major globally disseminated lineages, S. aureus CC30 has had a particularly 
profound impact on human health over a period of 6 decades, giving rise to 3 
pandemic lineages and the strains responsible for the TSS epidemic (Alesana-Slater 
et al., 2011; Altemeier et al., 1982; Blair et al., 1960; Collignon et al., 1998; DeLeo 
et al., 2011; Donahue et al., 1966; Fitzgerald et al., 2001; Nahmias et al., 1961; 
Robinson et al., 2005a).   
 
In the 1950s a clone of MSSA spread rapidly from hospitals, causing significant skin 
and soft tissue infections in the community.  Designated phage type 80/81, the clone 
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was characterised by resistance to penicillin, and production of the Panton-Valentine 
leukocidin (PVL) toxin (Donahue et al., 1966; Nahmias et al., 1961).  The prevalence 
of phage type 80/81 declined throughout the 1960s and 1970s with the introduction 
of new antibiotics (Blair et al., 1960; Goldie et al., 1971).   
 
Emerging in the 1990s in remote Pacific Island populations, the Southwest Pacific 
clone (SWP) is a contemporary PVL positive MRSA clone.  Like the phage type 
80/81 clone, the SWP clone is community-associated and spread globally causing 
skin and soft tissue infections of otherwise healthy individuals (Alesana-Slater et al., 
2011; Collignon et al., 1998).   
 
In contrast to phage type 80/ 81 and SWP, the EMRSA-16 (ST36) clone is restricted 
to the hospital setting and has reduced virulence due in part to low levels of 
expression of cytolytic toxins (DeLeo et al., 2011). The clone has been endemic in 
UK hospitals for over 20 years, although the prevalence has declined rapidly in 
recent years, partly as a result of changes in infection control and antibiotic 
prescribing regimens (Ellington et al., 2010; Knight et al., 2012; Wyllie et al., 2011).  
EMRSA-16 has been reported less commonly throughout Europe, Southeast Asia, 
South Africa, Australia, and North America (Carleton et al., 2004; Ho et al., 2009; 
Jansen van Rensburg et al., 2011; Pérez-Roth et al., 2004; Robinson et al., 2005a; 
Scicluna et al., 2010). 
 
Previously, the SWP clone was proposed to be a re-emergence of the phage type 
80/81 clone after acquisition of SCCmec-IV, and this hypothesis was supported by a 
 19 
combination of MLST and spa typing, along with comparison of the surface 
associated and virulence proteins carried by each clone (Diep et al., 2006; Robinson 
et al., 2005a).  The same model of CC30 evolution proposed that the EMRSA-16 
clone evolved, through the acquisition of SCCmec-II, in parallel with the 
community-associated lineages from a PVL negative ancestor, leading to the 
emergence of EMRSA-16.  However, a recent study based on phylogenetic 
reconstruction and comparative genome sequence analysis of 9 CC30 isolates 
demonstrated that the SWP clone is not a direct descendent of the phage 80/81 clone, 
but that each clone has evolved from a single ancestral strain that gave rise to all 
three CC30 pandemics, and the strains responsible for the TSS epidemic (DeLeo et 
al., 2011).  While DeLeo and colleagues demonstrated that the EMRSA-16 lineage 
have mutations in agr and hla genes that lead to reduced virulence in mouse models 
of infection, these mutations are also present in isolates from TSS infections in the 
community, indicating that they are not sufficient for restriction to the hospital 
environment (DeLeo et al., 2011). 
 
An understanding of the basis for the niche adaptation of each CC30 lineage is 
currently lacking, and comparative genomic analysis of CC30 strains could yield 
important insights into the molecular processes underlying the emergence of 
pandemic lineages. 
 
The repeated global emergence of S. aureus clones that have a major public health 
and economic costs highlights the need to understand the molecular correlates 
driving emergence and expansion.   
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1.3. Legionella pneumophila 
L. pneumophila is a Gram-negative, aerobic, non-capsulated bacillus (Heuner et al., 
2008).  Over 50 Legionella species have been identified, over half of which have 
been associated with human disease (Fields et al., 2002).  L. pneumophila is a 
ubiquitous intracellular pathogen of environmental protozoa that inhabits soil and 
freshwater reservoirs (Rowbotham, 1980).   
 
L. pneumophila was first isolated in 1976 following an outbreak of pneumonia 
among attendees of a convention of the American Legion at a hotel in Philadelphia, 
in which 182 people were infected and 29 died (Fraser et al., 1977; McDade et al., 
1977).  L. pneumophila can cause a spectrum of diseases, termed legionellosis, 
although some individuals can seroconvert without displaying any symptoms 
(Rudbeck et al., 2009).  Pathogenesis is mediated through the intracellular replication 
of L. pneumophila in human phagocytes and the Icm/Dot type IVB secretion system 
delivering effector proteins to the host cell (Luo et al., 2004; Nagai et al., 2002; 
Zusman et al., 2003).   Fusion of the phagosome and lysosome is prevented, 
inhibiting vacuole acidification and allowing proliferation of the bacteria leading to 
cell death by apoptosis, or necrosis mediated by pore-forming toxins (Gao et al., 
1999; Sadosky et al., 1993; Tateda et al., 2003). 
 
Legionellosis only occurs when an individual inhales an aerosol containing L. 
pneumophila and there have been no reported cases of onward transmission from 
infected individuals, suggesting that the environment is exclusively responsible for 
the infection source (Katz et al., 1982).  The risk of aerosolisation increases with 
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high levels of L. pneumophila in water reservoirs, which can occur if water 
reservoirs are not maintained to a high standard (Rogers et al., 1994).  L. 
pneumophila can persist in biofilms, and is more readily cultured from biofilm 
samples than from flowing water, suggesting that biofilm removal is an important 
measure for control of L. pneumophila levels in water reservoirs (Rogers et al., 
1994).  Several man-made water systems have been found to contain L. 
pneumophila, including cooling towers, hot tubs, and nebulizers (Mastro et al., 1991; 
Nguyen et al., 2006; Orrison et al., 1981; Thomas et al., 1993). 
 
Increased temperature and increased vapour pressure are significantly associated 
with aerosolisation (Conza et al., 2013), while incidence of legionellosis is greater 
during the summer season (Fisman et al., 2005; Li et al., 2002) and during periods of 
increased humidity (Fisman et al., 2005).  Distance from the environmental source 
(Nguyen et al., 2006), wind direction (White et al., 2013), and the L. pneumophila 
dose that an individual is exposed to (Brown et al., 1999) are important risk factors 
for infection.   
 
The non-fatal Pontiac fever form of legionellosis presents with symptoms similar to 
acute influenza (Fraser et al., 1979), while the more severe Legionnaires’ disease 
(LD) presents as a pneumonia and has a case fatality rate of up to 34 % (Benin et al., 
2002).  Clinical manifestations are variable between patients, and are of limited use 
for diagnosing Legionnaires' disease.  Therefore, a diagnosis of legionellosis can 
only be made based on the results of appropriate laboratory tests, such as the urinary 
antigen test, in patients presenting with pneumonia. 
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Human susceptibility to L. pneumophila infection is heterogeneous within the 
population, with smoking, older age, diabetes, malignancy, AIDS, and end stage 
renal disease being significantly associated with developing LD (Marston et al., 
1994).  Mortality as a result of LD has a significant association with older age, male 
gender, immunosuppression, end stage renal disease, and nosocomial acquisition of 
disease (Marston et al., 1994). 
 
The incidence rate of legionellosis is variable between countries.  In Scotland the 
annual incidence rate of legionellosis was 4.8/1,000,000 in 2009 and 3.4/1,000,000 
in 2010.  By comparison, the incidence rate across Europe is considerably higher, 
averaging 11.8/1,000,000 during 2007-08 and 11.2/1,000,000 in 2009 (Potts et al., 
2011). 
 
1.3.1. Genome organisation of L. pneumophila 
The genome of L. pneumophila is approximately 3.4 Mb in length, representing 
approximately 3,000 CDSs (Cazalet et al., 2004; Chien et al., 2004a).  Analysis of 
the available L. pneumophila whole genome sequences indicates that there has been 
substantial horizontal gene transfer among L. pneumophila strains (D’Auria et al., 
2010; Glöckner et al., 2008), and moreover several homologs of eukaryotic genes 
have also been identified in their genome (Cazalet et al., 2004; Chien et al., 2004b).   
A previous analysis of 5 whole genome sequences of L. pneumophila demonstrated 
that 67 % of the total identified CDSs are conserved in all strains, while 33 % are 
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part of a dispensable accessory genome (D’Auria et al., 2010), indicating a high level 
of genomic plasticity within the species. 
 
Type IV secretion systems (T4SS) are complexes of proteins that are required for 
conjugation-mediated genetic exchange, and can deliver effector proteins into host 
cells during infection (Fronzes et al., 2009); they are variably present among the 
sequenced L. pneumophila strains (D’Auria et al., 2010; Glöckner et al., 2008).  
Three families of T4SS have been identified, including T4ASS, T4BSS and the 
genomic island-associated T4SS (GI-T4SS) (Juhas et al., 2007).  Among the 
sequenced L. pnueumophila strains, 3 T4ASSs have been described; Lvh, Trb-1 and 
Trb-2 (Glöckner et al., 2008).  The Lvh T4ASS has a role in host-cell entry and 
intracellular replication (Bandyopadhyay et al., 2007), and contributes to 
establishment of infection at lower temperatures (Ridenour et al., 2003).  The roles of 
the Trb-1 and Trb-2 T4ASS remain to be determined, but a recent study showed that 
Trb-1 is not required for intracellular replication of L. pneumophila (Lautner et al., 
2013). 
 
The Dot/Icm system is encoded by a T4BSS and is essential for intracellular 
replication by translocating effector proteins into the host cell cytoplasm (Luo et al., 
2004; Nagai et al., 2002; Zusman et al., 2003).  The functions of many of the effector 
proteins are unclear, but a large number show significant homology to eukaryotic 
proteins (Brüggemann et al., 2006; Cazalet et al., 2004; Gomez-Valero et al., 2011), 
which may allow L. pneumophila to modulate the host response through structural 
mimicry of host components (Lomma et al., 2009). 
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1.3.2. Investigation of outbreaks of legionellosis 
Due to the threat posed to public health by L. pneumophila infection, determining the 
source of a legionellosis outbreak is critical in order for appropriate control measures 
to be implemented.  Sources are identified through a combination of typing and 
epidemiological methods.  There are 16 identified serogroups (Sg) of L. 
pneumophila, Sg 1, 3 and 6 being most associated with human disease, with Sg 1 
responsible for approximately 80 % of reported legionellosis in humans (Fields et al., 
2002).  L. pneumophila isolates of Sg 1, 4 and 5 can be assigned a monoclonal 
antibody (mAb) subgroup by indirect immunofluorescence or ELISA methods (Lück 
et al., 2013).  Further, a DNA sequence based typing (SBT) scheme using the 
nucleotide sequence of 7 loci under diversifying selection can be used to allocate an 
unambiguous sequence type (ST) to L. pneumophila isolates (Gaia et al., 2005; 
Ratzow et al., 2007).   
 
Spatial analysis of cases, combined with knowledge of meteorological conditions can 
suggest a likely water reservoir as a source (McCormick et al., 2012; White et al., 
2013), which can then be confirmed if the Sg, mAb type, and SBT of L. pneumophila 
from that source are concordant with the isolates from clinical cases.  The application 
of whole genome analysis to L. pneumophila outbreaks has the potential to greatly 
improve the understanding of both the epidemiology and the biology of a pathogen 
with an important impact on public health.   
   
Recently, whole genome sequencing has been used in an attempt to determine the 
source of an outbreak of L. pneumophila in Hampshire, UK, which resulted in a total 
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of 26 cases of LD over a 3 week period in 2003.  Traditional typing methods 
implicated 2 cooling towers on a single site as the likely source of the outbreak 
(Reuter et al., 2013).  The retrospective application of whole genome sequencing of 2 
outbreak strains and 4 environmental strains isolated at the time of the outbreak 
facilitated the identification of a close phylogenetic relationship between isolates 
from the cooling towers and isolates from patients.  However, an isolate obtained 
from a domestic spa pool also clustered with the outbreak strains, meaning this site 
cannot be ruled out as a source of the outbreak.  An isolate from a cooling tower on a 
separate site was phylogenetically distant to the outbreak strains and had previously 
been eliminated as being the likely source due to its distinct monoclonal antibody 
subgroup type (Reuter et al., 2013). 
 
The high case fatality rate associated with LD means that outbreaks must be rapidly 
contained through the identification and treatment of environmental sources.  The 
impact of whole genome sequencing on the understanding of L. pneumophila 
outbreaks remains to be thoroughly assessed, but it may be able to provide useful 




1.4. Bacterial population genetic methods 
Population genetics is the study of allele frequency within a population, and of the 
change in genetic composition within a population through processes including 
genetic drift, recombination and natural selection. Therefore, population genetic 
analysis can give an insight into the evolutionary history of an organism and inform 
on correlates of niche adaptation and population divergence (Okasha, 2012). 
 
Traditional typing techniques employed by epidemiologists studying bacterial 
pathogen populations suffer from a number of limitations.  Genetic fingerprinting 
methods such as pulsed field gel electrophoresis (PFGE) and enterobacterial 
repetitive intergenic consensus polymerase chain reaction (ERIC-PCR) are difficult 
to standardise between laboratories, are prone to subjective interpretation, and may 
not be applicable to some bacterial species due to degradation of genomic DNA by 
endonucleases during electrophoresis (Sampaio et al., 2006; van Belkum et al., 
1998). 
 
Typing methods based on DNA sequence offer an unambiguous means of typing 
bacterial strains, but are also not without limitations.  For example, staphylococcal 
protein A (spa) typing method is based on differences in tandem repeats in the major 
Staphylococcus aureus surface protein A, SpA, and is inexpensive and reproducible 
between laboratories (Koreen et al., 2004).  However, spa typing suffers from a lack 
of discriminatory power (Cookson et al., 2007) and incorrect clonal complex 
assignments have been reported due to homoplasies (Schouls et al., 2009). 
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Multilocus sequence typing (MLST) assigns an isolate to a clonal complex based on 
the nucleotide sequence of internal fragments of 7 housekeeping genes found in the 
core genome.  Each sequenced fragment is assigned an allele number, and the 
combination of alleles at the seven housekeeping loci defines the ST of the isolate 
(Maiden et al., 1998).  MLST has advantages over other methods, as the level of 
sequence diversity at the housekeeping loci within a bacterial species is sufficient for 
billions of potential sequence types to be assigned, and at the time of writing there 
are over 2,700 assigned STs of S. aureus.  MLST has been widely adopted and 
applied to the study of the evolution and epidemiology of major human pathogens 
including S. aureus (Enright et al., 2000), Helicobacter pylori (Wirth et al., 2004), 
and Streptococcus pneumoniae (Enright et al., 1998).  It is particularly useful for 
examining species-wide population structure, but is limited when examining 
diversification over short timescales, such as in outbreak investigations, as there is 
unlikely to be sufficient accrued sequence variation among the MLST loci to 
determine likely sources or transmission pathways.  
 
Furthermore, strains of the same ST often have remarkably different phenotypes 
related to virulence, resistance, and tissue/host tropism.  Specialist phenotypes often 
arise through expression of genes encoded by accessory elements, which can be 
rapidly acquired by or lost from a population.  Therefore 2 closely related isolates, 
with conserved core genomes, as assessed through traditional typing methods, might 
be phenotypically very divergent.  WGS offers a high-resolution view of the whole 
genome of an isolate, and important differences in accessory genome content can be 
identified.  As an example, the isolates MW2 and MSSA476 are both typed as S. 
 28 
aureus ST1 by MLST.  Both isolates belong to a highly virulent clone of S. aureus 
and infected immunocompenent individuals in the community, but were associated 
with very different pathologies (Baba et al., 2002; Holden et al., 2004).  MW2 
caused a fatal bacteraemia, whereas MSSA476 was responsible for an osteomyelitis 
from which the patient made a full recovery. These differences in disease outcome 
could be as a result of differing host factors, or may be attributable to five large scale 
genome changes leading to increased virulence of MW2.  Among these large scale 
changes are the acquisition by MW2 of SCCmec, leading to multidrug resistance, 
and a phage encoding the PVL loci, which is a marker for community-associated 
clones of S. aureus with elevated levels of virulence (Diep et al., 2010).   
 
1.5. Genomic epidemiology 
The ability to rapidly sequence large numbers of bacterial genomes is revolutionising 
the study of bacterial population genomics, evolution, and epidemiology.  While 
previously WGS of bacterial isolates represented a picture of a single organism at a 
given point in time, it is now possible to study the extent of variation within a 
pathogen population through space and time.   
 
These advancements have been made possible through the rapid pace of 
development of sequencing technologies that have seen a shift away from using 
conventional Sanger sequencing for WGS of bacterial pathogens (Metzker, 2010).  
High-throughput technologies such as Illumina’s HiSeq, Roche’s 454 GS-FLX+, and 
Pacific Biosystems RS platforms have the capacity to generate enormous volumes of 
sequence data rapidly and economically (Loman et al., 2012a).  Additionally, the 
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availability of high-throughput benchtop sequencers such as the Illumina MiSeq, 
Roche 454 Junior, and Life Biosciences Ion PGM are offering the ability to rapidly 
sequence pathogens to clinical and basic science research labs outside of specialist 
sequencing centres (Eyre et al., 2012; Loman et al., 2012b).  Increasingly, modern 
infectious disease epidemiology is making use of the higher level of resolution 
afforded by WGS to enhance the understanding of epidemiology over varying scales.  
It is now possible to study the evolution of a pathogen during infection of a single 
patient, reconstruct transmission pathways during outbreaks, and to elucidate the 
molecular mechanisms underpinning the emergence of successful epidemic or 
pandemic clones. 
 
1.5.1. Within-host evolution 
The dynamics between pathogen and host during infection determine disease 
progression.  Our understanding of bacterial evolution during infection has lagged 
behind that of infecting virus populations due to the lower mutation rate and the 
prohibitive costs associated with WGS of bacteria.   
 
A number of studies of the genome sequences of HIV isolated from a single patient 
have shown that it is possible to draw clinically relevant conclusions about the rate of 
disease progression from the mutation rate of the virus (Lemey et al., 2007; Mikhail 
et al., 2005).  Specifically, Lemey and colleagues identified that increased 
synonymous substitution rates were associated with shorter virus generation times 
and more rapid disease progression (Lemey et al., 2007).  This finding can directly 
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impact on clinical practice, by identifying patients at high risk of progressing from 
HIV to AIDS, allowing treatment to be tailored appropriately. 
 
Recently, WGS studies of bacterial populations within a single host have offered 
valuable insights into the evolutionary processes during the course of colonisation 
and infection (Bryant et al., 2013; Golubchik et al., 2013; Lieberman et al., 2011; 
Mwangi et al., 2007; Smith et al., 2006; Young et al., 2012). Within a single host, 
‘clouds’ of genetic heterogeneity have been described for pathogens including S. 
aureus, Mycobacterium tuberculosis, Mycobacterium abscessus, and Burkholderia 
dolosa, due to diversification of the bacterial population during carriage or infection 
(Bryant et al., 2013; Ford et al., 2011; Harris et al., 2013; Lieberman et al., 2011; 
Young et al., 2012).  Over time, as colonisation or infection progresses, random 
mutations become fixed due to host-specific selective pressures including coinfection 
with other microorganisms, the host immune system, and antimicrobial therapies 
(Lieberman et al., 2011; Mwangi et al., 2007; Smith et al., 2006; Young et al., 2012; 
Zdziarski et al., 2010).  In particular, a common phenomenon of persistent bacterial 
infection is the emergence of reduced virulence, antibiotic resistant bacteria 
associated with chronic infection and low mortality (Gao et al., 2010; Smith et al., 
2006).  For example, a comparative genomic study of Pseudomonas aeruginosa 
during chronic infection of a cystic fibrosis (CF) patient revealed a strong signal of 
genome-wide positive selection indicated by a dN/dS ratio of 1.4 (Smith et al., 
2006).  Of note, about 25 % of all mutations acquired over 96 months resulted in 
pseudogene formation through nonsense mutations leading to premature stop codons, 
frameshifts, transposon insertions or gene deletion events.  Importantly, expression 
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of numerous virulence factors was selected against, reflecting a shift from acute 
infection towards an enhanced ability to cause chronic inflammation (Smith et al., 
2006).   
 
Similarly, loss of virulence factor production, associated with evolution towards 
commensalism has been described in multiple independent patients undergoing 
therapeutic bladder colonisation with the prototype asymptomatic bacteriuria strain 
E. coli 83972 for the treatment of recurrent urinary tract infections (Zdziarski et al., 
2010).  Sequencing of isolates recovered from the patients at sequential time points 
post-inoculation revealed numerous mutations relative to the progenitor strain, with 
an overall trend to reduced virulence and adaptation to oxidative stresses (Zdziarski 
et al., 2010).  A number of mutations were unique to each host, and were recurrently 
observed in isolates obtained after repeat inoculation events in each patient, 
suggesting that the unique niche of each host strongly influenced the microevolution 
of the inoculated strain (Zdziarski et al., 2010).  These data suggest that pathogens 
evolve differently in individuals, implying that personalised therapeutic regimes 
could be effective for the treatment of bacterial infections.   
 
Conversely, convergent evolution in genes associated with antibiotic resistance and 
virulence has been observed during infection of multiple patients with P. aeruginosa 
and B. dolosa (Lieberman et al., 2011; Wong et al., 2011), and an understanding of 
the bacterial loci under selection in multiple patients can inform on treatment 
regimes and suggest targets for novel therapeutics. 
 32 
Acquisition of antibiotic resistance during infection, and the underlying molecular 
mechanism, has been demonstrated in S. aureus through the use of WGS of 
sequential isolates obtained from a patient undergoing antibiotic therapy for infective 
endocarditis (Mwangi et al., 2007).  Comparison of isolates obtained pre- and post- 
antimicrobial therapy with rifampin, imipenem, and vancomycin revealed a total of 
35 point mutations in 31 loci, including 6 loci that had previously been implicated 
with increased resistance to a range of antibiotics (Mwangi et al., 2007).  
Importantly, the ability to track the in vivo evolution of sequential drug resistance has 
the potential to inform bespoke prescription regimens with the aim of minimising the 
emergence of antibiotic resistance traits. 
 
As part of a long-term carriage study, Young et al. sequenced a total of 68 colonies 
of S. aureus isolated from 6 nasal swabs and a blood culture from a single patient 
with an ultimately fatal bacteraemia over a 13 month period (Young et al., 2012).  30 
polymorphisms were identified over the course of the study, a sufficient level of 
diversity for 3 clusters to be identified in a maximum-likelihood phylogenetic 
reconstruction representing isolates from early nasal carriage, late nasal carriage, and 
invasive bloodstream infection, respectively.  Strikingly, only 8 mutations separated 
late nasal carriage strains from strains isolated from the bloodstream, 50 % of which 
resulted in the premature truncation of protein coding genes.  The authors speculate 
that 1 of these mutations, in an AraC-family transcriptional regulator may have 
resulted in an increased potential for pathogenicity, and played an important role in 
disease progression.  The study clearly demonstrates the potential of whole genome 
sequencing for understanding the transition from commensal to pathogen, although 
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the feasibility of applying this methodology to larger cohorts remains to be 
determined. 
 
It is important to understand the selective forces acting on a bacterial population 
within the host, and how they drive the evolutionary processes leading to adaptation 
to long-term colonisation and persistence, or from commensal to pathogen. 
 
1.5.2. Using WGS to investigate outbreaks of bacterial infection 
1.5.2.1. Identification of transmission events during localised outbreaks 
Traditional typing methods for bacterial pathogens are often unable to discriminate 
between closely related strains, and are of limited use in tracing transmission routes 
during outbreaks.  The high-resolution afforded by bacterial WGS means that the 
distribution of genetic polymorphisms within a population of microbes can be used 
to determine the spread of a pathogen in space and time (Eyre et al., 2012; Gardy et 
al., 2011; Köser et al., 2012; Lewis et al., 2010). 
 
Analysis of the variation among bacterial genome sequences can identify potential 
transmission events between the hospital and community environments.  The 
relatedness of S. aureus isolates obtained from 5 patients sharing a ward together for 
overlapping periods of 1-2 days, and one from a relative of one of the patients were 
assessed using spa and PFGE typing (Eyre et al., 2012).  The spa and PFGE profiles 
were indistinguishable, and given the prolonged timescale of isolate collection these 
typing methods were insufficient to determine whether the outbreak isolates were 
derived from a point source, or circulating in the community.  A single polymorphic 
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site was identified within the core genomes of the 6 isolates, suggesting a point 
source for the infection in the very recent past (Eyre et al., 2012). 
 
Köser et al. investigated an outbreak of MRSA in a neonatal unit (Köser et al., 2012). 
MRSA isolates from 7 patients suspected of being part of the outbreak were 
sequenced, in addition to isolates from 7 patients that did not have an 
epidemiological link to the outbreak.  Genomic analysis revealed all of the outbreak 
strains, as well as 3 non-outbreak strains to be ST22, and a total of 102 polymorphic 
sites separated the outbreak strains from non-outbreak strains.  This high-resolution 
view allowed the authors to determine that the outbreak was self-contained, and that 
transmission of these strains was limited to the neonatal ward.  In addition, a full 
profile of resistance and virulence determinants could be identified from the 
sequence data, further illustrating the utility of whole genome sequencing in a 
clinical setting (Köser et al., 2012). 
 
Based on the results of multiple locus variable nucleotide tandem repeats analysis, a 
clonal population of M. tuberculosis was believed to be responsible for a sustained 
outbreak of tuberculosis in Canada (Gardy et al., 2011).  WGS analysis revealed the 
existence of 2 extant circulating lineages, and integration of sequence data with 
social network information identified an at-risk population of crack cocaine users 
that maintained transmission of the outbreak.  The combination of epidemiological 
and WGS data revealed the dynamics of the outbreak, information which could allow 
for targeted interventions to be designed, such as breaking transmission chains by 
treating highly connected individuals. 
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Often, the identification of outbreak isolates, and therefore the dynamics of the 
outbreak, can be obscured due to phenotypic differences between isolates that may 
have arisen due to horizontal gene transfer.  Sequence analysis of the core genome 
offers an unambiguous method for determining the relatedness of isolates.  For 
example, an outbreak of S. aureus on a single ward showed differences in the 
antibiotic sensitivity profiles between the isolates, despite identical spa and PFGE 
profiles, leading investigators to question whether multiple strains were circulating 
(Eyre et al., 2012).  Application of WGS to 10 isolates from 8 affected individuals 
revealed a total of 4 variable sites in the core genomes of the isolates, providing 
strong evidence of an outbreak from a point source.  Differences in resistance 
profiles in 2 isolates had initially caused confusion as to their origin, but this 
variation was found to be due to the carriage of resistance determinants on 2 
plasmids (Eyre et al., 2012). 
 
Through combining epidemiological data with analysis of bacterial population 
genome sequences, it is possible to infer the directionality of transmission in certain 
scenarios.  Phylogenetic methods have long been applied to viral sequences, and 
have elucidated pathways of patient to patient transmission for HIV (Ou et al., 1992) 
and hepatitis C virus (Heinsen et al., 2000).   One way to infer direction is based on 
patterns of genetic diversity within bacterial populations causing chronic infection.  
For example, analysis of B. dolosa genome sequences from 112 isolates from 14 CF 
patients over 16 years revealed that between patient transmission events could be 
inferred from the phylogenetic tree based on polymorphisms shared in isolates 
 36 
obtained from different patients (Lieberman et al., 2011).  A study of individuals 
with M. abscessus subspecies massiliense pulmonary infections identified greater 
diversity among isolates from a single patient, than among isolates from different 
patients (Bryant et al., 2013), strongly suggestive of between patient transmission of 
this pathogen.  Additionally, isolates with high levels of macrolide resistance were 
obtained from 3 patients that had not previously received treatment with this class of 
antibiotic, providing further evidence for transmission between patients (Bryant et 
al., 2013). 
 
Routine outbreak investigation can benefit greatly from the discriminatory power of 
WGS, and the integration of rapid sequencing of suspected outbreak strains can lead 
to changes in clinical practice and improved infection control.  Harris et al. 
demonstrated that it is possible to infer transmission events within the hospital, and 
between hospital and community settings (Harris et al., 2013).  A total of 34 
polymorphisms between 24 isolates collected from a single neonatal ward confirmed 
that the isolates were part of a single prolonged outbreak.  Interrogation of hospital 
records determined possible routes of transmission outside of the neonatal unit, with 
epidemiological links between parents of infants on the neonatal unit being 
established.  However, the isolates had been sampled over a timeframe that included 
3 periods in which the ward was determined to be free of MRSA.  Persistence of the 
outbreak strain led the investigators to believe that an asymptomatically colonised 
healthcare worker was responsible for repeated transmission to patients.  20 isolates 
from a staff member positive for MRSA colonisation were sequenced and segregated 
into two groups.  One group showed a close phylogenetic relationship to isolates 
 37 
from before an MRSA-free period, and the other group most closely related to an 
isolate obtained after this time, strongly implicating the healthcare worker in 
transmission of MRSA over the course of the outbreak.  Subsequent to 
decolonisation of the healthcare worker, no further cases of MRSA infection with the 
outbreak strain were identified, highlighting the role that whole genome sequencing 
can play in managing outbreaks.  However, the possibility remains that the full level 
of diversity within each patient was not sampled, which could confound the findings 
of the study. 
 
Taken together, these results suggest that WGS can aid the investigation of outbreaks 
at a local scale, and are able to identify transmission events within the hospital, in the 
community, and across the nosocomial/community barrier. 
 
1.5.2.2. Identification of the emergence and spread of pandemic lineages 
Bacterial populations accumulate polymorphisms over time as a result of genetic 
drift.  Over appropriate timescales, the level of genetic heterogeneity is such that the 
population may be termed a measurably evolving population (MEP), allowing for the 
calibration of a molecular clock (Drummond et al., 2003; Gray et al., 2011; Holden 
et al., 2013).  Utilising the accumulated levels of genetic variation within globally 
disseminated clonal lineages of bacteria, it is possible to reconstruct the demographic 
history of an organism, and potentially identify the geographic region and time 
period of clone emergence.   
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The S. aureus ST239 lineage is a globally disseminated multidrug resistant clone 
endemic in hospitals in Asia, and has been responsible for epidemics worldwide 
(Aires de Sousa et al., 2003; Alp et al., 2009; Smyth et al., 2010).   Typing methods 
such as spa and PFGE typing provide a limited ability for discrimination of strains 
within a given location, as clonal expansion can lead to one strain dominating large 
geographic areas.  Analysis of genome sequences from 63 isolates identified 4,310 
polymorphisms within the core genome of these isolates.  Subsequent phylogenetic 
reconstruction resulted in a robust tree that demonstrated geographic clustering of 
isolates within the phylogeny, facilitating identification of transmission pathways 
(Harris et al., 2010).  Further analysis utilising a Bayesian framework estimated the 
median time of emergence for the clone as between 1957 and 1972, concordant with 
the introduction of methicillin as an anti-staphylococcal agent.  Furthermore, 
incorporation of spatial data into the model shows frequent intercontinental 
transmission events throughout the 1990s (Gray et al., 2011).  
 
Vibrio cholerae is the causative agent of cholera and has been responsible for 
multiple pandemics throughout recorded history.  The current 7th pandemic, caused 
by the El Tor biotype, has given rise to 3 independent, but overlapping waves 
(Mutreja et al., 2011).  WGS and phylogenetic reconstruction has identified several 
intercontinental transmission events, primarily emerging from a source population 
located in the Bay of Bengal (Mutreja et al., 2011).  Comparative genomic analysis 
of V. cholerae isolated from patients during an epidemic following the 2010 Haitian 
earthquake showed these isolates are highly similar to strains circulating in Nepal, 
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implicating the movements of Nepali peacekeepers for transmission of cholera 
(Hendriksen et al., 2011). 
 
The ability to identify global routes of bacterial pathogen transmission using WGS 
has the potential to inform on control measures to limit pandemic spread.  For 
example, rapid identification of a source of a bacterial outbreak, such as the Haitian 
cholera epidemic, could help shape the public health response, and reduce the burden 
of disease. 
 
1.5.3. Basis for the emergence of successful pathogenic lineages 
Many bacteria capable of opportunistically causing a range of pathologies are 
ordinarily commensals and colonise their host without causing disease (Knapp et al., 
1988; Tenaillon et al., 2010; Wertheim et al., 2005).  Understanding the processes 
that lead to the selection for and emergence of successful pathogenic lineages that 
harbour virulence factors, immune evasion factors, and antibiotic resistance 
determinants could aid in developing treatment regimes that minimise the selective 
pressures for the emergence of virulent clones. 
 
The 7th cholera pandemic has comprised 3 independent waves, with the emergence 
and spread of the latter 2 waves appearing to have been driven through the 
acquisition of the SXT antibiotic resistance element (Mutreja et al., 2011).  The SXT 
element encodes resistance to several antibiotic classes and its initial acquisition 
appears to have occurred at the transition between the first and second pandemic 
waves.  The success of the second, and subsequent, pandemics may in part be as a 
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result of the increased levels of resistance to the antibiotics commonly used to treat 
cholera during the first wave (Mutreja et al., 2011). 
 
It has been shown that invasive Salmonella Typhimurium strains in sub-Saharan 
Africa belong to 2 highly conserved lineages within MLST-defined ST313.  When 
compared in the context of a species-wide whole genome phylogeny to the highly 
diverse Salmonella Typhimurium strains circulating globally, it is clear that these 2 
sub-Saharan African lineages represent distinct epidemics of invasive disease.  
Independent acquisition of a transposon encoding multidrug resistance genes has 
been postulated as a reason for the success of these 2 lineages.  However, the rate of 
the molecular clock in these lineages reveals that the estimated time of clonal 
expansion of each lineage strongly correlates with peaks in HIV incidence in the sub-
Saharan population.  This suggests that the success of these lineages has been due in 
part to the increase in immune-compromised hosts in the areas of the invasive 
Salmonella Typhimurium epidemics (Okoro et al., 2012). 
 
During 2011, an outbreak of bloody diarrhoea and haemolytic-uraemic syndrome 
(HUS) centred in Germany and southwest France was found to be caused by a clone 
of E. coli O104:H4 following acquisition of a Shiga-toxin encoding prophage and a 
plasmid encoding an extended spectrum β-lactamase.  The acquisition of the Shiga-
toxin gene by the O104:H4 lineage led to the emergence of a highly virulent strain 
causing significantly higher rates of HUS and mortality than most Shiga-toxin 
producing E. coli (Frank et al., 2011; Rasko et al., 2011; Rohde et al., 2011). 
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Human clinical practices can have a direct effect on the emergence of bacterial 
lineages.  Phylogenetic analysis of 240 isolates representative of the globally 
disseminated Streptococcus pneumoniae PMEN1 lineage revealed high levels of 
recombination throughout the sampled population.  Notably, 10 events were 
identified that resulted in a change of capsule type, with 1 such event resulting in a 
dramatic population shift coinciding with the introduction of a conjugate 
polysaccharide vaccine to the USA (Croucher et al., 2011).  The vaccine escape 
serotype 19A has rapidly expanded, inhabiting the niche once occupied by vaccine-
susceptible serotypes, demonstrating a rapid nationwide spread from the northeast of 
the United States (Golubchik et al., 2012).  These data highlight the need to account 




It is clear that WGS of populations of bacterial pathogens has the potential to vastly 
increase the knowledge of the evolutionary processes underpinning the dynamics of 
pathogen evolution on a scale ranging from infection of a single host, to the host 
population level.  New insights gained from the study of pathogen evolution within a 
single host may aid decisions regarding appropriate clinical interventions.  At the 
host population level, the ability to reconstruct transmission pathways on local and 
global scales can identify risk factors for the spread of pathogens, leading to the 




1.7. Study aims 
This work will evaluate the application of WGS to evolutionary and epidemiological 
studies of important bacterial pathogens.  Specifically, the diversity among genome 
sequences from populations of S. aureus and L. pneumophila from individual hosts, 
L. pneumophila from a localised outbreak, and a pandemic clone of S. aureus will be 
examined in order to: 
 
 Investigate the evolution of S. aureus within a single infected patient. 
 
 Investigate the emergence and spread of the pandemic S. aureus CC30 
lineage. 
 
 Evaluate the use of whole genome sequencing for the resolution of a 




2. Adaptive evolution of S. aureus during 




Cystic fibrosis (CF) is an autosomal recessive condition caused by mutations in the 
CF transmembrane conductance regulator (CFTR) protein.  In healthy individuals the 
CFTR protein regulates transepithelial flow of ions, helping to maintain the proper 
ionic composition and volume of the airway surface fluid.  The dysfunctional CFTR 
of CF patients leads to a change in the composition of the surface fluid which renders 
these patients susceptible to chronic endobronchial infections (Kerem et al., 1989; 
Rommens et al., 1989a, 1989b).  At birth, the airways of CF patients are sterile but 
impaired mucociliary clearance, insufficient aeration of the paranasal sinuses and 
nasal polyps, along with frequent hospital visits mean CF patients are at particularly 
high risk of S. aureus infections (Gysin et al., 2000; Vu-Thien et al., 2010).  
Commonly, S. aureus is one of the earliest pathogens isolated from the sputum of CF 
patients, with a median time of first isolation of 214 days (range 120–309 days) 
(Souza et al., 2006).  In CF patients, it is the oropharynx rather than the anterior 
nares that is the predominant site of S. aureus infection and persistence (Ridder-
Schaphorn et al., 2007) and the upper airways have been identified as a reservoir 
allowing for recurrent infection of the lower airways by the same clone (Mainz et al., 
2009).  Further, longitudinal studies have shown that isolates belonging to the same 
lineage are repeatedly recovered from most CF patients, indicating chronic infection 
with a single strain (Branger et al., 1996; Vu-Thien et al., 2010).  During chronic 
infection, S. aureus is subjected to numerous selective pressures resulting from 
antibiotic interventions, the host immune system and co-infection of the airways with 
other microorganisms (Harrison, 2007).  Adaptive strategies of S. aureus are thought 
to involve the emergence of antibiotic-resistant, low-virulence, persistent phenotypes 
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(Goerke et al., 2010a; Kahl, 2010).  Of note, a switch to small colony variants (SCV) 
is often observed in persistent infections and is associated with higher levels of 
resistance to antibiotics (Besier et al., 2007, 2008; Goerke et al., 2010a; Tuchscherr 
et al., 2011). In addition, hyper-mutable S. aureus strains with a defective DNA 
mismatch repair system have been isolated from CF infections which promote 
adaptation to encountered selective pressures (Oliver, 2010; Prunier et al., 2003, 
2005).  However, the molecular basis for the adaptation of S. aureus to the CF 
airways is not well understood and lags behind research into the CF pathogen 
Pseudomonas aeruginosa (Hogardt et al., 2010).  For example, a comparative 
genomic study revealed evidence for selection acting across the whole P. aeruginosa 
genome, reflected in an adapted virulence phenotype with loss of function of factors 
required for acute infection but enhanced ability to cause chronic inflammation 
(Smith et al., 2006).  Previous genome-scale analyses of S. aureus evolution during 
infection revealed that most mutations were the result of the strong selective pressure 
of antibacterial chemotherapy but may also be associated with promoting persistence 
(Gao et al., 2010; Mwangi et al., 2007). 
 
2.2. Aims 
 To understand the mechanism of in vivo adaptive diversification of S. aureus 
during chronic infection of the CF airways. 






2.3. Materials and methods 
2.3.1. S. aureus strains 
Sequential S. aureus strains were obtained from the sputum of a CF patient over a 
period of 26 months (Table 2.1).  The strains had previously been characterised by 
PFGE, capsule- and phage-typing, and had been determined to belong to the same 
clone (Branger et al., 1996).  No additional information was available regarding the 
patient, or antibiotic treatment administered during the course of infection. 
 
2.3.2. S. aureus growth conditions 
For isolation of individual colonies, culture was streaked on tryptic soy agar (TSA) 
plates, and incubated for 16 h at 37°C. 
For growth to stationary phase, 5 ml tryptic soy broth (TSB) was inoculated with a 
single S. aureus colony and incubated for 16 h at 37°C with shaking at 200 rpm. 
S. aureus cultures were stored in glycerol at -80°C. 
 
2.3.3. S. aureus genomic DNA extraction 
DNA was isolated from a 1 ml volume of stationary phase culture of S. aureus 
following the standard manufacturer’s instructions using either the Bacterial 
Genomic DNA Purification Kit (Edge Biosystems, MD, USA), or the QIAcube 






2.3.4. Growth in chemically defined media 
To assess growth phenotype in nutrient depleted conditions, cultures grown in TSB 
overnight were used to inoculate chemically defined media (CDM) at a ratio of 200:1 
and incubated at 37°C, with shaking at 200 rpm as described previously (Pohl et al., 
2009).  OD was measured at 30 m intervals using a FLUOstar OPTIMA plate reader 
(BMG Labtech, Germany). 
 
CDM consisted of ʟ-tryptophan (100 mg/l), ʟ-tyrosine (100 mg/l), ʟ- phenylalanine 
(100 mg/l), ʟ-cysteine (50 mg/l), ʟ-histidine (100mg/l), ʟ-methionine (100 mg/l), ʟ- 
glutamine (200 mg/l), ʟ-glutamic acid (100 mg/l), glycine (100 mg/l), ʟ-proline (100 
mg/l), ʟ- isoleucine (100 mg/l), ʟ-leucine (100 mg/l), ʟ-threonine (200 mg/l), ʟ-valine 
(100 mg/l), ᴅʟ-alanine (100 mg/l), ʟ-arginine (100 mg/l), ʟ-aspartic acid (100 mg/l), 
ʟ-lysine (100 mg/l), hydroxy-ʟ-proline (100 mg/l), ʟ-serine (100 mg/l), ρ-
aminobenzoic acid (0.2 mg/l), biotin (0.2 mg/l), folic acid (0.8 mg/l), niacinamide (1 
mg/l), β-NAD (2.5 mg/l), pantothenate calcium salt (2 mg/l), pyridoxal (1 mg/l), 
pyridoxamine dihydrochloride (1 mg/l), riboflavin (2 mg/l), thiamine hydrochloride 
(1 mg/l), vitamin B12 (0.1 mg/l), adenine (20 mg/l), guanine hydrochloride (20 
mg/l), uracil (20 mg/l), K2HPO4 (200 mg/l), KH2PO4 (1,000 mg/l), NaH2PO4 (3,195 
mg/l), MgSO4 (700 mg/l), CaCl2 (10 mg/l), Na2HPO4 (9,214 mg/l) and glucose 
(10,000 mg/l).  Where indicated, ʟ-threonine was omitted for some experiments.  





2.3.5. Haemolytic activity assay 
Haemolytic activity of strains was assessed after overnight culture of isolates at 37°C 
on TSA supplemented with sheep blood (Oxoid, UK). 
 
2.3.6. Antibiotic sensitivity testing 
Sensitivity to antibiotics including penicillin, oxacillin, gentamycin, kanamycin, 
tobramycin, ciprofloxacin, erythromycin, clindamycin, linezolid, teicoplanin, 
vancomycin, tetracycline, tigecycline, nitrofurantoin, fusidic acid, mupirocin, 
chloramphenicol, rifampicin, and trimethoprim, was performed using the Vitek 2 
system (bioMérieux, Basingstoke, UK). 
 
2.3.7. Genome sequencing 
Genome sequencing was performed on the Illumina Genome Analyzer II platform.  
S. aureus strain ED83 was sequenced with 36 bp paired end reads, and strains ED84 
and ED86 were sequenced with 36 bp single end reads.  A mean coverage of 34.2 
was achieved (range 25.7–44.1).  Sequence reads for the 3 genomes have been 
deposited in the NCBI SRA database (accession number SRA038522). 
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Table 2.1 Origin and typing of strains used in this study 
Isolate Date of Isolation MLST Antibiogram Reference 
ED83 November 1983 30 Pn Branger et al., 1996 
ED84 October 1984 30 Pn Branger et al., 1996 
ED86 January 1986 30 PnFu Branger et al., 1996 
MLST, Multilocus Sequence Type; Pn, penicillin; Fu, fusidic acid 
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2.3.8. Sequence read alignment and identification of polymorphisms 
Prior to alignment, 3 bp were trimmed from the 5’ end of the sequence reads using 
the FASTX toolkit (Gordon, 2010), due to a GC % at these sites not consistent with 
the average GC % of the S. aureus genome. 
 
Reads were aligned to the complete genome sequence of MRSA252 (accession 
number NC_002952) using Maq v0.7.1 (Li et al., 2008) and point mutations were 
identified from the pileup output from Maq at sites that varied from the reference 
sequence with a mapping quality greater than 30.  Short insertions and deletions were 
identified using Novoalign (http://www.novocraft.com/main/index.php), with 
progressive trimming of unaligned single end reads by 2 bp to a minimum length of 
15 bp.  Polymorphisms were confirmed by Sanger sequencing of PCR products. 
 
2.3.9. Identification of genetic content absent from the reference genome 
Sequence reads that failed to map to the MRSA252 genome were assembled de novo 
using Velvet v0.7.63 (Zerbino et al., 2008), and protein-coding regions were 
identified through a BLASTx search against the NCBI non-redundant protein 
database with default settings.   
Regions of difference were identified among the sequenced isolates using BRIG 
v0.71 (Alikhan et al., 2011) with MRSA252 as a reference, and the consensus 





2.3.10. Phylogenetic analysis 
Maximum likelihood phylogenetic reconstruction was performed using RAxML 
v7.2.6 (Stamatakis, 2006) for all variable sites present in a nucleotide alignment of 
the study isolates and 5 representative CC30 strains (MRSA252 (Holden et al., 
2004), WW2703_97, BTN1260, M1016 (Robinson et al., 2005a) and 07_1973 
(McAdam et al., 2012)).  A GTR model of nucleotide substitution was applied with 
the gamma model of rate heterogeneity.  Support for nodes was assessed using 1000 
bootstrap replicates.  
 
2.4. Results 
2.4.1. Sequential isolates are clonally related 
In order to examine the microevolution of S. aureus during chronic endobronchial 
infection of a CF patient, the genomes of 3 sequential isolates obtained over 26 
months from the airways of single patient were sequenced.  In a previous study, the 3 
isolates had been identified as being clonally related through a combination of 
PFGE, capsule- and phage-typing (Branger et al., 1996).  Analysis of the MLST loci 
revealed each of the 3 isolates to belong to ST30, a globally distributed clone 
responsible for hospital and community associated epidemics over more than 6 
decades (DeLeo et al., 2011; Robinson et al., 2005a). 
 
Within the genomes of the 3 sequenced isolates a total of 23 point mutations and 15 
insertion/deletions (indels) were identified, consisting of polymorphisms in 31 
coding sequences and in 6 intergenic regions (Table 2.2).  Phylogenetic analysis of 
the 3 sequential CF isolates in comparison to 5 representative strains of the same 
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clonal complex (CC30), based on core genome point mutations, indicates that the 3 
CF isolates form a very narrow, distinct clade within the CC30 tree (Figure 2.1). 
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Figure 2.1 Unrooted maximum likelihood phylogeny based on core genome point mutations for the 3 CF isolates in 
comparison to 5 additional CC30 isolates.  MRSA252 is representative of hospital associated epidemic ST36 strains 
(Holden et al., 2004), WW2703_97 is an ST30 MRSA strain, BTN1260 and M1016 are methicillin sensitive (MSSA) ST30 
isolates from a global collection (Robinson et al., 2005a), 07_1973 is a PVL positive MRSA strain (McAdam et al., 
2012).  Scale bar represents a genetic distance of 40 polymorphisms.
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2.4.2. The within-host S. aureus population is genetically heterogeneous 
Of the 391 polymorphisms (376 point mutations and 15 indels) shared by the core 
genomes of all 3 isolates compared to the reference genome, none resulted in 
pseudogenes, and there were no mutations in the methyl-mismatch repair system 
(MutS and MutL) suggesting that the strains are not hypermutators. 
Importantly, all 23 point mutations and 14 of the 15 indels identified among the 3 
isolates were strain-specific, indicating clonal diversification of the original infecting 
strain leading to a genetically heterogeneous infecting population (Table 2.2). 
The great majority of point mutations in coding sequences (94.7%) were non-
synonymous, consistent with previous studies that have reported a high ratio of non-
synonymous to synonymous point mutations within clonal complexes, in contrast to 
a higher frequency of synonymous point mutations between clonal complexes 
(Rocha et al., 2006). 
 
2.4.3. Polymorphisms are found in loci associated with resistance, 
virulence and regulatory functions 
Point mutations and indels were discovered in genes influencing global regulation, 
virulence, metabolism, and antibiotic resistance (Table 2.2).   
 
In the last sequential isolate (ED86), 2 amino acid-altering point mutations were 
identified in the fusA gene encoding elongation factor G (EF-G) including a H457Y 
amino acid replacement previously demonstrated to confer fusidic acid resistance 
(Nagaev et al., 2001).  Although the mutation is associated with a marked 
impairment in the biological fitness of S. aureus, the growth phenotype of ED86 
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compared favourably with that of the fusidic acid-susceptible isolates ED83 and 
ED84 in CDM (Figure 2.2).  This may be due to a compensatory function of the 
second observed mutation, T187I, as has previously been reported in fusidic acid 
resistant strains of S. aureus (Nagaev et al., 2001).  Consistent with the presence of 
these mutations, isolate ED86 was resistant to fusidic acid.  All 3 isolates were 
resistant to penicillin but were sensitive to each of the other antibiotics tested.  
 
Several of the identified mutations were in genes that may impact on virulence. For 
example, CodY is a global regulator and a potent repressor of virulence that links the 
metabolic state of the cell with virulence factor expression (Majerczyk et al., 2010; 
Pohl et al., 2009).  The branched chain amino acid binding pocket of CodY is 
invariant in all finished S. aureus genome sequences available in the GOLD database 
(Figure 2.2).  The gene encoding CodY in the third sequential isolate ED86 contains 
a non-synonymous point mutation resulting in a M65I amino acid replacement in the 
wall of the hydrophobic binding pocket which forms prominent hydrophobic 
interactions with the side chains of the branched chain amino acid ligand (Figure 2.3) 
(Levdikov et al., 2006).  Of note, the ED86 isolate containing the M65I replacement 
has increased growth rate in CDM deficient in threonine in comparison to isolates 
ED83 and ED84 which both contain wild type CodY alleles (Figure 2.4), a growth 




Figure 2.2 Alignment of the N-terminal domain amino acid sequence of CodY from 32 finished S. aureus genomes 
and the ED86 isolate.  Invariant amino acids are highlighted in red.  Stars indicate sites that form prominent 
interactions with branched chain amino acids in the hydrophobic binding pocket of CodY, the purple start indicates 
the variable residue in ED86.  Secondary structure elements as identified in the crystal structure of CodY from 
Bacillus subtilis (PDB accession number 2B18) are indicated above the alignment.  The alignment was generated 
using the program ClustalX2 (Larkin et al., 2007) and produced in ESPript (Gouet et al., 1999).
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Figure 2.3 3D surface representation of the branched chain amino acid 
binding pocket of CodY (Levdikov et al., 2006).  The non-synonymous 
substitution observed in isolate ED86 results in an amino acid change 






Figure 2.4 Growth curve of S. aureus isolates ED83 (large colony), 
ED84, and ED86 (large colony) in chemically defined media lacking 



















2.4.4. Multiple independent polymorphisms in the SigB regulon suggest 
these loci are subject to strong selective pressures in this patient 
Multiple, independent polymorphisms were observed in all 3 isolates which would 
influence expression of SigB, a regulator of the general stress response that 
influences the expression of virulence factors.  Specifically, a frameshift mutation 
resulting in a sigB pseudogene in strain ED83, a frameshift mutation in SpoVG, a 
proposed modulator of SigB activity (Meier et al., 2007), and an 18 bp in-frame 
deletion in the rsbU regulator of SigB in ED84, were identified.  Comparison of the 
ED84 rsbU allele with the crystal structure of the Bacillus subtilis RsbU protein 
(PDB accession number 2J70) suggests that the 18 bp deletion is likely to impair the 
phosphatase activity of RsbU. 
In addition, SpoVG and the histidine kinase ArlS, which have been shown to impact 
SigB-dependent capsule formation (Meier et al., 2007), are affected by a non-
synonymous point mutation and a frameshift insertion respectively in the ED86 
isolate.  The parallel evolution of mutations at SigB-associated loci in the 3 isolates 
represent a 119-fold increase in mutation rate when compared to the mutation rate 
across the whole genome (p < 0.05).  In order to further investigate this phenomenon, 
the DNA sequence for SigB-associated loci rsbU, rsbV, rsbW, sigB, spoVG, arlS, 
and arlR was determined for a panel of 16 S. aureus isolates from 4 CF patients 
persistently colonized with S. aureus (Branger et al., 1996).  However, only 2 
mutations (non-synonymous substitutions in the spoVG and arlR loci in different 
isolates) were observed, and no pseudogene forming mutations were identified at any 
of the loci examined.   
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2.4.5. Phenotypic variation was observed in colony size, haemolytic 
activity, and growth rate in minimal media 
Subculturing of single colonies of isolates ED83 and ED86 onto TSA containing 
sheep erythrocytes resulted in 2 distinct colony sizes that differed in haemolytic 
activity (large colonies were haemolytic and small colonies were non-haemolytic) 
revealing an unstable in vitro phenotype (Figure 2.5).  Subculturing of ED84 yielded 
only one colony morphology (haemolytic) (Figure 2.5). 
A difference in the growth rates in CDM deficient in threonine was observed for 
large and small variants of ED83 and ED86, with the large variant of each isolate 
having at a faster growth rate than the small variant (Figure 2.6). 
Of note, fitness as assessed by growth in CDM lacking threonine has increased in 
isolates from later time points during infection (Figure 2.4). 
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Figure 2.5 Haemolytic activity on tryptic soy agar supplemented with sheep erythrocytes for (a) colony variants of 
ED83, (b) ED84 and (c) colony variants of ED86
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Figure 2.6 Growth curve of large (L) and small (S) variants of (a) ED83 and (b) ED84 in chemically defined media lacking 
































2.4.6. Phage content varies among the study isolates 
Examination of the genome sequence of isolate ED83 revealed 3 prophages 
including a 48.3 kb phage related to Sa2 of MRSA252, a 43.5 kb -converting 
phage encoding the secreted virulence factors staphylococcus enterotoxin A (SEA) 
and staphylokinase (SAK), and a 20.2 kb phage remnant with homology to NM4 of 
S. aureus strain Newman.  Comparative genomic analysis indicates that isolate ED84 
had lost the β-converting phage whereas isolate ED86 lacked the Sa2 homologue 
(Figure 2.7).  Consistent with absence of the -converting phage, strain ED84 
demonstrated haemolytic activity for sheep erythrocytes, indicating the presence of a 




Figure 2.7 Schematic genome diagram of ED83, ED84, and ED86 with 
reference to MRSA252.  Gaps in alignment correspond to mobile 
genetic elements that are annotated in the outermost ring.
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Table 2.2 Genetic polymorphisms identified among study isolates 
Isolate Polymorphism Polymorphism effect1 Locus 
ED83 Point mutation NSS Hypothetical protein 
ED83 Point mutation NSS yycG (Sensor kinase protein) 
ED83 Point mutation NSS Putative cobalmin synthesis protein 
ED83 Point mutation NSS Putative acetyl transferase 
ED83 2 point mutations in single codon NSS sucA (2-oxoglutarate dehydrogenase E1 subunit) 
ED83 1bp deletion Frameshift affecting 46.6% of protein Hypothetical membrane protein 
ED83 1bp insertion Frameshift affecting 18.5% of protein rpsI (30S ribosomal protein S9) 
ED83 1bp insertion Frameshift affecting 80.8% of protein Hypothetical protein 
ED83, ED86 1bp deletion - Intergenic region 
ED83 1bp deletion Frameshift affecting 13.4% of protein Hypothetical protein 
ED83 1bp deletion Frameshift affecting 23.1% of protein phoR (alkaline phosphatase synthesis sensor) 
ED83 1bp insertion Frameshift affecting 36.7% of protein sigB (RNA polymerase sigma factor SigB) 
ED84 Point mutation - Intergenic region 
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Isolate Polymorphism Polymorphism effect1 Locus 
ED84 Point mutation NSS ABC transporter ATP-binding protein 
ED84 Point mutation NSS glmM (putative phsphoglucosamine mutase) 
ED84 Point mutation - Intergenic region 
ED84 Point mutation NSS fnbA (Fibronectin-binding protein precursor A) 
ED84 Point mutation - Intergenic region 
ED84 1bp deletion Frameshift affecting 89.0% of protein spoVG (regulatory protein SpoVG) 
ED84 18bp deletion Deletion of 6 amino acids rsbU (putative sigB regulation protein) 
ED84 1bp insertion Frameshift affecting 85.4% of protein Hypothetical protein 
ED84 1bp insertion - Intergenic region 
ED84 1bp insertion Frameshift affecting 46.3% of protein Putative membrane protein 
ED86 Point mutation NSS spoVG (Regulatory protein SpoVG) 
ED86 Point mutation NSS fusA (Elongation factor G) 
ED86 Point mutation NSS fusA (Elongation factor G) 
ED86 Point mutation SS Hypothetical membrane protein 
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Isolate Polymorphism Polymorphism effect1 Locus 
ED86 Point mutation NSS codY (Transcriptional repressor CodY) 
ED86 Point mutation NSS infB (Translation initiation factor IF-2) 
ED86 Point mutation NSS Prephenate dehydrogenase 
ED86 Point mutation NSS Putative peptidase 
ED86 Point mutation NSS ald1 (Alanine dehydrogenase) 
ED86 Point mutation NSS moaB (Putative molybdenum cofactor 
biosynthesis protein B) 
ED86 Point mutation NSS Transcriptional regulator (antiterminator) 
ED86 56bp deletion - Intergenic region 
ED86 1bp deletion Frameshift affecting 97.4% of protein Hypothetical membrane protein 
ED86 1bp insertion Frameshift affecting 41.2% of protein arlS (Sensor kinase protein) 
1NSS; Non-synonymous substitution, SS; Synonymous substitution 
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2.5. Discussion 
With the ability to rapidly sequence bacterial pathogen populations, it is possible to 
carry out real-time studies of pathogen evolution during long-term infection. 
Genome sequencing of 3 sequential isolates from a single CF patient showed the 
isolates were clonally related, in agreement with results from PFGE, capsule- and 
phage typing methods (Branger et al., 1996).  However, the resolution afforded by 
whole genome polymorphism identification reveals that the level of diversity present 
within the infecting S. aureus population is consistent with evolution following a 
single transmission event (Golubchik et al., 2013).  
 
Pathogenic bacteria have a close association with their host, being subject to 
selective pressures resulting from co-infection with other microorganisms, the 
immune system of the host, and antibiotic therapies (Harrison, 2007).  Adaptive 
strategies of bacteria to long-term colonisation are thought to include the emergence 
of antibiotic resistant, low virulence phenotypes that are able to establish chronic 
infection, without causing mortality in the host (Gao et al., 2010; Mwangi et al., 
2007; Smith et al., 2006).  Selection for antibiotic resistant phenotypes, and the 
molecular mechanism behind the resistance, have been demonstrated in S. aureus 
through the use of whole genome sequencing of isolates obtained from a patient 
undergoing antibiotic therapy for infective endocarditis (Mwangi et al., 2007).  A 
comparative genomic analysis of an antibiotic sensitive isolate taken before the 
initiation of antimicrobial therapy with a resistant isolate obtained 3 months later 
after treatment with rifampin, imipenem, and vancomycin revealed a total of 35 point 
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mutations in 31 loci.  At least 6 loci had previously been implicated in conferring 
resistance to a range of antibiotics.   
The identification of a fusidic acid resistant phenotype in isolate ED86, and that this 
strain harbours an allele of fusA previously shown to confer resistance to fusidic acid 
(Nagaev et al., 2001) highlights the potential of sequencing technologies in the 
clinical setting.  It is now possible to obtain genome bacterial genome sequences in a 
clinically relevant timeframe (Köser et al., 2012), and it has been demonstrated that 
the antibiotic resistance profile of an important clone of S. aureus can be identified 
from the genome sequence alone, with an accuracy of 99.8% (Holden et al., 2013). 
 
The high percentage of non-synonymous polymorphisms identified in coding regions 
(94.7%) supports the hypothesis that mildly deleterious mutations are maintained in 
the short term.  However, the high proportion of non-synonymous mutations are 
likely, at least in part, to be the result of strong selective pressures that exist in the 
unique environment of the CF airways.  Evolution from pathogenicity to 
commensalism is beneficial for the long-term survival of a microbe during the course 
of chronic infection of the host.  Within the 3 study isolates, a number of 
polymorphisms are identified in regulators of virulence.   
 
Multiple, independent polymorphisms were found in the SigB regulon.  SigB is a 
regulator of the general stress response that influences the expression of virulence 
factors (Meier et al., 2007).  The level of pseudogene formation within this regulon 
suggests that a strong selective pressure is acting on these loci leading to beneficial 
phenotypes adapted to the environment of the CF airways. 
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Several previous studies have identified a role for SigB in the development of SCVs 
and in the regulation of transcription of virulence factors during infection of CF 
patients (Goerke et al., 2010b; Meier et al., 2007; Moisan et al., 2006).  Data from 
this study suggest that there may be selective pressure for attenuation or loss of SigB 
expression during long-term infection.  However, the screening of isolates from an 
additional 4 patients with chronic S. aureus infection did not identify any evidence 
for selection within the SigB regulon.  Taken together, these data suggest that the 
elevated mutation rate in SigB-associated loci in S. aureus isolates ED83, ED84 and 
ED86 is related to the genetic background of the strain or to patient-specific selective 
pressures, and is not broadly applicable to all CF S. aureus isolates.  Of note, clinical 
isolates of S. aureus with SigB deficiency have been reported previously (Karlsson-
Kanth et al., 2006).  Entenza and colleagues investigated the role of SigB in a rat 
model of infective endocarditis and discovered increased bacterial densities of SigB-
deficient strains after prolonged infective endocarditis infection suggestive of a 
selective pressure for reduced SigB activity during infection (Entenza et al., 2005). 
 
In addition to polymorphisms of the core genome, variation in the accessory genome 
of the isolates was observed.  Phage content was variable among the 3 isolates 
(Figure 2.7), indicating that phage deletion and/or acquisition events occur during S. 
aureus infection of the CF airways, consistent with previous findings (Goerke et al., 
2004).  By maintaining phages that encode secreted virulence factors in a 
subpopulation of the infecting bacteria, the metabolic costs to the infecting 
population as a whole are reduced in nutritionally-starved niches.   
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It remains to be determined whether the observed genetic changes in observed in 
isolates from CF patients result in changes in fitness and transmissibility outside of 
the host, but recent work has shown that genetic variants of P. aeroginosa that 
emerge during growth in persistent biofilms have impaired fitness outside of this 
niche (Penterman et al., 2014). 
 
2.6. Conclusions 
The whole genome approach to the study of chronic bacterial infection offers a high-
resolution view of the process of within-host adaptive evolution.  Understanding the 
molecular basis for changes in antibiotic resistance profiles and in virulence factor 
expression offers a platform for the development of rapid diagnostic assays and 
personalised therapies. 
 
Overall, the genome-scale identification of polymorphisms affecting antibiotic 
resistance, growth, and global regulation of virulence indicate a profound impact on 
the ecology of S. aureus during chronic infection. The identification of loci under 
selective pressure during chronic S. aureus infection may indicate novel therapeutic 








3. Evolution and epidemiology of a 
pandemic clonal lineage of S. aureus
 74 
3.1. Introduction 
Staphylococcus aureus is a component of the normal flora of about 30% of the 
human population, but is capable of causing severe infections of 
immunocompromised patients in hospitals and healthy humans in the community 
(Wertheim et al., 2005).  Hospital-associated methicillin-resistant S. aureus (HA-
MRSA) is represented by a small number of clones that rarely cause disease outside 
of the healthcare setting and that are characterised by resistance to β-lactam 
antibiotics, in addition to other front-line antimicrobials (Chambers et al., 2009). 
During the last 6 decades, the S. aureus clonal complex 30 (CC30) has had a 
profound impact on global human health by giving rise to three pandemic waves and 
the toxic shock syndrome (TSS) epidemic (Altemeier et al., 1982; Robinson et al., 
2005a).  Furthermore, one study indicated S. aureus isolates from life-threatening 
endocarditis infections are more likely to belong to CC30 than to other S. aureus 
lineages (Nienaber et al., 2011).  The first CC30 pandemic was caused by 
methicillin-sensitive phage type 80/81 clone in the 1950s and 1960s, which spread 
from hospitals causing a significant disease burden in the community and was 
characterized by resistance to penicillin and production of the PVL toxin (Donahue 
et al., 1966; Goldie et al., 1971; Nahmias et al., 1961). The Southwest Pacific clone 
(SWP) is a contemporary PVL positive community-associated MRSA clone, which 
has spread to several continents and which largely causes skin and soft tissue 
infections of otherwise healthy individuals (Alesana-Slater et al., 2011; Collignon et 
al., 1998).  In contrast to phage type 80/ 81 and SWP, the EMRSA-16 (ST36) clone 
appears to be restricted to the hospital setting and has reduced virulence due in part 
to low levels of expression of cytolytic toxins (DeLeo et al., 2011).  Along with the 
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EMRSA-15 (ST22) clone, EMRSA-16 has been endemic in UK hospitals for over 20 
years and has also been reported less commonly in other European countries, 
Southeast Asia, South Africa, Australia, and North America (Carleton et al., 2004; 
Ho et al., 2009; Jansen van Rensburg et al., 2011; Robinson et al., 2005a; Scicluna et 
al., 2010).  The high rate of MRSA infections and the rapid spread of HA-MRSA 
between UK hospitals led the UK government to introduce stringent infection control 
legislation from 2003, resulting in a decrease in rates of nosocomial MRSA 
infection.  Of note, EMRSA-16 prevalence has declined more rapidly than that of 
EMRSA-15, implying the existence of unknown strain-dependent factors that confer 
increased susceptibility to hospital infection prevention and control measures 
(Ellington et al., 2010; Wyllie et al., 2011).  Despite its clinical importance, the 
evolution of the EMRSA-16 clone, in addition to the molecular basis for its success 
are poorly understood.  A phylogenomic approach was used to examine the diversity 
of EMRSA-16 relative to other CC30 pandemic clones.  The results represent a high-
resolution insight into the emergence, expansion, and transmission of a major clone 
of MRSA, revealing unique molecular correlates for its hospital association. 
TSS is a severe toxinoses caused largely by S. aureus strains that produce the 
superantigen toxic shock syndrome toxin-1 (TSST-1) (Bergdoll et al., 1981).  The 
TSST-1 gene (tst) is encoded on the Staphylococcal Pathogenicity Island (SaPI2), 
which is variably present in the S. aureus population (Subedi et al., 2007).  A major 
epidemic of TSS caused largely by strains of S. aureus CC30 occurred in the 1970s-
80s in menstruating women using a particular brand of hyper-absorbent tampons 
(Fitzgerald et al., 2001; Shands et al., 1980), although TSS can occur in non-
menstruating women, and in males (Davis et al., 1980).  Although the incidence of 
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TSS in the population has fallen significantly since the 1980s, the disease still poses 
a significant clinical problem (DeVries et al., 2011; Osterholm et al., 1982). 
 
3.2. Aims 
 Determine the evolutionary history of the CC30 lineage. 
 Identify molecular correlates of CC30 pandemic lineage emergence and 
adaptation. 
 Improve the understanding of the diversity and transmission routes of 
EMRSA-16 relative to other CC30 clones. 
 Determine the distribution of TSST-1 within the CC30 lineage, and identify 
those clones responsible for causing TSS. 
 
3.3. Materials and methods 
3.3.1. Strains selected for this study 
In addition to 7 publicly available complete or draft CC30 genome sequences, a total 
of 80 S. aureus isolates were selected from a larger collection for genome sequencing 
to represent the breadth of genotypic diversity within the CC30 lineage sampled 
through time and space.  The genetic diversity of CC30 isolates was based on 
molecular typing methods such as pulsed field gel electrophoresis (PFGE), 
staphylococcal protein A (spA), and MLST, in addition to limited information 
relating to the distribution of selected virulence and antibiotic resistance 
determinants.  Strain collection was focused primarily on EMRSA-16 isolates from 
the United Kingdom.  The completed strain collection consisted of 87 isolates in 
total, including 30 isolates from England, 29 from Scotland, 12 from USA, 5 from 
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Australia, 3 from France, 2 from Denmark and Finland, and 1 each from Germany, 
Hungary, Republic of Ireland and Sweden.  The 80 isolates sequenced for the current 
study were typed by MLST as ST30 (n = 21) or its single locus variant (slv) ST36 (n 
= 58), with one isolate identified as ST500, a single locus variant of both ST30 and 
ST36. 
 
3.3.2. S. aureus growth conditions 
For isolation of individual colonies, culture was streaked on tryptic soy agar (TSA) 
plates, and incubated for 16 h at 37°C. 
For growth to stationary phase, 5 ml tryptic soy broth (TSB) was inoculated with a 
single S. aureus colony and incubated for 16 h at 37°C with shaking at 200 rpm. 
S. aureus cultures were stored in glycerol at -80°C. 
 
3.3.3. S. aureus genomic DNA extraction 
DNA was isolated from a 1 ml volume of stationary phase culture of S. aureus 
following the standard manufacturer’s instructions using either the Bacterial 
Genomic DNA Purification Kit (Edge Biosystems, MD, USA), or the QIAcube 
Bacteria (Gram +) protocol, with the addition of 5μl 100μg/ml lysostaphin to the cell 
lysis step. 
 
3.3.4. Whole genome sequencing 
Whole genome sequencing of bacterial isolates was performed by ARK-Genomics 
(The Roslin Institute, University of Edinburgh).  Sequencing libraries were prepared 
using the standard TruSeq or Nextera protocols for multiplexed single or paired end 
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reads (Illumina, San Diego, CA).  Short DNA reads were produced using the 
Illumina GA2 platform. 
 
3.3.5. Pre-assembly read processing 
Raw FASTQ files were examined for Illumina adaptor sequences using cutadapt v1.2 
(Martin, 2011) to facilitate removal of adaptor contamination.  The 5′ and 3′ ends of 
reads were trimmed to remove low quality scoring bases (Q <30) using Sickle v1.2 
(https://github.com/najoshi/sickle).  Reads containing low frequency sequencing 
errors were corrected with Quake v0.3 using a kmer size of 15 (Kelley et al., 2010). 
 
3.3.6. Mapping of sequence reads 
Reads from the previously sequenced ED83, ED84, ED86 (McAdam et al., 2011) 
and WW2703/97 (Thomas et al., 2011) isolates were included in this study.  Adaptor 
sequences were trimmed from Illumina reads using the ea-utils FASTQ processing 
tool (Aronesty, 2011).  Illumina reads were mapped to the ST36 MRSA252 genome 
sequence (Holden et al., 2004) using the Burrows–Wheeler short-read aligner 
(BWA) with the Smith–Waterman alignment of unmapped mates disabled for paired 
end reads (Li et al., 2009).  Reads generated on the 454 platform were trimmed using 
the Biopython SeqIO module and mapped to MRSA252 with the BWA long-read 
aligner (Li et al., 2010).  Consensus sequences were called and point mutations and 
insertions/deletions (indels) identified for sites covered by at least 3 reads, with 
average mapping and PHRED scores greater than 30.  Consensus genomes and 
whole genomes representative of the EMRSA-16 clone (MRSA252), SWP clone 
(TCH60, acc. no. CP002110.1), and other epidemic CC30 (MN8, accession number 
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CM000952.1) were aligned using the progressiveMauve algorithm and gap positions 
removed (Darling et al., 2010).  Sites in the core genome were defined as those sites 
present in all sequenced isolates. 
The presence of the PVL locus was assessed by mapping sequence reads to 
previously sequenced phage with either an elongated (ΦSa2958, accession number 
AP009363) or icosahedral (Φ108PVL, accession number AB243556) head 
morphology.  The presence of the SapI2 integrase and TSST-1 was assessed by 
mapping sequence reads to the SaPI2 sequence from strain RN3984 (accession 
number EF010993). 
 
3.3.7. Bayesian phylogenetic analysis 
Bayesian analysis of evolutionary rates and divergence times was performed using 
BEAST v1.6.1 (Drummond et al., 2007) with the Hasegawa–Kishino–Yano model of 
nucleotide substitution and a gamma correction for rate heterogeneity.  The SWP and 
Phage 80/81 clades were constrained together on the basis of a robust, maximum 
likelihood phylogeny rooted using an ST5 outgroup.  All isolates were dated on the 
basis of year and month (when known) of isolation.  Before carrying out the 
Bayesian analysis, the dataset was assessed for temporal signal using a linear 
regression of root-to-tip branch length against date of isolation for the maximum 
likelihood phylogeny (Figure 3.1).  Markov chain Monte Carlo (MCMC) samples 
from three independent analyses each run for 1.5 × 108 iterations, sampled every 
1,000 generations, with the first 10% discarded as burn-in, were combined for 
estimation of posterior probabilities.  The lognormal relaxed molecular clock model 
was used, as a Bayes Factor test favoured this over a strict clock, with a constant 
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coalescent prior (Drummond et al., 2006).  The presence of recombinant regions in 
the alignment was assessed using the phi test in the SplitsTree package (Huson et al., 
2006), and the consistency index for the phylogeny was calculated in PAUP 
(Wilgenbusch et al., 2003).
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Figure 3.1 Linear regression of root-to-tip branch length against date of 
isolation for the maximum likelihood phylogeny of CC30 was performed 
using Path-O-Gen v1.3 (http://tree.bio.ed.ac.uk/software/pathogen/).  
Gradient is equivalent to rate of molecular evolution. Gradient = 1.46E-6, 
R2 = 0.86 
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3.3.8. Bayesian phylogeographic analysis 
For an alignment of the UK isolates of the EMRSA-16 clone, phylogeographic 
distribution was examined using the discrete diffusion model (Lemey et al., 2009) 
with distance-informed priors and using the clock rate determined for the whole 
dataset.  Isolates were grouped by geographic region (London, southeast, south, and 
central England and north, east, and west Scotland).  A Bayes factor of 3.0 was set as 
the limit for significant links between locations. 
 
3.4. Results 
3.4.1. Phylogenetic analysis of CC30 strains reveals 3 distinct pandemic 
clades and a fourth associated with community-acquired infections 
The core genome of the 87 CC30 isolates examined consisted of 2,381,276 bases 
(82% of the MRSA252 reference genome), containing a total of 4,499 high-
confidence polymorphic sites.  The application of a Bayesian coalescent method 
using a relaxed molecular clock model to infer the phylogeny of the CC30 lineage 
indicated the existence of 3 major clades within the CC30 lineage, representative of 
the major pandemic clones, 80/81, SWP, and EMRSA-16, in addition to an EMRSA-
16 sister clade represented by other epidemic CC30 isolates (Figure 3.2).  There was 
strong posterior support for the majority of nodes in the tree and parsimony analysis 
indicated a low frequency of homoplasies across the phylogenetic tree (consistency 




Figure 3.2 Bayesian phylogenetic reconstruction of the CC30 lineage using all sites in core genome.  The lineage is 
divided into multiple distinct clades, characterised by the presence or absence of different virulence and 
antimicrobial resistance determinants.  Blue, green, red, and grey shading correspond to the 80/81, southwest 
Pacific, EMRSA-16, and other epidemic CC30 clones respectively.  Presence of the pvl loci is denoted by shaded 
black circles, tst carriage by shaded blue circles, intact crtM gene by shaded yellow circles, and SCCmec type is 
indicated for MRSA isolates.  Branch lengths are scaled with respect to time.  Nodes have posterior probabilities of 
>0.8 unless indicated with an asterisk.  Tip and node labels are shown in appendix 2.
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implemented in SplitsTree returned a p-value > 0.05, indicating the absence of 
significant levels of recombination in the dataset. 
 
3.4.2. Bayesian evolutionary analysis determines the rate of the molecular 
clock for CC30 and facilitates estimates of the times of emergence of 
pandemic clones 
The rate of the molecular clock was estimated simultaneously with the phylogeny.  
The mean nucleotide substitution rate within CC30 was 1.42 × 10−6 substitutions per 
site per year [95% highest posterior densities (HPDs) 1.04 × 10−6 to 1.80 × 10−6].  
Given the rate of molecular evolution determined for the CC30 lineage, the 
calculated time of the most recent common ancestor (MRCA) for each of the 3 major 
clades that correspond to the 3 pandemic CC30 clones was calculated.  The date for 
the MRCA of the 80/81 clone was estimated as 1936 (95% HPDs, 1926–1945), the 
date for the MRCA of the SWP clone was estimated as 1967 (95% HPDs, 1952–
1984), and the date for the MRCA of the EMRSA-16 clone was estimated as 1975 
(95% HPDs, 1965–1983).  Finally, the date for the MRCA of the entire CC30 
lineage was estimated as 1842 (95% HPDs, 1765–1909). 
 
3.4.3. Multiple independent acquisitions of pvl occurred during the 
evolution of CC30 pandemic clones 
A BLAST search to identify the pvl locus (lukS-PV and lukF-PV) in the genomes of 
the CC30 isolates included in the current study revealed it to be present in 19 of 21 
isolates belonging to the community-associated phage type 80/81 and SWP clones 
and absent from the EMRSA-16 and other epidemic CC30 clones (Figure 3.2). 
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The pvl loci are encoded by temperate phage that can be differentiated into distinct 
morphological groups on the basis of their elongated- or icosahedral-head types (Ma 
et al., 2008).  Sequence analysis of the small and large terminase subunits of the PVL 
phage revealed that 3/4 SWP clone isolates contained the elongated-head phage type, 
whereas the remaining SWP isolate and the phage type 80/81 isolates had the 
icosahedral-head phage type.  Phylogenetic analysis of the small and large terminase 
subunit gene products indicates the close relatedness of the icosahedral phage heads 
of the SWP and phage type 80/81 clones (Figure 3.3), suggesting that a progenitor of 
the SWP and phage type 80/81 clones, which existed over 100 years ago, had 
previously acquired an icosahedral-head phage type encoding PVL (although 
independent horizontal acquisition cannot be ruled out). Subsequently, the phage was 
replaced by the elongated-head phage type in some isolates of the SWP clone (Figure 
3.2). 
 
3.4.4. Identification of polymorphisms that correlate with the nosocomial 
habitat of EMRSA-16 
Genome-wide analysis of the CC30 sequences indicates that 58 of 60 EMRSA-16 
isolates contained the type II staphylococcal cassette chromosome mec element 
(SCCmecII), and that this cassette is restricted to the EMRSA-16 lineage (Figure 
3.2).   
In addition, non-synonymous mutations were identified in loci implicated in 
resistance, including genes encoding penicillin binding proteins 2 and 4, the vraD 
component of the bacitracin resistance pathway, and the gene encoding the multidrug 
efflux transporter NorA in 50 of 60 EMRSA-16 isolates.  Specifically, a S84L 
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replacement in DNA gyrase subunit A, and an S80F replacement in DNA 
topoisomerase IV subunit A have been demonstrated to confer resistance to 
fluoroquinolones (Banerjee et al., 2010; Couto et al., 2008; Hiron et al., 2011; Łeski 
et al., 2005).  Of note, a selection of 16 EMRSA-16 isolates tested on the Vitek 2 
system (bioMérieux, Basingstoke, UK) were all fluoroquinolone resistant (data not 
shown).  Finally, plasmids encoding resistance to quaternary ammonium compounds 
were identified in 7 of 60 EMRSA-16 isolates. 
 
In addition to polymorphisms impacting on antibiotic sensitivity, mutations were 
observed in the virulence determinants agr and hla previously identified in an 
ancestor of the EMRSA-16 clone by DeLeo and colleagues (DeLeo et al., 2011).  
The agr and hla polymorphisms were demonstrated to result in reduced virulence 
phenotypes in murine models of infection (DeLeo et al., 2011).  In the current study 
these polymorphisms were identified in the hospital restricted EMRSA-16 clade and 
in strains belonging to the sister clade, annotated as other epidemic CC30. 
Furthermore, a nonsense mutation occurred in the squalene desaturase gene (crtM) 
leading to pseudogene formation and disruption of the terminal portion of the 
mevalonate pathway, which leads to staphyloxanthin carotenoid biosynthesis (Liu et 
al., 2005). This is consistent with the non-pigmented colony phenotype of strains 
described in the earliest reports of the EMRSA-16 clone (CDRW, 1997). 
In addition, non-synonymous mutations were identified in genes encoding proteins 
involved in virulence including the virulence gene regulator CcpA and, for a 




Figure 3.3 Phage type 80/81 and southwest Pacific strains harbour 
closely related PVL phage with icosahedral head morphology.  
Neighbour-joining tree of coding sequence for terminase large and 
small subunits for CC30 isolates containing the icosahedral-head 
phage type.  Blue and green shading denotes isolates belonging to 
80/81 and southwest Pacific clone respectively.  Unshaded branches 
represent other PVL phage with icosahedral head type.  Scale bar 
represents substitutions per site.
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Figure 3.4 Large population centres are hubs for transmission of EMRSA-16. (A) Bayesian phylogenetic 
reconstruction of UK EMRSA-16 isolates.  Terminal branches representing London and Glasgow isolates are 
coloured red and blue respectively.  Black branches represent isolates from other UK locations.  Branches are scaled 
with time, and the scale bar represents 1 year.  Grey shading indicates examples of geographically restricted 
subclades a and b. (B) Map of he UK indicating regions represented in the phylogeographic analysis (Coloured 
yellow, red, and blue).  Isolates were grouped by geographic region; L, London; SEE, southeast England; SE, south 
England; CE, central England; NS, north Scotland; ES, east Scotland; WS, west Scotland).  Blue and red shaded 
regions represent Glasgow (G) and London (L) respectively.
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3.4.5. Phylogeographic analysis of UK EMRSA-16 sequences suggests that 
large populations centres are hubs for transmission 
Bayesian phylogenetic analysis of a subset of the genome sequence data, which 
included the UK EMRSA-16 isolates only (54 of 60 EMRSA-16 isolates), resolved 
several subclades, consistent with the existence of EMRSA-16 strains that are 
endemic to particular hospitals or regions (Figure 3.4a).  In particular, EMRSA-16 
strains isolated in Aberdeen Royal Infirmary between 2006 and 2007 are more 
closely related to each other (subclade a) than to other EMRSA-16 isolates (Figure 
3.4a).  In addition, subclade b consists largely of isolates from central Scotland, 
implying the existence of an EMRSA-16 subtype, which is endemic to this region 
(Figure 3.4a).  However, isolates from London and Glasgow are widely distributed 
among clusters of closely related isolates from regional hospitals, consistent with 
hospitals in major population centres acting as reservoirs for EMRSA-16 UK 
transmissions.  To examine this observation further, the discrete phylogeographic 
diffusion model implemented in BEAST was used, with isolates grouped by 
geographic region (London, southeast, south, and central England and north, east, 
and west Scotland (Figure 3.4b)).  Using the regional groupings, statistical support 
was identified for transmission events of EMRSA-16 between London and the south 
and southeast regions of England (Bayes factors 3.00 and 4.36, respectively).  In 
addition, Glasgow (west Scotland) was identified as a reservoir for transmission of 
EMRSA-16 to surrounding population centres in the north and east of Scotland 
(Bayes factors 4.04 and 7.16, respectively). 
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3.4.6. A single acquisition of the tst gene led to CC30 strains responsible 
for the toxic shock syndrome epidemic 
Previous studies have demonstrated that the majority of cases of menstrual TSS are 
caused by a single clone that corresponds to CC30 (Fitzgerald et al., 2001; Peacock 
et al., 2002).  However, the distribution of the tst gene encoding the toxic shock 
syndrome toxin 1 (TSST-1) among CC30 subclades has not been previously 
examined.  As the tst gene is not present in the MRSA252 reference strain, contigs 
assembled de novo were interrogated using BLAST for presence of the tst locus.  
Sequence analysis determined that the tst gene in these strains is harboured by the 
staphylococcal pathogenicity island 2 (SaPI2), and is present in 55 of 66 (83%) of 
the isolates in the sister clades represented by EMRSA-16 and other CC30 epidemic 
isolates (Figure 3.2), but is not present in any of the 21 (0%) isolates from the clades 
represented by the SWP and 80/81 clones.  These data imply the restriction of the tst 
gene to specific contemporary CC30 clones and its absence from the phage 80/81 
and SWP clones. 
 
The high level of sequence identity of SaPI2 among the 55 tst positive isolates (5 or 
fewer polymorphic sites in 14.7-kb SaPI2) strongly suggests that a single acquisition 
event occurred in an ancestor that existed 10–140 years before the TSS epidemic of 
the 1970/80s (Figure 3.2). 
 
3.4.7. Extended population analysis of the origin of the TSS epidemic 
In order to further investigate the lineage restriction of TSST-1, an additional 67 
CC30 sequences were selected for whole genome sequencing.  In particular the 
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diversity and evolutionary history of S. aureus strains associated with TSS was 
examined.  Strains were selected based on the results of MLST, PFGE and PCR 
screening for the presence of tst.  Additionally, isolates from known cases of TSS 
(Fitzgerald et al., 2001), or TSST-1 related food poisoning were included.  In total 
117/154 isolates positive for tst were included, with isolation dates ranging from 
1964 to 2012 (Appendix 1). 
 
A maximum-likelihood phylogenetic analysis built using the core genome sequence 
resulted in a well-supported tree, reconstructed using a core genome alignment of 
1,803,190 bp with 9,510 variable sites (Figure 3.5).  The majority of the newly 
sequenced isolates clustered with the strains defined as other epidemic CC30 (42/67), 
10/67 belonged to the SWP clone, and 2/67 were positioned basally within the 
EMRSA-16 lineage.  5/67 were identified as ST39, a double locus variant of both 
ST30 and ST36, and formed a distinct clade within the CC30 phylogeny.  The 
remaining 8 sequenced isolates were positioned on long branches with ancestral 
nodes basal to the ST39 and other epidemic clades. 
 
Of the 67 additional isolates, 46 were positive for the tst gene.  Sequence analysis of 
the integrase gene of the associated SaPI suggests 4 independent acquisitions of 
TSST-1 by CC30 strains (Figure 3.6), but a single diverse clade of community-
associated CC30 strains was responsible for the majority of the TSS epidemic of the 
late 1970s, and for subsequent cases of TSS in the UK and USA (Figure 3.5).  There 
was an additional acquisition of a TSST-1 carrying SaPI on the branch leading to the 
ST39 clade (yellow), and 2 separate acquisitions by single locus variants of ST30.  
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Of note, within the previously defined EMRSA-16 clade, 2 isolates from known TSS 
infections were situated basally (Figure 3.5).
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Figure 3.5 Maximum-likelihood phylogenetic reconstruction of the CC30 lineage using all sites in core genome.  
Blue, green, red, grey, and yellow shading correspond to the 80/81, southwest Pacific, EMRSA-16, toxic shock 
epidemic, and ST39 CC30 clones respectively.  Presence of the tst locus is indicated by shaded blue circles, and 
acquisitions of SaPIs carrying the tst locus are indicated by stars.  80/81, southwest Pacific, and contemporary 
EMRSA-16 clades are collapsed at the most recent common ancestor of each clade. Tips are labelled with isolate 
















Figure 3.6 Staphylococcus aureus CC30 isolates contain 3 distinct pathogenicity islands (SaPIs) encoding the tst 
locus.  Predicted coding sequences are indicated with shaded arrows; integrase, toxin, and chromosomal genes 
are shaded red, orange, and green respectively.  Regions of nucleotide identity (>85%) between SaPIs are 
highlighted with grey shading.  Isolates MSA 1832 and MN8 are from known cases of TSS, HAR24, PS16, and MSA 
1836, and MSA 3412 are representative of ST36, ST39, ST442, and ST37 respectively.
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3.4.8. Expression levels of TSST-1 and resistance to oxacillin are variable 
among tst+ CC30 isolates 
Differences in expression levels of TSST-1 by isolates representative of different 
clades within the CC30 phylogeny were assessed by Western immunoblotting (work 
performed by Robyn A. Cartwright, Figure 3.7).  Isolates from known cases of TSS 
displayed high levels of expression, with the exception of a single strain (PS12) that 
is of ST500 and is positioned basal to the EMRSA-16 clade in the CC30 
phylogenetic tree (Figure 3.5).  Isolates of the ST36 displayed low levels of TSST-1 
expression, with the exception of the most basal strain (MSA 3407), which displayed 
a high level of expression.  
 
Differences in the minimum inhibitory concentration (MIC) of oxacillin for a 
representative sample of EMRSA-16 isolates was assessed using the Etest method 
(bioMérieux).  The EMRSA-16 isolates displayed a high level of resistance to 
oxacillin (MIC > 256 μg/ml), with the exception of the most basal isolate, MSA 3407 
(Figure 3.5), which had a 4-fold lower MIC of 64 μg/ml (Figure 3.7) (work 
performed by Robyn A. Cartwright). 
 
Taken together, these observations suggest that progenitors of the EMRSA-16 
lineage were capable of causing TSS, and that subsequent reduction of TSST-1 
expression, together with an increased level of resistance to oxacillin may account 






Figure 3.7 Expression levels of TSST-1 are variable across CC30 isolates that carry the tst locus.  Concentrated 
supernatants expressing TSST-1, resolved on SDS-PAGE gel.  Yellow, grey, and red shaded isolates are 
representative of ST39, TSS-epidemic, and EMRSA-16 isolates respectively, non-shaded isolates do not belong to an 
identifiable clade.  MRSA252 is included as a negative control, purified TSST-1 is included as a positive control.  The 
oxacillin MIC is shown for EMRSA-16 isolates, R indicates an MIC > 256 μg/ml.
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3.4.9. Identification of polymorphisms coinciding with reduced capability 
to cause TSS 
In order to examine the potential molecular correlates of TSS infection, basal TSS 
associated isolates within the EMRSA-16 lineage were compared with hospital-
associated isolates.  A total of 26 core-genome polymorphisms were identified on 
branch A (Figure 3.5).  Of note, 4 non-synonymous substitutions were observed 
within the extracellular L2 loop of the penicillin binding protein encoded by blaR1.  
The L2 loop forms an intra-molecular interaction with the C-terminal β-lactam 
receptor, which when disrupted results in transcription of blaZ and mecA, and 
increased levels of resistance to β-lactam antibiotics (Figure 3.8) (Hackbarth et al., 
1993; Hanique et al., 2004; Thumanu, 2006).  The polymorphisms within blaR1 
could have a dual effect on the antibiotic resistance phenotype and virulence 
potential of hospital-associated clones.  Expression of the mecA encoded PBP2a 
represses agr activity, leading to reduced expression of virulence factors, including 
TSST-1 (Figure 3.8) (Pozzi et al., 2012; Recsei et al., 1986; Rudkin et al., 2012). 
 
In addition, a non-synonymous polymorphism was identified in the virulence gene 
regulator ccpA.  Isolates from TSS cases, and the most basal EMRSA-16 isolate, 
MSA 3407 (isolates with high levels of TSST-1 expression), had the same sequence 
at the ccpA locus, while the remainder of the EMRSA-16 isolates shared an allele 
with the amino acid altering polymorphism.  Like blaR1, ccpA is a regulator of 
TSST-1 expression (Figure 3.8) (Seidl et al., 2008), and ccpA mutants have been 
shown to have reduced levels of resistance to oxacillin  (Seidl et al., 2006).  
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Figure 3.8 Regulation of expression of virulence factor and antibiotic 
resistance loci by ccpA and blaR1. Transcription of the tst locus is 
directly regulated by ccpA, and indirectly through blaR1.  Resistance to 
β-lactam antibiotics is mediated through blaR1 regulation of mecA and 





S. aureus CC30 is a globally disseminated lineage that has had an important impact 
on human health over a number of decades (Altemeier et al., 1982; Nahmias et al., 
1961; Robinson et al., 2005a).  The 80/81 and SWP clones have been responsible for 
severe community associated infections, while the EMRSA-16 clone is endemic in 
UK hospitals causing significant morbidity and mortality.  Previously, Robinson and 
colleagues used a combination of MLST and PCR genotyping to examine the 
evolution of CC30 pandemic clones and inferred that the SWP clone originated from 
the historic phage type 80/81 clone (Robinson et al., 2005a).  However, an important 
recent study by DeLeo et al. based on a comparative genome sequence analysis of 9 
CC30 isolates demonstrated that the SWP clone is not a direct descendent of the 
phage 80/81 clone, but that each clone has evolved from a single ancestral strain, 
which gave rise to all 3 CC30 pandemics (DeLeo et al., 2011).  Consistent with these 
findings, the phylogenetic analysis of the current dataset clearly demonstrates the 
independent origins of each of the three major CC30 pandemic clones. 
Furthermore, the number of genome sequences included in this study facilitated the 
use of a Bayesian coalescent method to estimate the rate of molecular evolution 
within CC30, the date of emergence of each of the major pandemic clones, and the 
timing of other important CC30 evolutionary events.  The estimate of the 
evolutionary rate reported here is consistent with those reported for other S. aureus 
clonal complexes (Harris et al., 2010; Holden et al., 2013; Nübel et al., 2010).  
Calibration of the molecular clock allows the date of emergence of each of the major 
pandemic clones, and the timing of other important CC30 evolutionary events to be 
estimated.  Temporal analysis of bacterial epidemics may implicate 
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contemporaneous environmental factors or human practices that promoted their 
emergence and expansion. For example, the phage type 80/81 clone is predicted to 
have emerged shortly before a time of intensive penicillin use, which may have 
provided a selection for clonal expansion after acquisition of a β-lactamase plasmid 
(Gould, 1958; Robinson et al., 2005a; Rountree et al., 1961).  For each of the CC30 
pandemic clones, the predicted date of the MRCA is several years earlier than the 
time that these clones were first reported as clinical isolates in the literature, 
consistent with observations for the pandemic ST239 clone of S. aureus (Gray et al., 
2011; Harris et al., 2010; Smyth et al., 2010).  Early strains of the emergent clones 
may have existed for some time before acquiring mobile genetic elements, or before 
encountering selective pressures, which promoted rapid clonal expansion. 
Furthermore, it is feasible that EMRSA-16 strains were causing low-level clinical 
infections for several years before they were first described in the literature as a 
significant clinical problem. 
 
Comparative genomic analysis of closely related isolates from epidemics occupying 
different niches or associated with different disease manifestations is a powerful 
means for identifying genetic events that may have contributed to clone emergence 
and pathogenesis (Croucher et al., 2011; Harris et al., 2010; Hendriksen et al., 2011; 
Mutreja et al., 2011; Price et al., 2012).  PVL has been a marker for community-
associated clones of S. aureus associated with skin and soft tissue infections or 
severe necrotizing pneumonia (Diep et al., 2010), although increased identification 
of PVL positive strains associated with nosocomial infections weakens this 
correlation (Popovich et al., 2008; Rossney et al., 2007).  The finding that the PVL 
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phage harboured by the phage type 80/81 clone shares a head morphology with an 
isolate from the SWP clone suggests that PVL has a long residency with some 
community-associated S. aureus clones, having been maintained in CC30 clades 
since a likely acquisition event that occurred about 137 y ago (95% HPDs, 86–197 y 
ago).  Consistent with these findings, others have described SWP and phage type 
80/81 strains harbouring similar PVL phage types (Chen et al., 2013).  These data are 
consistent with a central role for PVL in the success of some community-associated 
S. aureus clones (Diep et al., 2004). 
 
Since the major TSS epidemic among menstruating women began in 1978, the 
incidence has fallen from 13.7/100,000 population to 0.52/100,000 population in the 
years 2000-2003, but TSS remains a important clinical problem (DeVries et al., 
2011).  The current study demonstrates that carriage of the tst gene is restricted to 
defined sublineages within the CC30 population, representative of both community-
associated and hospital-associated strains.  Of note, a large proportion of strains 
belonging to the hospital-associated EMRSA-16 clone encode TSST-1, but these 
strains are not associated with TSS infections.  The low level of sequence diversity 
within SaPI2, the pathogenicity island that harbours TSST-1, is suggestive of a single 
acquisition of SaPI2 prior to clonal expansion of the strains responsible for the TSS 
epidemic, and EMRSA-16.  This interpretation supports the earlier finding based on 
electrophoretic typing that the TSS epidemic was caused by already widely 
disseminated TSST-1 positive strains rather than rapid clonal expansion of a single 
strain that had acquired a fitness advantage (e.g., SaPI2 acquisition) (Fitzgerald et al., 
2001).  The restricted distribution of TSST-1 across the CC30 lineage, and the 
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finding that there are limited introductions prior to clonal expansion, further supports 
the pre-adapted clone hypothesis. 
 
It remains to be determined why this clone continues to harbour the tst locus, but the 
presence of TSST-1 in a large proportion of contemporary isolates from the 
EMRSA-16 clone may suggest another function in addition to the role of TSST-1 as 
a superantigen.  In addition, SaPI2 may harbour a yet to be determined locus that 
confers an advantage to EMRSA-16 strains in the hospital setting.  This study shows 
that CC30 has acquired TSST-1 on at least 4 occasions, but a single diverse clade of 
community-associated CC30 strains was responsible for the TSS epidemic of the late 
1970s, and for subsequent cases of TSS in the UK and North America.  Phenotypic 
analysis of TSST-1 identified considerable variation in expression levels among 
CC30 clades, which may influence the capacity to cause TSS in the hospital setting 
with the majority of EMRSA-16 isolates tested displaying low levels of TSST-1 
expression.  High-resolution genomic analysis revealed genetic determinants that 
may underlie this variation, specifically a non-synonymous polymorphism in ccpA, 
together with 4 non-synonymous mutations present in the extracellular L2 loop of 
blaR1 of contemporary EMRSA-16 strains and their immediate ancestral strains.  
These polymorphisms have the potential to alter the expression of PBP2a through 
regulation of mecA transcription (Figure 3.8) (Hanique et al., 2004; Thumanu, 2006), 
which in turn could lead to a reduction in TSST-1 expression through repression of 
the agr system (Recsei et al., 1986; Rudkin et al., 2012), although this hypothesis 
warrants further investigation.  Overall, these data resolve the evolutionary history of 
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TSS caused by S. aureus and reveal novel genetic determinants that may profoundly 
influence pathogenic potential. 
 
The hospital environment provides a unique array of insults that bacteria must 
overcome, including numerous classes of antibiotics used in treatment and routine 
use of disinfectants and antiseptics.  However, in contrast to the community setting, 
the hospital provides a continuous supply of immune-compromised hosts, who offer 
plentiful opportunities for infection and transmission.  Given the strong selective 
pressures encountered in the nosocomial environment, it is unsurprising that the 
EMRSA-16 clone carries numerous antibiotic resistance determinants.  Acquiring 
resistance to fluoroquinolones has been shown to have been an important event in the 
evolution of the endemic UK hospital-associated EMRSA-15 clone (Holden et al., 
2013), and likely contributes to the ability of EMRSA-16 to survive in the 
nosocomial setting.  Further differences in antibiotic sensitivity between countries 
suggests that differing antimicrobial prescribing practices select for the emergence of 
resistance at a local level (Holden et al., 2013). 
 
Acquisition of SCCmecII was a critical genetic event in the evolution of the 
EMRSA-16 clone as a hospital-associated antibiotic-resistant clone refractory to 
treatment with β-lactam antibiotics. Of note, the type II SCCmec element has been 
demonstrated to reduce the toxicity of MRSA CC30 strains in comparison with 
methicillin sensitive CC30 strains (Collins et al., 2010), and prevents normal 
stationary phase induction of the agr system, leading to decreased expression of 
cytolytic toxins (Rudkin et al., 2012).  It is speculated that this reduction in energy 
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requirement could compensate for the metabolically costly maintenance of a large 
SCCmec element and its associated methicillin resistance, but which would likely 
lead to reduced fitness outside of the hospital setting.  Recently, the carriage of the 
psm-mec locus on type II and III SCCmec, has been demonstrated to reduce the 
expression of the PSMα toxin through repression of the agr system (Kaito et al., 
2013), although this effect was not replicated in an EMRSA-16 strain, suggesting 
that the reduced virulence effect of psm-mec carriage is dependent on the genetic 
background of a strain (Kaito et al., 2013; Queck et al., 2009). 
 
In contrast, the EMRSA-15 clone emerged following the single acquisition of 
SCCmecIV, a smaller cassette that encodes fewer resistance determinants, and is 
capable of causing infection in the community (Espadinha et al., 2013; Holden et al., 
2013).  The level of cytolytic toxin expression of strains carrying a type IV SCCmec 
element is comparable to isogenic strains with the SCCmec element deleted (Collins 
et al., 2010), which may help to explain the success of the clone in the community. 
As proposed by the DeLeo et al., mutations in agr and hla may have contributed to 
the hospital association of contemporary CC30 isolates (DeLeo et al., 2011).  
However, isolates that belong to the sister clade to EMRSA-16, annotated as other 
epidemic CC30 contain the same agr and hla mutations but have been isolated from 
episodes of severe community-associated infections of healthy humans such as TSS 
(Figure 3.2) (Subedi et al., 2007).   Therefore, while agr and hla mutations are 
indeed likely to influence the capacity of CC30 isolates to cause certain types of 
infection, they are probably not sufficient to explain the hospital restriction of the 
EMRSA-16 clone since its differentiation from the other epidemic CC30 clade.   
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Additional polymorphisms are predicted to have an impact on the virulence potential 
of EMRSA-16.  For example, the formation of a crtM pseudogene, leads to 
disruption of the staphyloxanthin biosynthesis pathway.  Bacterial carotenoids confer 
resistance to oxidative killing during phagocytosis, and staphyloxanthin-deficient S. 
aureus mutants have diminished virulence in animal models of infection (Liu et al., 
2005).  The loss of metabolically expensive pigment production may in part 
compensate for the energy cost of maintaining the large SCCmecII element 
mediating antibiotic resistance. In turn, and in combination with the previously 
described hla and agr mutations, lack of pigment may affect its capacity to cause 
disease of healthy humans outside of the hospital setting.  There are a number of 
other polymorphisms in loci that could be implicated in affecting virulence potential, 
such as in the virulence gene regulator CcpA in, the cell wall-associated proteins Fib, 
SasH, IsdB, and Ebh.  Similar polymorphisms are observed in cell wall-associated 
proteins in the EMRSA-15 lineage, with a nonsense mutation causing the formation 
of a Ebh pseudogene, and a fusion of the FnbPA and FnbPB CDSs (Holden et al., 
2013).   It should be pointed out that some of the mutations are likely to be the result 
of fixation due to genetic drift before clonal expansion rather than the result of 
selective pressures encountered in hospitals. 
 
Whereas the examples discussed are selected on the basis of known or implicated 
roles in virulence, the possibility that some of the other non-synonymous mutations 
identified among EMRSA-16 strains may also have had a role in shaping its hospital-
specialist lifestyle cannot be dismissed. In contrast to DeLeo et al. who neatly 
demonstrated the virulence-attenuating effects of mutations in agr and hla (DeLeo et 
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al., 2011), the functional consequences of the polymorphisms described here have 
not yet been elucidated.  However, the identification of EMRSA-16 clade-specific 
mutations provides important avenues for future studies examining the hospital 
specialization of this important clone. 
 
The geographic spread of hospital-associated bacterial clones is not well understood. 
Whole genome sequencing of large numbers of nosocomial isolates allows the high-
resolution tracking of the transmission of strains through space and time (Beres et al., 
2010; Mutreja et al., 2011; Okoro et al., 2012).   Phylogeographic analysis of the 
EMRSA-15 clone revealed a likely origin in central England, with restriction to this 
region until the late 1980s, followed by repeated transmission events via multiple 
routes throughout the UK and Europe (Holden et al., 2013).  The predicted timings 
of emergence for a given region were concordant with the first clinical reports of 
EMRSA-15 (Holden et al., 2013).  The phylogeographic analysis of the UK 
EMRSA-16 strains provide evidence for transmission routes from hospitals in major 
cities to UK regions, leading to endemic strains circulating in local hospitals. These 
findings are consistent with a recent US study that estimated high transmission rates 
between large hospitals and long-term care facilities using a simulation model 
(Barnes et al., 2011).  It has previously been postulated that an increase in the 
willingness of patients to travel further for treatment, coupled with the centralization 
of specialist treatment centres have been contributing factors to the spread of MRSA 
throughout the United Kingdom (Murchan et al., 2004).  These data could inform the 
design of infection control protocols, such as decolonization of patients before 
transfer from large hospitals, to limit inter-hospital transmission as a major driving 
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force for epidemics.  The number of isolates included, and the relatively small 
number of hospitals sampled limits the analysis, as large regions of the United 
Kingdom are not represented in the dataset.  For example, it would be interesting to 
examine the transmission dynamics between hospitals within a single healthcare 
trust, or to integrate epidemiological data such patient transfer and bed occupancy 
rates into the phylogeographic analysis. 
 
Recently, the prevalence of EMRSA-16 has declined within UK hospitals and this 
has variously been attributed to improved infection control programs, phage 
epidemics, and changes in prescribing habits (Ellington et al., 2010; Knight et al., 
2012; Wyllie et al., 2011).  Integrating genomic data with these observations could 
offer an insight into the molecular correlates underpinning the decline, and lead to 
improved infection control programs in future. 
 
Increasingly, the boundaries between the community and hospital are becoming 
blurred, and lineages are emerging capable of causing pathology in both settings 
(Espadinha et al., 2013; Popovich et al., 2008; Rossney et al., 2007).  Identification 
of transmission pathways will be key to controlling the spread of these strains, and 
WGS offers a rapid and proven way of determining pathogen spread (Harris et al., 
2013; Lieberman et al., 2011). 
 
3.6. Conclusions 
The current study builds on recent findings that revealed the independent origin of 
phage 80/81 and SWP pandemics and identified mutations leading to reduced 
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virulence among contemporary CC30 strains (DeLeo et al., 2011).  The capacity to 
rapidly sequence the genome of large numbers of bacterial isolates can result in 
enhanced insights into bacterial epidemics. By using a high-resolution phylogenomic 
approach, a timeframe has been determined for the emergence and expansion of 
CC30 pandemics, and identified pathways of transmission of a major hospital-
associated MRSA clone, which may be used to inform control methods.  In addition, 
unique genetic events that correlate with its adaptation to the hospital niche were 
identified, some of which may help to explain its lack of success in the community 
setting.  The use of a similar approach for other hospital-associated bacteria could 
lead to the identification of risk factors that promote the emergence and expansion of 
epidemics, and thereby inform the rational design of methods for controlling their 
inter- and intra-hospital spread. 
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4. Molecular epidemiology of an outbreak 




Legionella pneumophila is ubiquitous in both natural and manmade freshwater 
reservoirs (Brown et al., 1999; Fliermans et al., 1979; Morris et al., 1979; Sanchez et 
al., 2008; Thomas et al., 1993), and at low doses does not pose a risk to human 
health.  Aerosolisation of L. pneumophila due to increased temperatures, vapour 
pressure, and bacterial density in a reservoir result in increased exposure of the 
human population to the pathogen, leading to an elevated risk of developing 
legionellosis (Brown et al., 1999; Conza et al., 2013).  Male gender, older age, 
smoking and underlying respiratory pathology are associated with increased risk of 
developing the severe form of legionellosis, Legionnaires’ disease (LD) (Marston et 
al., 1994). 
 
In Scotland, the incidence of disease associated with L. pneumophila ranges between 
15 and 40 cases per year, with approximately two-thirds of cases attributed to 
infection during travel (Potts et al., 2011).  Between 31st May and 17th July 2012, a 
total of 56 confirmed and 35 suspected cases of LD were reported with an 
epidemiological link to the south-west region of Edinburgh, Scotland.  Analysis of 
meteorological conditions preceding and during the outbreak suggested a cluster of 
cooling towers in the north-east of the affected area as the likely source of the 
outbreak (McCormick et al., 2012).  Patients were linked to the outbreak based on 
the results of traditional typing methods for L. pneumophila of sequence based 
typing (SBT), serotyping, and monoclonal antibody (mAb) subgrouping 
(McCormick et al., 2012).  However, traditional typing methods have limited 
potential for resolving the source of an outbreak in situations where a genotype is 
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present in multiple potential sources.  Previously, an outbreak of L. pneumophila in 
Hampshire resulted in a total of 26 cases of LD over a 3 week time period in 2003.  
Traditional typing methods implicated 2 cooling towers on a single site as the likely 
source of the outbreak (Reuter et al., 2013).  The retrospective application of whole 
genome sequencing of 2 outbreak strains and 4 environmental strains isolated at the 
time of the outbreak offered insights into the relationship between the isolates.  A 
close phylogenetic relationship was identified between isolates from the cooling 
towers and isolates from patients.  However, an isolate obtained from a domestic spa 
pool also clustered with the outbreak strains, meaning this site cannot be ruled out as 
a source of the outbreak.  An isolate from a cooling tower on a separate site was 
phylogenetically distant to the outbreak strains and had previously been eliminated 
as being the likely source due to having a monoclonal antibody subgroup type 
distinct from the outbreak strains. 
 
In the current study, whole genome sequencing was utilised to explore the diversity 
of L. pneumophila isolates from individuals within the Edinburgh outbreak.  
Application of phylogenetic and comparative genomic techniques revealed an 
unexpectedly high level of genomic diversity among the outbreak strains, with 
important implications for future investigations of infectious disease outbreaks. 
 
4.2. Aims 
 To understand the levels of diversity present in isolates related to an outbreak. 
 To evaluate the utility of whole genome sequencing over traditional typing 




4.3.1. Identification of LD 
Cases of LD are defined as a patient having a clinically defined pneumonia together 
with either isolation of Legionella species from respiratory secretions, detection of L. 
pneumophila antigen in urine, or a positive L. pneumophila Sg 1 antibody response.  
Isolates were successfully cultured from 18/91 patients, and epidemiologically-
linked to the outbreak on the basis of isolation date, location, and typing results of Sg 
1, SBT of ST191, and a mAb subgroup of Knoxville (Table 4.1).  No viable cultures 
were obtained from water samples of the suspected sources of the outbreak.  5 
historical isolates reported as ST191 in the database of the Public Health England 
(PHE), and 3 contemporaneous but not epidemiologically-linked isolates from 
Scotland were selected for sequencing, in addition to all cultured isolates from the 
outbreak (Table 4.1). 
 
4.3.2. L. pneumophila culture conditions 
L. pneumophila was incubated on buffered charcoal yeast extract (BCYE) agar at 
37°C for 48 h in an airtight container with 2 ml water. 
 
4.3.3. L. pneumophila genomic DNA extraction and sequencing 
A sweep of L. pneumophila was taken from a BCYE agar plate cultured for 48 h 
using a 10 μl loop, suspended in 2 ml PBS, and pelleted by centrifugation for 10 min 
at 5000 x g.  Genomic DNA extraction was performed according to the standard 
isolation of DNA from Gram-negative bacteria protocol using the QIAcube platform 
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(QIAgen, Netherlands).  Genomic DNA libraries were prepared using the Illumina 
TruSeq kit, and sequenced using either 150 bp paired end runs on an Illumina MiSeq, 
or 100 bp paired end runs on an Illumina HiSeq 2000. 
 
4.3.4. De novo genome assembly 
Processed sequence reads for each isolate were assembled de novo using the de 
Bruijn graph based assembler Velvet v1.1 (Zerbino et al., 2008).  Optimal kmer 
length and coverage cut-off parameters were calculated using the VelvetOptimiser 
v2.2.5 script (http://bioinformatics.net.au/software.velvetoptimiser.shtml). 
 
4.3.5. Whole genome alignments 
Assembled contigs, along with the genome sequences of representative clinical and 
environmental isolates from public databases (Table 4.2), were aligned using 
progressiveMauve with default parameters (Darling et al., 2010).  Locally collinear 
blocks (LCBs) not common to all sequences or <1000bp in length were removed, 
resulting in a gap free core genome alignment. 
 
4.3.6. Recombination detection 
To assess the level of recombination among the sequences in the alignment, the gap 
free genome alignments from progressiveMauve were used as input for BratNextGen 
(Marttinen et al., 2011).  100 iterations of recombination learning were performed, 
until parameters had converged, and predicted recombinant regions were removed 
from the alignment. 
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4.3.7. Phylogenetic reconstruction 
Genome alignments were used as input for maximum likelihood phylogenetic 
reconstruction in RAxML v7.2.6 (Stamatakis, 2006).  A GTR model of nucleotide 
substitution was applied with the gamma model of rate heterogeneity.  Support for 
nodes was assessed using 1000 bootstrap replicates, and species tree was rooted by 
using the sequence of a Legionella longbeachae isolate as an outgroup. 
 
4.3.8. Genome annotation and identification of variable gene content 
Variable gene content among the outbreak isolates was examined using a 
combination of genome annotation and alignment.  Predicted protein and RNA 
coding sequences in the assembled contigs for the sequenced isolates were annotated 
using the prokka pipeline v1.5.2 
(http://www.vicbioinformatics.com/software.prokka.shtml), and a custom BLAST 
database of Legionella sequences.  The Gram negative option was specified to 
predict signal sequences appropriate for L. pneumophila.  The annotated assembled 
contigs were aligned using Mugsy v1r.2.2 (Angiuoli et al., 2011b) and gene 
presence/absence determined with mugsy-annotator v0.5 (Angiuoli et al., 2011a). 
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Table 4.1 Origin and typing results of L. pneumophila isolates sequenced for this study 













2 12_4030 31/05/2012 1 Knoxville 191 
12_4054 31/05/2012 1 Knoxville 191 
3 12_4042 01/06/2012 1 Knoxville 191 
4 12_4117 02/06/2012 10 NA 1418 
5 12_4058 03/06/2012 1 Knoxville 191 
6 12_4053 04/06/2012 1 Knoxville 191 
7 12_4561 06/06/2012 1 Knoxville 191 
8 12_4169 06/06/2012 1 Knoxville 191 
9 12_4555 06/06/2012 1 Knoxville 191 
10 12_4563 07/06/2012 1 Knoxville 191 
11 12_4251 07/06/2012 1 Philadelphia 616 
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Patient Isolate Date of isolation Serogroup mAb SBT 
12 12_4499 08/06/2012 1 Knoxville 191 
12_4480 Not recorded 1 Knoxville 191 
13 12_5064 08/06/2012 1 Knoxville 191 
12_4437 12/06/2012 1 Knoxville 191 
14 12_4240 11/06/2012 1 Knoxville 191 
15 12_4903 17/06/2012 1 Knoxville 191 
16 12_5223 20/06/2012 1 Knoxville 191 
17 12_4904 21/06/2012 1 Philadelphia 37 
18 12_5251 29/06/2012 1 Knoxville 191 
12_5392 29/06/2012 1 Knoxville 191 
12_5383 29/06/2012 1 Knoxville 191 
12_5414 29/06/2012 1 Knoxville 191 
12_5415 29/06/2012 1 Knoxville 191 
NA H080160261 2008 6 NA 191 
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Patient Isolate Date of isolation Serogroup mAb SBT 
NA H080160262 2008 6 NA 191 
NA H080160263 2008 6 NA 191 
NA H064020049 2006 1 Allentown 591 
NA H092620872 2009 6 NA 191 
mAb, monoclonal antibody subtype; SBT, sequence based typing
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Sg mAb SBT Source Reference 
        
Alcoy 1999 Spain 1 ND 578 Clinical (D’Auria et al., 2010) 
Corby NA UK 1 Knoxville 51 Clinical (Glöckner et al., 2008) 
ATCC43290 1987 USA 12 NA 187 Clinical (Amaro et al., 2012) 
130b 1978 USA 1 Benidorm 42 Clinical (Schroeder et al., 2010) 
Lens NA France 1 Benidorm 15 Clinical (Cazalet et al., 2004) 
Paris NA France 1 Philadelphia 1 Clinical (Gomez-Valero et al., 2011) 
Philadelphia 1974 USA 1 Philadelphia 36 Clinical (Chien et al., 2004b) 
NC_018139 NA France 1 ND 47 Clinical www.genoscope.cns.fr/agc/microscope 
NC_018140 NA France 1 ND 734 Environmental www.genoscope.cns.fr/agc/microscope 




4.4.1. Phylogenetic analysis indicates that the Edinburgh outbreak 
isolates are genetically distinct from contemporaneous Scottish isolates 
and other ST191 isolates 
In order to determine the level of genetic diversity among isolates from a LD 
outbreak, the genomes of 22 outbreak-associated L. pneumophila isolates were 
sequenced in addition to 8 isolates not linked to the outbreak (Table 4.1).  Sequences 
were assembled resulting in 26 to 103 contigs per genome, with N50 values ranging 
from 81,559 to 718,197 bp.  In addition, 9 genome sequences from previously 
published studies were included (Table 4.2). 
 
The ST191 isolates linked to the outbreak shared a core genome of 2,814,826 bp.  
Phylogenetic reconstruction indicated they were more closely related to each other 
than to non-outbreak isolates, but formed 2 distinct clades within the species 
phylogeny (Figure 4.1).  There were a total of 344 polymorphisms distributed across 
the genome that distinguished the 2 clades A and B (Figure 4.2), and therefore the 
most recent common ancestor is unlikely to have existed in a timeframe 
commensurate with the duration of the outbreak.  Three independent methods for 
detecting recombination events, BratNextGen (Marttinen et al., 2011), single 
breakpoint analysis (Kosakovsky Pond et al., 2005), and GARD (Kosakovsky Pond 
et al., 2006), did not find any evidence of recombination within the core genome 
alignments (analysis performed by Melissa Ward).  Therefore the genetic variation 
between the 2 clades is unlikely to be the result of recombination.  Among clade A 
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isolates 29 polymorphic sites were identified, while only 4 variable sites were 
identified in clade B.   
 
The isolate 12_4117 was presumed to be a part of the outbreak based on the results 
of initial typing at the SHLMPRL, which defined the isolate as Sg1, SBT191 and 
mAb Knoxville.  However, isolate 12_4117 was genetically distinct from all Scottish 
isolates, and was most related to the L. pneumophila strains Alcoy and Corby (Figure 
4.1). 
 
The 3 Scottish isolates (12_3965, 12_4251, and 12_4904) not linked to the outbreak 
were distributed across the tree, and the 4 environmental ST191 isolates were most 




Figure 4.1 Maximum-likelihood phylogeny of L. pneumophila, labelled with results of traditional typing schemes.  
Outbreak isolates from Edinburgh are shaded in red.  Tree is rooted on the branch leading to a L. longbeachae 




Figure 4.2 Maximum-likelihood phylogeny based on non-recombinant core genome of ST191 outbreak isolates.  Two 
distinct clades are identifiable, labelled a and b.  Colours correspond to patients for which there were multiple 
isolates: Yellow, patient 2; Green, patient 12; Blue, patient 13; Red, patient 1.  Presence of an Lvh T4SS and a novel 
T4SS are denoted by black and purple shaded circles respectively.
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4.4.2. Outbreak infections can be caused by multiple genetic subtypes of 
L. pneumophila 
Multiple isolates were available for sequencing from patients 2, 12, 13 and 18 (Table 
4.1 and Figure 4.2).  Isolates 12_4030 and 12_4054 were obtained from patient 2, 
and belonged to clades A and B respectively (Figure 4.2), indicating either a 
heterogeneous infecting population from a single source, or exposure to 2 sources 
harbouring different populations of L. pneumophila.  More limited heterogeneity was 
observed among the isolates from patients 13 and 18, indicative of within patient 
diversification from a single infecting strain, or acquisition of a closely related but 
heterogeneous infecting population. 
 
The isolate 12_4117 was typed prior to whole genome sequencing and found to be 
Sg 1 ST191.  However, the nucleotide sequence of the SBT loci from the whole 
genome sequence of the isolate was inconsistent with ST191, and typed the isolate as 
ST1418.  To examine this discrepancy, multiple colonies from the original culture 
from the patient was reassessed by PCR and Sanger sequencing, which confirmed 
the presence of 2 distinct strains of L. pneumophila infecting this patient.  This 
finding is suggestive of simultaneous infection of an individual patient with multiple 
STs of L. pneumophila. 
 
Taken together the unexpected levels of diversity among isolates from this outbreak 
suggest that individuals were exposed to sources containing heterogeneous 




4.4.3. Examination of the accessory genome reveals variation in the 
complement of type 4 secretion systems among ST191 outbreak isolates 
Variation in gene content was observed among the ST191 outbreak isolates with 2 
distinct T4SS identified as being variably present in a subset of the outbreak isolates.  
A subset of 9 isolates from clade A (Figure 4.2), had 38 predicted CDSs with an 
average of 99.3% pairwise identity to a previously characterised T4SS that carries 
lvh, a locus involved in host cell entry, intracellular replication, and establishing 
infection at lower temperatures (Bandyopadhyay et al., 2007; Chien et al., 2004b; 
Ridenour et al., 2003).  In addition, isolates belonging to clade B, and isolate 
12_4240 from clade A (Figure 4.2), carried a previously uncharacterised T4SS with 
45 predicted CDSs, including orthologs of lvrA, lvrB, lvrC, and virB4 (Figure 4.3).  
The best scoring BLASTx results for the predicted lvr CDSs are to Legionella 
drancourtii, Legionella longbeachae and L. pneumophila but none show greater than 
66% identity at the amino acid level.   
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Figure 4.3 Schematic diagram of the novel T4SS present in isolates from clade B, and isolate 12_4240.  Arrows 
represent predicted CDSs identified using the prokka annotation pipeline.  Unlabelled CDSs are predicted 
hypothetical proteins.  Figure produced using EasyFig.
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4.4.4. Comparison of traditional typing methods with comparative 
genomic and phylogenetic analyses 
The traditional typing methods of SBT, mAb typing and serotyping were compared 
with comparative genomic and phylogenetic analyses in order to determine the level 
of discriminatory power of each method (Figure 4.1) 
 
21/22 of the outbreak isolates were typed as ST191, mAb subtype Knoxville and Sg 
1.  The remaining outbreak isolate was typed as ST1418 and Sg 10.  Non-outbreak 
isolates from Scotland could be differentiated from the Edinburgh outbreak isolates 
based on differences in the SBT profiles and mAb subtypes.  The ST191 
environmental isolates were typed as Sg 6, and so were distinguishable from the 
Edinburgh outbreak based on serogroup. 
 
However, SBT, mAb typing and serotyping failed to resolve the ST191 Edinburgh 
outbreak isolates into 2 distinct clades, and were unable to determine the presence or 
absence of accessory genomic elements among the outbreak isolates. 
 
4.5. Discussion 
Whole-genome sequencing of bacterial pathogens is increasingly being applied to the 
investigation of infectious disease outbreaks.  The sequencing of L. pneumophila 
isolates obtained over the time course of a LD outbreak in Edinburgh in the current 
study added valuable new insights into the dynamics of the outbreak. 
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Outbreak isolates were readily distinguished from non-outbreak isolates on the basis 
of their position in the phylogenetic tree.  95% (21/22) of outbreak isolates were Sg 
1, ST191, mAb Knoxville.  Sg 1 is internationally disseminated and has previously 
been reported to be associated with human infections.  For example, a study in 
France reported that 28.2% of environmental Legionella spp. isolates were L. 
pneumophila Sg 1, compared to 95.4% of clinical isolates (Doleans et al., 2004).   
However, ST191 is not commonly associated with human infection, but has been 
detected in environmental samples from the UK, Germany, the Netherlands, Poland, 
and Russia (PHE Legionella Database).  The wide dissemination of ST191 in the 
environment, and its apparent pathogenicity highlights its potential for future 
outbreaks. 
 
The current study clearly illustrates the potential of genomic epidemiology to add 
significant power to the investigation of infectious disease outbreaks by providing a 
higher resolution view of the L. pneumophila population than is possible through the 
use of traditional techniques such as SBT, serotyping and monoclonal antibody 
typing.  The levels of genetic variation within the isolates from 4 of the patients raise 
questions as to how these levels of diversity arose.  It has been demonstrated that a 
cloud of variation exists within the infecting populations of patients with bacterial 
infections (Harris et al., 2013; Young et al., 2012), and that this heterogeneity may 
arise through either within-host pathogen evolution, or from multiple pathogen 
acquisition events (Bryant et al., 2013; Lieberman et al., 2011).  This is an unlikely 
scenario for LD outbreaks given the lack of person-to-person transmission for L. 
pneumophila, and the timescale between exposure to and isolation of the pathogen 
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during the Edinburgh outbreak.  Alternatively, the initial exposure may be to a 
heterogeneous L. pneumophila population.  Multiple genotypes of L. pneumophila, 
can persist in cooling towers for periods of at least 5 years, allowing for high levels 
of genetic diversity within a single environmental source (Sanchez et al., 2008).  In 
addition, the same study demonstrated the presence of L. pneumophila with 
indistinguishable PFGE patterns in multiple cooling towers within a 1 km radius, 
suggesting that the possibility of cross-contamination of water reservoirs needs to be 
accounted for during outbreak investigations (Sanchez et al., 2008).   
 
Intra- and inter-species horizontal gene transfer of is common within L. 
pneumophila, and variations in T4SS content between strains have been reported 
previously (Bandyopadhyay et al., 2007; D’Auria et al., 2010; Schroeder et al., 
2010).  However, differences in T4SS content have not previously been identified 
among strains from a single outbreak.  Within the ST191 outbreak isolates, variation 
in content of 2 different T4SS was identified.  The phenotypic effect of this variation 
remains to be determined, but it is possible that the strains may display differences in 
pathogenic potential.  T4SS can deliver effector proteins into host cells and are 
involved in host cell entry, intracellular replication, modulation of host immunity, 
and establishing infection at lower temperatures (Bandyopadhyay et al., 2007; 
Fronzes et al., 2009; Lomma et al., 2009; Ridenour et al., 2003). 
 
The levels of variation identified within the Edinburgh outbreak raise important 
issues relating to outbreak detection, and also disease progression within the patient.  
The effect on the patient of co-infection with multiple strains of L. pneumophila is 
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not currently known and further investigation is required in order to determine the 
prevalence of co-infection within this outbreak, and whether co-infection can be used 
as a predictive indicator of disease progression.  Attenuation of the pathogenic 
potential of T4SS mutants in comparison to wild-type L. pneumophila strains have 
been observed using the larvae of the wax moth Galleria mellonella as an infection 
model (Harding et al., 2012).  This infection model may be a suitable system in 
which to test the virulence phenotype of the isolates obtained for this study. 
 
While the methods presented here have clear advantages over traditional typing 
methods, there are a number of limitations with the current study.  The full level of 
diversity within each patient has not been sampled here, but the methods described 
offer the opportunity to do so and could shed further light on the potential source of 
the outbreak. 
 
The use of the whole genome sequencing approach may be limited in the 
investigation of LD outbreaks.  Clinical laboratories do not routinely culture 
specimens due to the time and expertise required to isolate L. pneumophila from 
sputum, but this may change if the information generated can have a meaningful 
impact on transmission control or patient treatment.  Isolates were only successfully 
cultured from 18/91 (19.8%) of patients with a confirmed or suspected case of LD, 
raising the likelihood that a level of L. pneumophila variation within the outbreak 
remains to be captured.  In addition, the use of whole genome sequencing to identify 
the source of an outbreak is currently dependent on a viable culture from a suspected 
source.  In the current study, L. pneumophila was not successfully cultured from 
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suspected sources, possibly due to water samples being collected after Legionella 
control measures had been implemented.  It would perhaps be useful to routinely 
sample L. pneumophila reservoirs in order to build up a database of Legionella 
diversity, to which sequences of isolates from any subsequent outbreaks can be 
compared. 
 
The limitations of L. pneumophila culture could be overcome by culture-free 
sequencing methodologies.  It has recently been demonstrated that pathogen genome 
sequences can be derived directly from clinical samples, without the need for 
culturing (Loman et al., 2013; Seth-Smith et al., 2013).  Application of culture-free 
sequencing has the potential to revolutionise the study of difficult to culture 
pathogens, and could be used to obtain whole genome sequences of L. pneumophila 
directly from a patient’s sputum or from environmental water sources. 
 
4.6. Conclusions 
Whole genome sequencing presents the opportunity to revolutionise the investigation 
of bacterial epidemics.  Being able to identify potential sources of infection, and 
transmission pathways allows for the design of effective control measures that can 
halt the progress of an outbreak, reducing disease burden.  The current study 
suggests that the diversity within this L. pneumophila outbreak may preclude the use 
of WGS for the definitive identification of a source reservoir, and could be of limited 
benefit for resolving legal issues relating to outbreaks.  Characterising the levels of 
diversity among epidemic strains, and comparisons with non-epidemic strains may 
lead to the identification of molecular correlates of outbreak success.  Routine 
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sequencing of environmental water reservoirs could lead to shifts in bacterial 









5.1. Revolutionising infectious disease epidemiology through WGS 
The emergence of bacterial pathogens, together with the re-emergence of existing 
clones with altered resistance or virulence phenotypes pose a serious threat to the 
health of the global population.  In order to develop novel therapeutic agents and 
effective infection control measures, it is essential to understand the evolution and 
dynamics of pathogenic bacterial clones.  In particular, the impact of anthropogenic 
practices such as antimicrobial prescription and vaccination programmes on the 
emergence of clones is not well understood.  Throughout the last century, the 
improvement in the treatment of bacterial disease was driven by increased levels of 
nutrition and sanitation, and through the development of effective vaccines and 
antimicrobials.  Currently, standards of nutrition and sanitation in the developed 
world are unlikely to improve much further, necessitating the development of novel 
methods for pathogen control.  The current work provides examples of the 
application of WGS of bacterial populations to further the understanding of bacterial 
evolution on different scales of space and time, highlighting the advances possible 
from the level of a single patient, to the study of pandemic clones affecting 
thousands of people.   
 
5.2. Bacterial WGS in the clinic 
The study of bacterial evolution during infection has been limited by the resolution 
afforded by traditional molecular typing methods, which are unable to identify small-
scale genetic changes that may have profound effects on host-pathogen interactions.  
In the past, monoclonal infections have been assumed to involve a single infecting 
strain and the high-resolution technologies have not existed to characterise the 
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variation levels present within an infection.  In reality, there likely exists a ‘cloud’ of 
diversity within an infecting bacterial population that must be considered when 
characterising host-pathogen interactions (Bryant et al., 2013; Lieberman et al., 
2011).  Information derived from the analysis of WGS has numerous potential 
implications in clinical settings.  WGS vastly increases the resolution of genetic 
variation that can be determined in comparison to traditional molecular typing 
methods (Lieberman et al., 2011; McAdam et al., 2011; Mwangi et al., 2007).   
 
An understanding of the heterogeneity of the infecting population may ultimately 
inform on disease progression and outcome.  It has previously been demonstrated 
that microorganisms can evolve differently under the selective pressures found in 
different hosts (Zdziarski et al., 2010) and this has implications for the development 
of personalised genomic medicine, and tailored therapies.  In contrast, convergent 
evolution of pathogens during long term infection of independent hosts has been 
described (Lieberman et al., 2011) indicating potential new targets for therapeutics.   
The current work demonstrates the variation that is present during chronic S. aureus 
infection of a cystic fibrosis patient (McAdam et al., 2011).  In particular, differences 
in resistance and virulence phenotype were observed, highlighting the need to think 
of a bacterial infection in terms of a diverse population, rather than as a monoclonal 
organism.  Within the patient, the SigB locus appeared to be under selection in the 
isolates from the study patient, highlighting a potential target for antimicrobial 
therapy.  An integrated systems biology approach of linking polymorphisms to 
virulence would aid in the prediction of disease progression (Priest et al., 2012), 
 138 
phenotypic testing in conjunction with genotyping could provide a framework for 
developing predictive models. 
 
In addition, the ability to predict the antibiotic resistance profile of an isolate from its 
genome sequence has been demonstrated with high levels of accuracy (Holden et al., 
2013; Köser et al., 2012) and the full repertoire of toxins carried by an isolate may be 
identified, providing information relevant to pathogenic potential and disease 
outcome (Köser et al., 2012).  In the current study, a fusidic acid resistant phenotype 
emerged during the course of infection, and the specific polymorphism conferring in 
resistance was identified in the fusA gene (McAdam et al., 2011).  Ultimately, 
bacterial WGS may replace traditional methods of determining resistance, due to the 
high throughput capacity, and decreasing cost (Loman et al., 2012b; Priest et al., 
2012).   
 
5.3. WGS of bacteria as a tool for outbreak detection and 
molecular epidemiology 
Comparative genomic and phylogenetic analyses of bacterial populations have 
resulted in the identification of transmission pathways within hospitals, countries, 
and across continents (Harris et al., 2010; Holden et al., 2013; Lewis et al., 2010; 
McAdam et al., 2011).  Network modelling approaches have shown that the infection 
rate of a given hospital is positively correlated with its level of connectedness to 
other hospitals in the network (Donker et al., 2010, 2012).  This is consistent with the 
findings of the current work, which identified large population centres within the UK 
as hubs of transmission for the hospital restricted EMRSA-16 lineage (McAdam et 
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al., 2012).  Patient referrals may be the reason for the observed pattern of 
transmission, but the development of methodologies integrating phylogenetic and 
epidemiological models could facilitate formal evaluation of risk factors.  Methods 
integrating predictive epidemiological models with empirical data from WGS can 
simultaneously reconstruct spatiotemporal history and evaluate the impact of risk 
factors for pathogen spread.  For example, a phylogeographic model for the seasonal 
emergence and spread of H3N2 influenza that incorporated sequence data, isolate 
location, population size, and airline passenger flux data identified passenger flux as 
a major contributor to global influenza transmission (Lemey et al., 2012).  The 
spatial spread of H1N1 and H1N2 in US swine populations has been shown to follow 
long distance movements of swine populations from southeast and south-central 
USA to the Midwest (Nelson et al., 2011).   By integrating sequence data and 
epidemiological information, risk factors for pathogen spread can be objectively 
evaluated using empirical evidence, which could ultimately be used to influence the 
rational design of control programs. 
 
Many pathogens have emerged as a direct result of human practices such as 
industrialisation and globalisation, as highlighted by the rapid spread of dengue virus 
from regions of Southeast Asia and South America since the 1960s.  A combination 
of demographic factors has resulted in conditions favouring viral transmission by the 
mosquito vector Aedes aegypti.  Rapid human population growth, coupled with 
increased rural to urban migration has resulted large, densely populated areas, while 
increases in solid waste has created habitats within urban centres capable of 
supporting the vector.  Subsequently, global geographic expansion of the mosquito 
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vector has been driven through international trade routes (Gubler, 2011).  Similarly, 
Legionnaire’s disease is a product of the manmade environment.  Increased 
industrialisation has seen the widespread construction of cooling towers that transfer 
excess heat generated by machinery to the atmosphere, and offer a habitat for 
Legionella species in the midst of large human populations.  Furthermore, measures 
designed to increase human comfort such as air conditioning units offer an ideal 
habitat for growth of Legionella species, and a ready means of dispersal to large 
numbers of hosts (Ward et al., 2010).  Previously, sources of epidemic L. 
pneumophila have been identified through the use of traditional typing methods 
(Hugosson et al., 2007; White et al., 2013).  However, the high-resolution afforded 
by WGS of isolates from the 2012 Edinburgh outbreak of Legionnaire’s disease in 
the current work revealed unprecedented levels of diversity, suggesting 
diversification of L. pneumophila over a time period greatly in excess of the 
timescale of the outbreak.  This has important implications for outbreak 
investigation, it may well prove impossible to definitively identify a single location 
as the likely source of a L. pneumophila epidemic, unless the full diversity of 
environmental L. pneumophila can be sequenced.  Even if the full diversity of L. 
pneumophila can be characterised, the possibility of cross-contamination of water 
reservoirs cannot be excluded.   A study of cooling towers in Spain showed the 
presence of L. pneumophila with indistinguishable PFGE patterns in multiple sites 
within a 1 km radius (Sanchez et al., 2008).  Taken together, these observations 
suggest that WGS may be unable to determine the source of L. pneumophila 




5.4. Using bacterial WGS to study pandemic clone emergence and 
adaptation 
The impact of globalisation on the dynamics of infectious disease is incompletely 
understood.  Previously disparate populations are becoming increasingly 
interconnected as a result of the easy availability of global travel.  Prior to the 
widespread use of air travel, an individual’s social network was relatively self-
contained with a predictable level of organisation.  However, increased range and 
frequency of travel increases the complexity of individual social networks by 
introducing an element of randomness, resulting in ‘small-world’ networks, where 2 
individuals are linked by a relatively small number of mutual connections (Watts et 
al., 1998).  Modelling of infectious disease transmission throughout these networks 
has identified a decrease in the level of infectivity that is required to infect 50% of a 
susceptible population, and a decrease in the time taken to do so (Watts et al., 1998).  
The current work describes the global distribution of 3 lineages of S. aureus CC30, 
and identifies an independent origin for each pandemic clone, highlighting the 
potential of successful clones to rapidly disseminate and cause an important clinical 
burden in many regions (McAdam et al., 2012). 
 
Advancements in medical interventions designed to reduce disease burden can 
inadvertently promote the increased prevalence of pathogenic bacterial clones.  
Vaccines that are ineffective against the full range of diversity present in the 
population can select for the population expansion of resistant strains that fill the 
niche vacated by susceptible lineages (Croucher et al., 2011; Golubchik et al., 2012).  
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In the current work, Bayesian coalescent analyses were employed to determine the 
dates of emergence of important pandemic lineages of S. aureus CC30, and 
determine whether they coincide with changes in medical practice.  Specifically, the 
emergence of the penicillin-resistant phage-type 80/81 clone was predicted to be 
commensurate with the introduction of penicillin as an antimicrobial therapy 
(McAdam et al., 2012). 
 
The role of horizontal gene transfer has been demonstrated in niche adaptation 
(Guinane et al., 2010; Lowder et al., 2009) and in the acquisition of antibiotic 
resistance and virulence traits (Baba et al., 2002; Chang et al., 2003; Fitzgerald et al., 
2001; Holden et al., 2004; Mutreja et al., 2011; Rohde et al., 2011).  The current 
work has identified molecular correlates of pandemic lineage emergence and niche 
restriction and was dependent on a large genome sequence set for comparisons 
(McAdam et al., 2012).  Specifically, the adaptation of EMRSA-16 to the hospital 
environment can be linked to the acquisition of the type II SCCmec element that 
confers multidrug resistance, while a number of mutations that could result in a low 
virulence phenotype were also described (McAdam et al., 2012). 
 
The full potential of WGS of bacterial populations depends on the ability to place 
strains in their appropriate temporal and spatial context in order to identify the 
processes that led to their selection and emergence.  An understanding of the core 
genome of a bacterial species is required in order to determine molecular correlates 
that may lead to adaptation to novel niches.  
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During the 2011 European O104:H4 E. coli outbreak, the success in identifying the 
cause of increased virulence in the O104:H4 E. coli strains was dependent on 
researchers having a solid understanding of related genomes and having data from 
other sequenced genomes available for comparisons (Rohde et al., 2011).  In order 
for rapid comparisons of new sequences to be achievable, there needs to be 
consensus across the research community with regards to standards of sequencing, 
genome assembly and data availability. 
 
5.5. The future of bacterial WGS 
A major drawback to the WGS approach using current widely available sequencing 
technologies is that sequence assemblies are typically incomplete.  Repeat regions of 
pathogen genomes preclude a single contiguous assembly of short read data, and 
additional uncertainty can be introduced in a number of ways.  Inaccurate nucleotide 
base calls may be introduced through poor filtering of raw data, mapping of sequence 
reads to multiple regions of the genome, and from errors inherent in the sequencing 
technology used.  Additionally, identification of novel strain specific elements is not 
possible using a mapping approach, and requires genomes to be assembled de novo, 
with subsequent annotation of contigs.  Single-molecule sequencing technologies 
have the capability to sequence bacterial genomes on a single contig and to a 
finished-grade quality (Koren et al., 2013).  However, the costs are currently 






In conclusion, this work demonstrates the utility of applying WGS to whole bacterial 
populations and offers new insights into pathogen evolution within host, and within 
the larger host population.  Molecular correlates of pathogen emergence have been 
identified and linked to changes in human activity.  It has important implications for 
the design of control measures, therapeutic and public health interventions should be 
rationally designed so as to prevent the emergence of lineages with elevated levels of 
antibiotic resistance or virulence.  The ultimate use of WGS of bacterial pathogens 
would be to identify molecular correlates of disease progression at the single host 







AIRES DE SOUSA, M., CRISOSTOMO, M. I., SANCHES, I. S., WU, J. S., 
FUZHONG, J., TOMASZ, A. & DE LENCASTRE, H. 2003. Frequent 
recovery of a single clonal type of multidrug-resistant Staphylococcus aureus 
from patients in two hospitals in Taiwan and China. J Clin Microbiol, 41, 
159-63. 
 
AIRES DE SOUSA, M., MIRAGAIA, M., SANCHES, I. S., AVILA, S., 
ADAMSON, I., CASAGRANDE, S. T., BRANDILEONE, M. C., 
PALACIO, R., DELL'ACQUA, L., HORTAL, M., CAMOU, T., ROSSI, A., 
VELAZQUEZ-MEZA, M. E., ECHANIZ-AVILES, G., SOLORZANO-
SANTOS, F., HEITMANN, I. & DE LENCASTRE, H. 2001. Three-year 
assessment of methicillin-resistant Staphylococcus aureus clones in Latin 
America from 1996 to 1998. J Clin Microbiol, 39, 2197-205. 
 
AIRES DE SOUSA, M., SANCHES, I. S., FERRO, M. L., VAZ, M. J., SARAIVA, 
Z., TENDEIRO, T., SERRA, J. & DE LENCASTRE, H. 1998. 
Intercontinental spread of a multidrug-resistant methicillin-resistant 
Staphylococcus aureus clone. J Clin Microbiol, 36, 2590-6. 
 
ALESANA-SLATER, J., RITCHIE, S. R., HEFFERNAN, H., CAMP, T., 
RICHARDSON, A., HERBISON, P. & NORRIS, P. 2011. Methicillin-
resistant Staphylococcus aureus, Samoa, 2007-2008. Emerg Infect Dis, 17, 
1023-9. 
 
ALIKHAN, N. F., PETTY, N. K., BEN ZAKOUR, N. L. & BEATSON, S. A. 2011. 
BLAST Ring Image Generator (BRIG): simple prokaryote genome 
comparisons. BMC Genomics, 12, 402. 
 
ALP, E., KLAASSEN, C. H., DOGANAY, M., ALTOPARLAK, U., AYDIN, K., 
ENGIN, A., KUZUCU, C., OZAKIN, C., OZINEL, M. A., TURHAN, O. & 
VOSS, A. 2009. MRSA genotypes in Turkey: persistence over 10 years of a 
single clone of ST239. J Infect, 58, 433-8. 
 147 
 
AMARO, F., GILBERT, J. A., OWENS, S., TRIMBLE, W. & SHUMAN, H. A. 
2012. Whole-genome sequence of the human pathogen Legionella 
pneumophila serogroup 12 strain 570-CO-H. J Bacteriol, 194, 1613-4. 
 
ANGIUOLI, S. V., DUNNING HOTOPP, J. C., SALZBERG, S. L. & TETTELIN, 
H. 2011. Improving pan-genome annotation using whole genome multiple 
alignment. BMC Bioinformatics, 12, 272. 
 
ANGIUOLI, S. V. & SALZBERG, S. L. 2011. Mugsy: fast multiple alignment of 
closely related whole genomes. Bioinformatics, 27, 334-42. 
 
ARONESTY, E. 2011. ea-utils. code.google.com/p/ea-utils/ 
 
AYLIFFE, G. A. 1997. The progressive intercontinental spread of methicillin-
resistant Staphylococcus aureus. Clin Infect Dis, 24 Suppl 1, S74-9. 
 
BABA, T., TAKEUCHI, F., KURODA, M., YUZAWA, H., AOKI, K., OGUCHI, 
A., NAGAI, Y., IWAMA, N., ASANO, K., NAIMI, T., KURODA, H., CUI, 
L., YAMAMOTO, K. & HIRAMATSU, K. 2002. Genome and virulence 
determinants of high virulence community-acquired MRSA. Lancet, 359, 
1819-27. 
 
BANDYOPADHYAY, P., LIU, S., GABBAI, C. B., VENITELLI, Z. & 
STEINMAN, H. M. 2007. Environmental mimics and the Lvh type IVA 
secretion system contribute to virulence-related phenotypes of Legionella 
pneumophila. Infect Immun, 75, 723-35. 
 
BANERJEE, R., GRETES, M., HARLEM, C., BASUINO, L. & CHAMBERS, H. F. 
2010. A mecA-negative strain of methicillin-resistant Staphylococcus aureus 
with high-level beta-lactam resistance contains mutations in three genes. 
Antimicrob Agents Chemother, 54, 4900-2. 
 148 
 
BARNES, S. L., HARRIS, A. D., GOLDEN, B. L., WASIL, E. A. & FURUNO, J. P. 
2011. Contribution of interfacility patient movement to overall methicillin-
resistant Staphylococcus aureus prevalence levels. Infect Control Hosp 
Epidemiol, 32, 1073-8. 
 
BEGIER, E. M., FRENETTE, K., BARRETT, N. L., MSHAR, P., PETIT, S., 
BOXRUD, D. J., WATKINS-COLWELL, K., WHEELER, S., 
CEBELINSKI, E. A., GLENNEN, A., NGUYEN, D., HADLER, J. L. & 
CONNECTICUT BIOTERRORISM FIELD EPIDEMIOLOGY RESPONSE 
TEAM. 2004. A high-morbidity outbreak of methicillin-resistant 
Staphylococcus aureus among players on a college football team, facilitated 
by cosmetic body shaving and turf burns. Clin Infect Dis, 39, 1446-53. 
 
BENIN, A. L., BENSON, R. F. & BESSER, R. E. 2002. Trends in legionnaires 
disease, 1980-1998: declining mortality and new patterns of diagnosis. Clin 
Infect Dis, 35, 1039-46. 
 
BERES, S. B., CARROLL, R. K., SHEA, P. R., SITKIEWICZ, I., MARTINEZ-
GUTIERREZ, J. C., LOW, D. E., MCGEER, A., WILLEY, B. M., GREEN, 
K., TYRRELL, G. J., GOLDMAN, T. D., FELDGARDEN, M., BIRREN, B. 
W., FOFANOV, Y., BOOS, J., WHEATON, W. D., HONISCH, C. & 
MUSSER, J. M. 2010. Molecular complexity of successive bacterial 
epidemics deconvoluted by comparative pathogenomics. Proc Natl Acad Sci 
U S A, 107, 4371-6. 
 
BERGDOLL, M. S., CRASS, B. A., REISER, R. F., ROBBINS, R. N. & DAVIS, J. 
P. 1981. A new staphylococcal enterotoxin, enterotoxin F, associated with 
toxic-shock-syndrome Staphylococcus aureus isolates. Lancet, 1, 1017-21. 
 
BESIER, S., LUDWIG, A., BRADE, V. & WICHELHAUS, T. A. 2003. Molecular 




BESIER, S., SMACZNY, C., VON MALLINCKRODT, C., KRAHL, A., 
ACKERMANN, H., BRADE, V. & WICHELHAUS, T. A. 2007. Prevalence 
and clinical significance of Staphylococcus aureus small-colony variants in 
cystic fibrosis lung disease. J Clin Microbiol, 45, 168-72. 
 
BESIER, S., ZANDER, J., KAHL, B. C., KRAICZY, P., BRADE, V. & 
WICHELHAUS, T. A. 2008. The thymidine-dependent small-colony-variant 
phenotype is associated with hypermutability and antibiotic resistance in 
clinical Staphylococcus aureus isolates. Antimicrob Agents Chemother, 52, 
2183-9. 
 
BLAIR, J. E. & CARR, M. 1960. Distribution of Phage Groups of Staphylococcus 
aureus in the Years 1927 through 1947. Science, 132, 1247-8. 
 
BOISSY, R., AHMED, A., JANTO, B., EARL, J., HALL, B. G., HOGG, J. S., 
PUSCH, G. D., HILLER, L. N., POWELL, E., HAYES, J., YU, S., 
KATHJU, S., STOODLEY, P., POST, J. C., EHRLICH, G. D. & HU, F. Z. 
2011. Comparative supragenomic analyses among the pathogens 
Staphylococcus aureus, Streptococcus pneumoniae, and Haemophilus 
influenzae using a modification of the finite supragenome model. BMC 
Genomics, 12, 187. 
 
BOYLE-VAVRA, S. & DAUM, R. S. 2007. Community-acquired methicillin-
resistant Staphylococcus aureus: the role of Panton-Valentine leukocidin. Lab 
Invest, 87, 3-9. 
 
BRAN, J. L., LEVISON, M. E. & KAYE, D. 1972. Survey for methicillin-resistant 
staphylococci. Antimicrob Agents Chemother, 1, 235-6. 
 
BRANGER, C., GARDYE, C. & LAMBERT-ZECHOVSKY, N. 1996. Persistence 
 150 
of Staphylococcus aureus strains among cystic fibrosis patients over extended 
periods of time. J Med Microbiol, 45, 294-301. 
 
BROWN, C. M., NUORTI, P. J., BREIMAN, R. F., HATHCOCK, A. L., FIELDS, 
B. S., LIPMAN, H. B., LLEWELLYN, G. C., HOFMANN, J. & CETRON, 
M. 1999. A community outbreak of Legionnaires' disease linked to hospital 
cooling towers: an epidemiological method to calculate dose of exposure. Int 
J Epidemiol, 28, 353-9. 
 
BRUGGEMANN, H., CAZALET, C. & BUCHRIESER, C. 2006. Adaptation of 
Legionella pneumophila to the host environment: role of protein secretion, 
effectors and eukaryotic-like proteins. Curr Opin Microbiol, 9, 86-94. 
 
BRYANT, J. M., GROGONO, D. M., GREAVES, D., FOWERAKER, J., 
RODDICK, I., INNS, T., REACHER, M., HAWORTH, C. S., CURRAN, M. 
D., HARRIS, S. R., PEACOCK, S. J., PARKHILL, J. & FLOTO, R. A. 2013. 
Whole-genome sequencing to identify transmission of Mycobacterium 
abscessus between patients with cystic fibrosis: a retrospective cohort study. 
Lancet, 381, 1551-1560. 
 
BURGDORFER, W., BARBOUR, A. G., HAYES, S. F., BENACH, J. L., 
GRUNWALDT, E. & DAVIS, J. P. 1982. Lyme disease-a tick-borne 
spirochetosis? Science, 216, 1317-9. 
 
CARLETON, H. A., DIEP, B. A., CHARLEBOIS, E. D., SENSABAUGH, G. F. & 
PERDREAU-REMINGTON, F. 2004. Community-adapted methicillin-
resistant Staphylococcus aureus (MRSA): population dynamics of an 
expanding community reservoir of MRSA. J Infect Dis, 190, 1730-8. 
 
CAZALET, C., RUSNIOK, C., BRUGGEMANN, H., ZIDANE, N., MAGNIER, A., 
MA, L., TICHIT, M., JARRAUD, S., BOUCHIER, C., VANDENESCH, F., 
KUNST, F., ETIENNE, J., GLASER, P. & BUCHRIESER, C. 2004. 
 151 
Evidence in the Legionella pneumophila genome for exploitation of host cell 
functions and high genome plasticity. Nat Genet, 36, 1165-73. 
 
CDC 1999. Achievements in Public Health, 1900-1999: Control of Infectious 
Diseases. MMWR. Morbidity and mortality weekly report, 48, 621-629. 
 
CDRW 1997. Epidemic methicillin resistant Staphylococcus aureus. Commun Dis 
Rep CDR Wkly., 7, 191-191. 
 
CHAMBERS, H. F. & DELEO, F. R. 2009. Waves of resistance: Staphylococcus 
aureus in the antibiotic era. Nat Rev Microbiol, 7, 629-41. 
 
CHANG, S., SIEVERT, D. M., HAGEMAN, J. C., BOULTON, M. L., TENOVER, 
F. C., DOWNES, F. P., SHAH, S., RUDRIK, J. T., PUPP, G. R., BROWN, 
W. J., CARDO, D., FRIDKIN, S. K. & VANCOMYCIN-RESISTANT 
STAPHYLOCOCCUS AUREUS INVESTIGATIVE TEAM 2003. Infection 
with vancomycin-resistant Staphylococcus aureus containing the vanA 
resistance gene. N Engl J Med, 348, 1342-7. 
 
CHEN, L., CHAVDA, K. D., SOLANKI, M., MEDIAVILLA, J. R., MATHEMA, 
B., SCHLIEVERT, P. M. & KREISWIRTH, B. N. 2013. Genetic variation 
among Panton-Valentine leukocidin-encoding bacteriophages in 
Staphylococcus aureus clonal complex 30 strains. J Clin Microbiol, 51, 914-
9. 
 
CHIEN, M., MOROZOVA, I., SHI, S., SHENG, H., CHEN, J., GOMEZ, S. M., 
ASAMANI, G., HILL, K., NUARA, J., FEDER, M., RINEER, J., 
GREENBERG, J. J., STESHENKO, V., PARK, S. H., ZHAO, B., 
TEPLITSKAYA, E., EDWARDS, J. R., PAMPOU, S., GEORGHIOU, A., 
CHOU, I. C., IANNUCCILLI, W., ULZ, M. E., KIM, D. H., GERINGER-
SAMETH, A., GOLDSBERRY, C., MOROZOV, P., FISCHER, S. G., 
SEGAL, G., QU, X., RZHETSKY, A., ZHANG, P., CAYANIS, E., DE 
 152 
JONG, P. J., JU, J., KALACHIKOV, S., SHUMAN, H. A. & RUSSO, J. J. 
2004. The genomic sequence of the accidental pathogen Legionella 
pneumophila. Science, 305, 1966-8. 
 
COLEMAN, D. C., SULLIVAN, D. J., RUSSELL, R. J., ARBUTHNOTT, J. P., 
CAREY, B. F. & POMEROY, H. M. 1989. Staphylococcus aureus 
bacteriophages mediating the simultaneous lysogenic conversion of beta-
lysin, staphylokinase and enterotoxin A: molecular mechanism of triple 
conversion. J Gen Microbiol, 135, 1679-97. 
 
COLLIGNON, P., GOSBELL, I., VICKERY, A., NIMMO, G., 
STYLIANOPOULOS, T. & GOTTLIEB, T. 1998. Community-acquired 
meticillin-resistant Staphylococcus aureus in Australia. Australian Group on 
Antimicrobial Resistance. Lancet, 352, 145-6. 
 
COLLINS, J., RUDKIN, J., RECKER, M., POZZI, C., O'GARA, J. P. & MASSEY, 
R. C. 2010. Offsetting virulence and antibiotic resistance costs by MRSA. 
ISME J, 4, 577-84. 
 
CONNOR, R. I., SHERIDAN, K. E., CERADINI, D., CHOE, S. & LANDAU, N. R. 
1997. Change in coreceptor use correlates with disease progression in HIV-1-
-infected individuals. J Exp Med, 185, 621-8. 
 
CONZA, L., CASATI, S., LIMONI, C. & GAIA, V. 2013. Meteorological factors 
and risk of community-acquired Legionnaires' disease in Switzerland: an 
epidemiological study. BMJ Open, 3. 
 
COOKSON, B. D., ROBINSON, D. A., MONK, A. B., MURCHAN, S., 
DEPLANO, A., DE RYCK, R., STRUELENS, M. J., SCHEEL, C., 
FUSSING, V., SALMENLINNA, S., VUOPIO-VARKILA, J., CUNY, C., 
WITTE, W., TASSIOS, P. T., LEGAKIS, N. J., VAN LEEUWEN, W., VAN 
BELKUM, A., VINDEL, A., GARAIZAR, J., HAEGGMAN, S., OLSSON-
 153 
LILJEQUIST, B., RANSJO, U., MULLER-PREMRU, M., HRYNIEWICZ, 
W., ROSSNEY, A., O'CONNELL, B., SHORT, B. D., THOMAS, J., 
O'HANLON, S. & ENRIGHT, M. C. 2007. Evaluation of molecular typing 
methods in characterizing a European collection of epidemic methicillin-
resistant Staphylococcus aureus strains: the HARMONY collection. J Clin 
Microbiol, 45, 1830-7. 
 
COUTO, I., COSTA, S. S., VIVEIROS, M., MARTINS, M. & AMARAL, L. 2008. 
Efflux-mediated response of Staphylococcus aureus exposed to ethidium 
bromide. J Antimicrob Chemother, 62, 504-13. 
 
COX, R. A., CONQUEST, C., MALLAGHAN, C. & MARPLES, R. R. 1995. A 
major outbreak of methicillin-resistant Staphylococcus aureus caused by a 
new phage-type (EMRSA-16). J Hosp Infect, 29, 87-106. 
 
CROUCHER, N. J., HARRIS, S. R., FRASER, C., QUAIL, M. A., BURTON, J., 
VAN DER LINDEN, M., MCGEE, L., VON GOTTBERG, A., SONG, J. H., 
KO, K. S., PICHON, B., BAKER, S., PARRY, C. M., LAMBERTSEN, L. 
M., SHAHINAS, D., PILLAI, D. R., MITCHELL, T. J., DOUGAN, G., 
TOMASZ, A., KLUGMAN, K. P., PARKHILL, J., HANAGE, W. P. & 
BENTLEY, S. D. 2011. Rapid pneumococcal evolution in response to 
clinical interventions. Science, 331, 430-4. 
 
D'AURIA, G., JIMENEZ-HERNANDEZ, N., PERIS-BONDIA, F., MOYA, A. & 
LATORRE, A. 2010. Legionella pneumophila pangenome reveals strain-
specific virulence factors. BMC Genomics, 11, 181. 
 
DARLING, A. E., MAU, B. & PERNA, N. T. 2010. progressiveMauve: multiple 
genome alignment with gene gain, loss and rearrangement. PLoS One, 5, 
e11147. 
 
DAVIES, J. & DAVIES, D. 2010. Origins and evolution of antibiotic resistance. 
 154 
Microbiol Mol Biol Rev, 74, 417-33. 
 
DAVIS, J. P., CHESNEY, P. J., WAND, P. J. & LAVENTURE, M. 1980. Toxic-
shock syndrome: epidemiologic features, recurrence, risk factors, and 
prevention. N Engl J Med, 303, 1429-35. 
 
DAVIS, K. A., STEWART, J. J., CROUCH, H. K., FLOREZ, C. E. & 
HOSPENTHAL, D. R. 2004. Methicillin-resistant Staphylococcus aureus 
(MRSA) nares colonization at hospital admission and its effect on subsequent 
MRSA infection. Clin Infect Dis, 39, 776-82. 
 
DELEO, F. R., KENNEDY, A. D., CHEN, L., BUBECK WARDENBURG, J., 
KOBAYASHI, S. D., MATHEMA, B., BRAUGHTON, K. R., WHITNEY, 
A. R., VILLARUZ, A. E., MARTENS, C. A., PORCELLA, S. F., 
MCGAVIN, M. J., OTTO, M., MUSSER, J. M. & KREISWIRTH, B. N. 
2011. Molecular differentiation of historic phage-type 80/81 and 
contemporary epidemic Staphylococcus aureus. Proc Natl Acad Sci U S A, 
108, 18091-6. 
 
DELEO, F. R., OTTO, M., KREISWIRTH, B. N. & CHAMBERS, H. F. 2010. 
Community-associated meticillin-resistant Staphylococcus aureus. Lancet, 
375, 1557-68. 
 
DEVRIES, A. S., LESHER, L., SCHLIEVERT, P. M., ROGERS, T., VILLAUME, 
L. G., DANILA, R. & LYNFIELD, R. 2011. Staphylococcal toxic shock 
syndrome 2000-2006: epidemiology, clinical features, and molecular 
characteristics. PLoS One, 6, e22997. 
 
DIEP, B. A., CARLETON, H. A., CHANG, R. F., SENSABAUGH, G. F. & 
PERDREAU-REMINGTON, F. 2006. Roles of 34 virulence genes in the 
evolution of hospital- and community-associated strains of methicillin-
resistant Staphylococcus aureus. J Infect Dis, 193, 1495-503. 
 155 
 
DIEP, B. A., CHAMBERS, H. F., GRABER, C. J., SZUMOWSKI, J. D., MILLER, 
G., HAN, L. L., CHEN, J. H., LIN, F., LIN, J., PHAN, T. H., CARLETON, 
H. A., MCDOUGAL, L. K., TENOVER, F. C., COHEN, D. E., MAYER, K. 
H., SENSABAUGH, G. F. & PERDREAU-REMINGTON, F. 2008. 
Emergence of multidrug-resistant, community-associated, methicillin-
resistant Staphylococcus aureus clone USA300 in men who have sex with 
men. Ann Intern Med, 148, 249-57. 
 
DIEP, B. A., CHAN, L., TATTEVIN, P., KAJIKAWA, O., MARTIN, T. R., 
BASUINO, L., MAI, T. T., MARBACH, H., BRAUGHTON, K. R., 
WHITNEY, A. R., GARDNER, D. J., FAN, X., TSENG, C. W., LIU, G. Y., 
BADIOU, C., ETIENNE, J., LINA, G., MATTHAY, M. A., DELEO, F. R. & 
CHAMBERS, H. F. 2010. Polymorphonuclear leukocytes mediate 
Staphylococcus aureus Panton-Valentine leukocidin-induced lung 
inflammation and injury. Proc Natl Acad Sci U S A, 107, 5587-92. 
 
DIEP, B. A., SENSABAUGH, G. F., SOMBOONNA, N., SOMBOONA, N. S., 
CARLETON, H. A. & PERDREAU-REMINGTON, F. 2004. Widespread 
skin and soft-tissue infections due to two methicillin-resistant Staphylococcus 
aureus strains harboring the genes for Panton-Valentine leucocidin. J Clin 
Microbiol, 42, 2080-4. 
 
DOLEANS, A., AURELL, H., REYROLLE, M., LINA, G., FRENEY, J., 
VANDENESCH, F., ETIENNE, J. & JARRAUD, S. 2004. Clinical and 
environmental distributions of Legionella strains in France are different. J 
Clin Microbiol, 42, 458-60. 
DONAHUE, J. A. & BALDWIN, J. N. 1966. Hemolysin and leukocidin production 
by 80/81 strains of Staphylococcus aureus. J Infect Dis, 116, 324-8. 
 
DONKER, T., WALLINGA, J. & GRUNDMANN, H. 2010. Patient referral patterns 
and the spread of hospital-acquired infections through national health care 
 156 
networks. PLoS Comput Biol, 6, e1000715. 
 
DONKER, T., WALLINGA, J., SLACK, R. & GRUNDMANN, H. 2012. Hospital 
networks and the dispersal of hospital-acquired pathogens by patient transfer. 
PLoS One, 7, e35002. 
 
DRUMMOND, A. J., HO, S. Y., PHILLIPS, M. J. & RAMBAUT, A. 2006. Relaxed 
phylogenetics and dating with confidence. PLoS Biol, 4, e88. 
 
DRUMMOND, A. J., PYBUS, O. G., RAMBAUT, A., FORSBERG, R. & 
RODRIGO, A. G. 2003. Measurably evolving populations. Trends Ecol Evol, 
18, 481-488. 
 
DRUMMOND, A. J. & RAMBAUT, A. 2007. BEAST: Bayesian evolutionary 
analysis by sampling trees. BMC Evol Biol, 7, 214. 
 
ELLINGTON, M. J., HOPE, R., LIVERMORE, D. M., KEARNS, A. M., 
HENDERSON, K., COOKSON, B. D., PEARSON, A. & JOHNSON, A. P. 
2010. Decline of EMRSA-16 amongst methicillin-resistant Staphylococcus 
aureus causing bacteraemias in the UK between 2001 and 2007. J Antimicrob 
Chemother, 65, 446-448. 
 
ENRIGHT, M. C., DAY, N. P., DAVIES, C. E., PEACOCK, S. J. & SPRATT, B. G. 
2000. Multilocus sequence typing for characterization of methicillin-resistant 
and methicillin-susceptible clones of Staphylococcus aureus. J Clin 
Microbiol, 38, 1008-15. 
 
ENRIGHT, M. C. & SPRATT, B. G. 1998. A multilocus sequence typing scheme for 
Streptococcus pneumoniae: identification of clones associated with serious 
invasive disease. Microbiology, 144 ( Pt 11), 3049-60. 
 
ENTENZA, J. M., MOREILLON, P., SENN, M. M., KORMANEC, J., DUNMAN, 
 157 
P. M., BERGER-BACHI, B., PROJAN, S. & BISCHOFF, M. 2005. Role of 
sigmaB in the expression of Staphylococcus aureus cell wall adhesins ClfA 
and FnbA and contribution to infectivity in a rat model of experimental 
endocarditis. Infect Immun, 73, 990-8. 
 
ESPADINHA, D., FARIA, N. A., MIRAGAIA, M., LITO, L. M., MELO-
CRISTINO, J., DE LENCASTRE, H. & MEDICOS SENTINELA, N. 2013. 
Extensive dissemination of methicillin-resistant Staphylococcus aureus 
(MRSA) between the hospital and the community in a country with a high 
prevalence of nosocomial MRSA. PLoS One, 8, e59960. 
 
EYRE, D. W., GOLUBCHIK, T., GORDON, N. C., BOWDEN, R., PIAZZA, P., 
BATTY, E. M., IP, C. L., WILSON, D. J., DIDELOT, X., O'CONNOR, L., 
LAY, R., BUCK, D., KEARNS, A. M., SHAW, A., PAUL, J., WILCOX, M. 
H., DONNELLY, P. J., PETO, T. E., WALKER, A. S. & CROOK, D. W. 
2012. A pilot study of rapid benchtop sequencing of Staphylococcus aureus 
and Clostridium difficile for outbreak detection and surveillance. BMJ Open, 
2, e001124. 
 
FEIL, E. J., COOPER, J. E., GRUNDMANN, H., ROBINSON, D. A., ENRIGHT, 
M. C., BERENDT, T., PEACOCK, S. J., SMITH, J. M., MURPHY, M., 
SPRATT, B. G., MOORE, C. E. & DAY, N. P. J. 2003. How Clonal Is 
Staphylococcus aureus? J Bacteriol, 185, 3307-3316. 
 
FEIL, E. J., NICKERSON, E. K., CHANTRATITA, N., WUTHIEKANUN, V., 
SRISOMANG, P., COUSINS, R., PAN, W., ZHANG, G., XU, B., DAY, N. 
P. & PEACOCK, S. J. 2008. Rapid detection of the pandemic methicillin-
resistant Staphylococcus aureus clone ST 239, a dominant strain in Asian 
hospitals. J Clin Microbiol, 46, 1520-2. 
 
FIELDS, B. S., BENSON, R. F. & BESSER, R. E. 2002. Legionella and 




FISCHETTI, V. A., NOVICK, R. P., FERRETTI, J. J., PORTNOY, D. A. & ROOD, 
J. I. 2006. Gram-Positive Pathogens, Amer Society for Microbiology. 
 
FISMAN, D. N., LIM, S., WELLENIUS, G. A., JOHNSON, C., BRITZ, P., 
GASKINS, M., MAHER, J., MITTLEMAN, M. A., SPAIN, C. V., HAAS, C. 
N. & NEWBERN, C. 2005. It's not the heat, it's the humidity: wet weather 
increases legionellosis risk in the greater Philadelphia metropolitan area. J 
Infect Dis, 192, 2066-73. 
 
FITZGERALD, J. R., STURDEVANT, D. E., MACKIE, S. M., GILL, S. R. & 
MUSSER, J. M. 2001. Evolutionary genomics of Staphylococcus aureus: 
insights into the origin of methicillin-resistant strains and the toxic shock 
syndrome epidemic. Proc Natl Acad Sci U S A, 98, 8821-6. 
 
FLIERMANS, C. B., CHERRY, W. B., ORRISON, L. H. & THACKER, L. 1979. 
Isolation of Legionella pneumophila from nonepidemic-related aquatic 
habitats. Appl Environ Microbiol, 37, 1239-42. 
 
FORD, C. B., LIN, P. L., CHASE, M. R., SHAH, R. R., IARTCHOUK, O., 
GALAGAN, J., MOHAIDEEN, N., IOERGER, T. R., SACCHETTINI, J. C., 
LIPSITCH, M., FLYNN, J. L. & FORTUNE, S. M. 2011. Use of whole 
genome sequencing to estimate the mutation rate of Mycobacterium 
tuberculosis during latent infection. Nat Genet, 43, 482-6. 
 
FRANK, C., WERBER, D., CRAMER, J. P., ASKAR, M., FABER, M., AN DER 
HEIDEN, M., BERNARD, H., FRUTH, A., PRAGER, R., SPODE, A., 
WADL, M., ZOUFALY, A., JORDAN, S., KEMPER, M. J., FOLLIN, P., 
MULLER, L., KING, L. A., ROSNER, B., BUCHHOLZ, U., STARK, K., 
KRAUSE, G. & TEAM, H. U. S. I. 2011. Epidemic profile of Shiga-toxin-




FRANK, D. N., FEAZEL, L. M., BESSESEN, M. T., PRICE, C. S., JANOFF, E. N. 
& PACE, N. R. 2010. The human nasal microbiota and Staphylococcus 
aureus carriage. PLoS One, 5, e10598. 
 
FRASER, D. W., DEUBNER, D. C., HILL, D. L. & GILLIAM, D. K. 1979. 
Nonpneumonic, short-incubation-period Legionellosis (Pontiac fever) in men 
who cleaned a steam turbine condenser. Science, 205, 690-1. 
 
FRASER, D. W., TSAI, T. R., ORENSTEIN, W., PARKIN, W. E., BEECHAM, H. 
J., SHARRAR, R. G., HARRIS, J., MALLISON, G. F., MARTIN, S. M., 
MCDADE, J. E., SHEPARD, C. C. & BRACHMAN, P. S. 1977. 
Legionnaires' disease: description of an epidemic of pneumonia. N Engl J 
Med, 297, 1189-97. 
 
FRONZES, R., CHRISTIE, P. J. & WAKSMAN, G. 2009. The structural biology of 
type IV secretion systems. Nat Rev Microbiol, 7, 703-14. 
 
GAIA, V., FRY, N. K., AFSHAR, B., LUCK, P. C., MEUGNIER, H., ETIENNE, J., 
PEDUZZI, R. & HARRISON, T. G. 2005. Consensus sequence-based 
scheme for epidemiological typing of clinical and environmental isolates of 
Legionella pneumophila. J Clin Microbiol, 43, 2047-52. 
 
GAO, L. Y. & ABU KWAIK, Y. 1999. Apoptosis in macrophages and alveolar 
epithelial cells during early stages of infection by Legionella pneumophila 
and its role in cytopathogenicity. Infect Immun, 67, 862-70. 
 
GAO, W., CHUA, K., DAVIES, J. K., NEWTON, H. J., SEEMANN, T., 
HARRISON, P. F., HOLMES, N. E., RHEE, H. W., HONG, J. I., 
HARTLAND, E. L., STINEAR, T. P. & HOWDEN, B. P. 2010. Two novel 
point mutations in clinical Staphylococcus aureus reduce linezolid 
 160 
susceptibility and switch on the stringent response to promote persistent 
infection. PLoS Pathog, 6, e1000944. 
 
GARCIA-ALVAREZ, L., HOLDEN, M. T., LINDSAY, H., WEBB, C. R., 
BROWN, D. F., CURRAN, M. D., WALPOLE, E., BROOKS, K., 
PICKARD, D. J., TEALE, C., PARKHILL, J., BENTLEY, S. D., 
EDWARDS, G. F., GIRVAN, E. K., KEARNS, A. M., PICHON, B., HILL, 
R. L., LARSEN, A. R., SKOV, R. L., PEACOCK, S. J., MASKELL, D. J. & 
HOLMES, M. A. 2011. Meticillin-resistant Staphylococcus aureus with a 
novel mecA homologue in human and bovine populations in the UK and 
Denmark: a descriptive study. Lancet Infect Dis, 11, 595-603. 
 
GARDETE, S., WU, S. W., GILL, S. & TOMASZ, A. 2006. Role of VraSR in 
antibiotic resistance and antibiotic-induced stress response in Staphylococcus 
aureus. Antimicrob Agents Chemother, 50, 3424-34. 
 
GARDY, J. L., JOHNSTON, J. C., HO SUI, S. J., COOK, V. J., SHAH, L., 
BRODKIN, E., REMPEL, S., MOORE, R., ZHAO, Y., HOLT, R., 
VARHOL, R., BIROL, I., LEM, M., SHARMA, M. K., ELWOOD, K., 
JONES, S. J., BRINKMAN, F. S., BRUNHAM, R. C. & TANG, P. 2011. 
Whole-genome sequencing and social-network analysis of a tuberculosis 
outbreak. N Engl J Med, 364, 730-9. 
 
GILLET, Y., ETIENNE, J., LINA, G. & VANDENESCH, F. 2008. Association of 
necrotizing pneumonia with Panton-Valentine leukocidin-producing 
Staphylococcus aureus, regardless of methicillin resistance. Clin Infect Dis, 
47, 985-6. 
 
GLOCKNER, G., ALBERT-WEISSENBERGER, C., WEINMANN, E., JACOBI, 
S., SCHUNDER, E., STEINERT, M., HACKER, J. & HEUNER, K. 2008. 
Identification and characterization of a new conjugation/type IVA secretion 
system (trb/tra) of Legionella pneumophila Corby localized on two mobile 
 161 
genomic islands. Int J Med Microbiol, 298, 411-28. 
 
GOERKE, C., MATIAS Y PAPENBERG, S., DASBACH, S., DIETZ, K., 
ZIEBACH, R., KAHL, B. C. & WOLZ, C. 2004. Increased frequency of 
genomic alterations in Staphylococcus aureus during chronic infection is in 
part due to phage mobilization. J Infect Dis, 189, 724-34. 
 
GOERKE, C. & WOLZ, C. 2010. Adaptation of Staphylococcus aureus to the cystic 
fibrosis lung. Int J Med Microbiol, 300, 520-5. 
 
GOLDIE, D. J., ALDER, V. G. & GILLESPIE, W. A. 1971. Changes in the drug 
resistance of Staphylococcus aureus in a non-hospital population during a 20-
year period. J Clin Pathol, 24, 44-7. 
 
GOLUBCHIK, T., BATTY, E. M., MILLER, R. R., FARR, H., YOUNG, B. C., 
LARNER-SVENSSON, H., FUNG, R., GODWIN, H., KNOX, K., 
VOTINTSEVA, A., EVERITT, R. G., STREET, T., CULE, M., IP, C. L., 
DIDELOT, X., PETO, T. E., HARDING, R. M., WILSON, D. J., CROOK, 
D. W. & BOWDEN, R. 2013. Within-host evolution of Staphylococcus 
aureus during asymptomatic carriage. PLoS One, 8, e61319. 
 
GOLUBCHIK, T., BRUEGGEMANN, A. B., STREET, T., GERTZ, R. E., JR., 
SPENCER, C. C., HO, T., GIANNOULATOU, E., LINK-GELLES, R., 
HARDING, R. M., BEALL, B., PETO, T. E., MOORE, M. R., DONNELLY, 
P., CROOK, D. W. & BOWDEN, R. 2012. Pneumococcal genome 
sequencing tracks a vaccine escape variant formed through a multi-fragment 
recombination event. Nat Genet, 44, 352-5. 
 
GOMEZ-VALERO, L., RUSNIOK, C., CAZALET, C. & BUCHRIESER, C. 2011. 
Comparative and functional genomics of Legionella identified eukaryotic like 




GORDON, A. 2010. FASTX-toolkit. http://hannonlab.cshl.edu/fastx_toolkit/ 
 
GOUET, P., COURCELLE, E., STUART, D. I. & METOZ, F. 1999. ESPript: 
analysis of multiple sequence alignments in PostScript. Bioinformatics, 15, 
305-8. 
 
GOULD, J. C. 1958. Environmental Penicillin and Penicillin-Resistant 
Staphylococcus aureus. Lancet, 271, 489-493. 
 
GRAY, R. R., TATEM, A. J., JOHNSON, J. A., ALEKSEYENKO, A. V., PYBUS, 
O. G., SUCHARD, M. A. & SALEMI, M. 2011. Testing spatiotemporal 
hypothesis of bacterial evolution using methicillin-resistant Staphylococcus 
aureus ST239 genome-wide data within a Bayesian framework. Mol Biol 
Evol, 28, 1593-603. 
 
GRUNDMANN, H., AIRES-DE-SOUSA, M., BOYCE, J. & TIEMERSMA, E. 
2006. Emergence and resurgence of meticillin-resistant Staphylococcus 
aureus as a public-health threat. Lancet, 368, 874-885. 
 
GUBLER, D. J. 2011. Dengue, Urbanization and Globalization: The Unholy Trinity 
of the 21(st) Century. Trop Med Health, 39, 3-11. 
 
GUINANE, C. M., BEN ZAKOUR, N. L., TORMO-MAS, M. A., WEINERT, L. A., 
LOWDER, B. V., CARTWRIGHT, R. A., SMYTH, D. S., SMYTH, C. J., 
LINDSAY, J. A., GOULD, K. A., WITNEY, A., HINDS, J., BOLLBACK, J. 
P., RAMBAUT, A., PENADES, J. R. & FITZGERALD, J. R. 2010. 
Evolutionary genomics of Staphylococcus aureus reveals insights into the 
origin and molecular basis of ruminant host adaptation. Genome Biol Evol, 2, 
454-66. 
 
GYSIN, C., ALOTHMAN, G. A. & PAPSIN, B. C. 2000. Sinonasal disease in cystic 
 163 
fibrosis: clinical characteristics, diagnosis, and management. Pediatr 
Pulmonol, 30, 481-9. 
 
HACKBARTH, C. J. & CHAMBERS, H. F. 1993. blaI and blaR1 regulate beta-
lactamase and PBP2a production in methicillin-resistant Staphylococcus 
aureus. Antimicrob Agents Chemother, 37, 1144-9. 
 
HANIQUE, S., COLOMBO, M. L., GOORMAGHTIGH, E., SOUMILLION, P., 
FRERE, J. M. & JORIS, B. 2004. Evidence of an intramolecular interaction 
between the two domains of the BlaR1 penicillin receptor during the signal 
transduction. J Biol Chem, 279, 14264-72. 
 
HANSSEN, A. M. & ERICSON SOLLID, J. U. 2006. SCCmec in staphylococci: 
genes on the move. FEMS Immunol Med Microbiol, 46, 8-20. 
 
HARDING, C. R., SCHROEDER, G. N., REYNOLDS, S., KOSTA, A., COLLINS, 
J. W., MOUSNIER, A. & FRANKEL, G. 2012. Legionella pneumophila 
pathogenesis in the Galleria mellonella infection model. Infect Immun, 80, 
2780-90. 
 
HARRIS, S. R., CARTWRIGHT, E. J., TOROK, M. E., HOLDEN, M. T., BROWN, 
N. M., OGILVY-STUART, A. L., ELLINGTON, M. J., QUAIL, M. A., 
BENTLEY, S. D., PARKHILL, J. & PEACOCK, S. J. 2013. Whole-genome 
sequencing for analysis of an outbreak of meticillin-resistant Staphylococcus 
aureus: a descriptive study. Lancet Infect Dis, 13, 130-6. 
 
HARRIS, S. R., FEIL, E. J., HOLDEN, M. T., QUAIL, M. A., NICKERSON, E. K., 
CHANTRATITA, N., GARDETE, S., TAVARES, A., DAY, N., LINDSAY, 
J. A., EDGEWORTH, J. D., DE LENCASTRE, H., PARKHILL, J., 
PEACOCK, S. J. & BENTLEY, S. D. 2010. Evolution of MRSA during 
hospital transmission and intercontinental spread. Science, 327, 469-74. 
 
 164 
HARRISON, F. 2007. Microbial ecology of the cystic fibrosis lung. Microbiology, 
153, 917-23. 
 
HEALTH PROTECTION AGENCY. 2012. Healthcare-Associated Infection and 
Antimicrobial Resistance: 2010-2011.  Online report. 
  
HEALTH PROTECTION AGENCY. 2012. Results from the mandatory surveillance 
of MRSA bacteraemia.  Online report. 
 
HEINSEN, A., BENDTSEN, F. & FOMSGAARD, A. 2000. A phylogenetic analysis 
elucidating a case of patient-to-patient transmission of hepatitis C virus 
during surgery. J Hosp Infect, 46, 309-13. 
 
HENDRIKSEN, R. S., PRICE, L. B., SCHUPP, J. M., GILLECE, J. D., KAAS, R. 
S., ENGELTHALER, D. M., BORTOLAIA, V., PEARSON, T., WATERS, 
A. E., UPADHYAY, B. P., SHRESTHA, S. D., ADHIKARI, S., SHAKYA, 
G., KEIM, P. S. & AARESTRUP, F. M. 2011. Population genetics of Vibrio 
cholerae from Nepal in 2010: evidence on the origin of the Haitian outbreak. 
MBio, 2, e00157-11. 
 
HEROLD, B. C., IMMERGLUCK, L. C., MARANAN, M. C., LAUDERDALE, D. 
S., GASKIN, R. E., BOYLE-VAVRA, S., LEITCH, C. D. & DAUM, R. S. 
1998. Community-acquired methicillin-resistant Staphylococcus aureus in 
children with no identified predisposing risk. JAMA, 279, 593-8. 
 
HEUNER, K. & SWANSON, M. 2008. Legionella: Molecular Microbiology, Caister 
Academic Press. 
 
HIRAMATSU, K., ARITAKA, N., HANAKI, H., KAWASAKI, S., HOSODA, Y., 
HORI, S., FUKUCHI, Y. & KOBAYASHI, I. 1997. Dissemination in 
Japanese hospitals of strains of Staphylococcus aureus heterogeneously 
resistant to vancomycin. Lancet, 350, 1670-1673. 
 165 
 
HIRON, A., FALORD, M., VALLE, J., DEBARBOUILLE, M. & MSADEK, T. 
2011. Bacitracin and nisin resistance in Staphylococcus aureus: a novel 
pathway involving the BraS/BraR two-component system (SA2417/SA2418) 
and both the BraD/BraE and VraD/VraE ABC transporters. Mol Microbiol, 
81, 602-22. 
 
HO, P. L., CHOW, K. H., LO, P. Y., LEE, K. F. & LAI, E. L. 2009. Changes in the 
epidemiology of methicillin-resistant Staphylococcus aureus associated with 
spread of the ST45 lineage in Hong Kong. Diagn Microbiol Infect Dis, 64, 
131-7. 
 
HOGARDT, M. & HEESEMANN, J. 2010. Adaptation of Pseudomonas aeruginosa 
during persistence in the cystic fibrosis lung. Int J Med Microbiol, 300, 557-
62. 
 
HOLDEN, M. T., FEIL, E. J., LINDSAY, J. A., PEACOCK, S. J., DAY, N. P., 
ENRIGHT, M. C., FOSTER, T. J., MOORE, C. E., HURST, L., ATKIN, R., 
BARRON, A., BASON, N., BENTLEY, S. D., CHILLINGWORTH, C., 
CHILLINGWORTH, T., CHURCHER, C., CLARK, L., CORTON, C., 
CRONIN, A., DOGGETT, J., DOWD, L., FELTWELL, T., HANCE, Z., 
HARRIS, B., HAUSER, H., HOLROYD, S., JAGELS, K., JAMES, K. D., 
LENNARD, N., LINE, A., MAYES, R., MOULE, S., MUNGALL, K., 
ORMOND, D., QUAIL, M. A., RABBINOWITSCH, E., RUTHERFORD, 
K., SANDERS, M., SHARP, S., SIMMONDS, M., STEVENS, K., 
WHITEHEAD, S., BARRELL, B. G., SPRATT, B. G. & PARKHILL, J. 
2004. Complete genomes of two clinical Staphylococcus aureus strains: 
evidence for the rapid evolution of virulence and drug resistance. Proc Natl 
Acad Sci U S A, 101, 9786-91. 
 
HOLDEN, M. T., HSU, L. Y., KURT, K., WEINERT, L. A., MATHER, A. E., 
HARRIS, S. R., STROMMENGER, B., LAYER, F., WITTE, W., DE 
 166 
LENCASTRE, H., SKOV, R., WESTH, H., ZEMLICKOVA, H., COOMBS, 
G., KEARNS, A. M., HILL, R. L., EDGEWORTH, J., GOULD, I., GANT, 
V., COOKE, J., EDWARDS, G. F., MCADAM, P. R., TEMPLETON, K. E., 
MCCANN, A., ZHOU, Z., CASTILLO-RAMIREZ, S., FEIL, E. J., 
HUDSON, L. O., ENRIGHT, M. C., BALLOUX, F., AANENSEN, D. M., 
SPRATT, B. G., FITZGERALD, J. R., PARKHILL, J., ACHTMAN, M., 
BENTLEY, S. D. & NUBEL, U. 2013. A genomic portrait of the emergence, 
evolution, and global spread of a methicillin-resistant Staphylococcus aureus 
pandemic. Genome Res, 23, 653-64. 
 
HOLDEN, M. T., LINDSAY, J. A., CORTON, C., QUAIL, M. A., COCKFIELD, J. 
D., PATHAK, S., BATRA, R., PARKHILL, J., BENTLEY, S. D. & 
EDGEWORTH, J. D. 2010. Genome sequence of a recently emerged, highly 
transmissible, multi-antibiotic- and antiseptic-resistant variant of methicillin-
resistant Staphylococcus aureus, sequence type 239 (TW). J Bacteriol, 192, 
888-92. 
 
HOLT, D. C., HOLDEN, M. T., TONG, S. Y., CASTILLO-RAMIREZ, S., 
CLARKE, L., QUAIL, M. A., CURRIE, B. J., PARKHILL, J., BENTLEY, S. 
D., FEIL, E. J. & GIFFARD, P. M. 2011. A very early-branching 
Staphylococcus aureus lineage lacking the carotenoid pigment 
staphyloxanthin. Genome Biol Evol, 3, 881-95. 
 
HUGOSSON, A., HJORTH, M., BERNANDER, S., CLAESSON, B. E., 
JOHANSSON, A., LARSSON, H., NOLSKOG, P., PAP, J., SVENSSON, N. 
& ULLERYD, P. 2007. A community outbreak of Legionnaires' disease from 
an industrial cooling tower: assessment of clinical features and diagnostic 
procedures. Scand J Infect Dis, 39, 217-24. 
 
HUSON, D. H. & BRYANT, D. 2006. Application of phylogenetic networks in 
evolutionary studies. Mol Biol Evol, 23, 254-67. 
 
 167 
JANSEN VAN RENSBURG, M. J., ELIYA MADIKANE, V., WHITELAW, A., 
CHACHAGE, M., HAFFEJEE, S. & GAY ELISHA, B. 2011. The dominant 
methicillin-resistant Staphylococcus aureus clone from hospitals in Cape 
Town has an unusual genotype: ST612. Clin Microbiol Infect, 17, 785-92. 
 
JEVONS, M. P. 1961. "Celbenin"-resistant Staphylococci. BMJ, 1, 113-4. 
 
JOHNSON, A. P., PEARSON, A. & DUCKWORTH, G. 2005. Surveillance and 
epidemiology of MRSA bacteraemia in the UK. J Antimicrob Chemother, 56, 
455-62. 
 
JONES, R. N. 2003. Global epidemiology of antimicrobial resistance among 
community-acquired and nosocomial pathogens: a five-year summary from 
the SENTRY Antimicrobial Surveillance Program (1997-2001). Semin Respir 
Crit Care Med, 24, 121-34. 
 
JUHAS, M., CROOK, D. W., DIMOPOULOU, I. D., LUNTER, G., HARDING, R. 
M., FERGUSON, D. J. & HOOD, D. W. 2007. Novel type IV secretion 
system involved in propagation of genomic islands. J Bacteriol, 189, 761-71. 
 
KAHL, B. C. 2010. Impact of Staphylococcus aureus on the pathogenesis of chronic 
cystic fibrosis lung disease. Int J Med Microbiol, 300, 514-9. 
 
KAITO, C., SAITO, Y., IKUO, M., OMAE, Y., MAO, H., NAGANO, G., 
FUJIYUKI, T., NUMATA, S., HAN, X., OBATA, K., HASEGAWA, S., 
YAMAGUCHI, H., INOKUCHI, K., ITO, T., HIRAMATSU, K. & 
SEKIMIZU, K. 2013. Mobile genetic element SCCmec-encoded psm-mec 
RNA suppresses translation of agrA and attenuates MRSA virulence. PLoS 
Pathog, 9, e1003269. 
 
KARLSSON-KANTH, A., TEGMARK-WISELL, K., ARVIDSON, S. & 
OSCARSSON, J. 2006. Natural human isolates of Staphylococcus aureus 
 168 
selected for high production of proteases and alpha-hemolysin are sigmaB 
deficient. Int J Med Microbiol, 296, 229-36. 
 
KATZ, S. M., HABIB, W. A., HAMMEL, J. M. & NASH, P. 1982. Lack of airborne 
spread of infection by Legionella pneumophila among guinea pigs. Infect 
Immun, 38, 620-2. 
 
KELLEY, D. R., SCHATZ, M. C. & SALZBERG, S. L. 2010. Quake: quality-aware 
detection and correction of sequencing errors. Genome Biol, 11, R116. 
 
KEREM, B., ROMMENS, J. M., BUCHANAN, J. A., MARKIEWICZ, D., COX, T. 
K., CHAKRAVARTI, A., BUCHWALD, M. & TSUI, L. C. 1989. 
Identification of the cystic fibrosis gene: genetic analysis. Science, 245, 1073-
80. 
 
KLEIN, E., SMITH, D. L. & LAXMINARAYAN, R. 2007. Hospitalizations and 
deaths caused by methicillin-resistant Staphylococcus aureus, United States, 
1999-2005. Emerg Infect Dis, 13, 1840-6. 
 
KLUYTMANS, J., VAN BELKUM, A. & VERBRUGH, H. 1997. Nasal carriage of 
Staphylococcus aureus: epidemiology, underlying mechanisms, and 
associated risks. Clin Microbiol Rev, 10, 505-20. 
 
KNAPP, J. S. & HOOK, E. W., 3RD 1988. Prevalence and persistence of Neisseria 
cinerea and other Neisseria spp. in adults. J Clin Microbiol, 26, 896-900. 
 
KNIGHT, G. M., BUDD, E. L., WHITNEY, L., THORNLEY, A., AL-GHUSEIN, 
H., PLANCHE, T. & LINDSAY, J. A. 2012. Shift in dominant hospital-
associated methicillin-resistant Staphylococcus aureus (HA-MRSA) clones 
over time. J Antimicrob Chemother, 67, 2514-22. 
 
KOCK, R., BECKER, K., COOKSON, B., VAN GEMERT-PIJNEN, J. E., 
 169 
HARBARTH, S., KLUYTMANS, J., MIELKE, M., PETERS, G., SKOV, R. 
L., STRUELENS, M. J., TACCONELLI, E., NAVARRO TORNE, A., 
WITTE, W. & FRIEDRICH, A. W. 2010. Methicillin-resistant 
Staphylococcus aureus (MRSA): burden of disease and control challenges in 
Europe. Euro Surveill, 15, 19688. 
 
KOREEN, L., RAMASWAMY, S. V., GRAVISS, E. A., NAIDICH, S., MUSSER, 
J. M. & KREISWIRTH, B. N. 2004. spa typing method for discriminating 
among Staphylococcus aureus isolates: implications for use of a single 
marker to detect genetic micro- and macrovariation. J Clin Microbiol, 42, 
792-9. 
 
KOREN, S., HARHAY, G. P., SMITH, T. P., BONO, J. L., HARHAY, D. M., 
MCVEY, S. D., RADUNE, D., BERGMAN, N. H. & PHILLIPPY, A. M. 
2013. Reducing assembly complexity of microbial genomes with single-
molecule sequencing. Genome Biol, 14, R101. 
 
KOS, V. N., DESJARDINS, C. A., GRIGGS, A., CERQUEIRA, G., VAN 
TONDER, A., HOLDEN, M. T., GODFREY, P., PALMER, K. L., BODI, K., 
MONGODIN, E. F., WORTMAN, J., FELDGARDEN, M., LAWLEY, T., 
GILL, S. R., HAAS, B. J., BIRREN, B. & GILMORE, M. S. 2012. 
Comparative genomics of vancomycin-resistant Staphylococcus aureus 
strains and their positions within the clade most commonly associated with 
Methicillin-resistant S. aureus hospital-acquired infection in the United 
States. MBio, 3. 
 
KOSAKOVSKY POND, S. L., FROST, S. D. & MUSE, S. V. 2005. HyPhy: 
hypothesis testing using phylogenies. Bioinformatics, 21, 676-9. 
 
KOSAKOVSKY POND, S. L., POSADA, D., GRAVENOR, M. B., WOELK, C. H. 
& FROST, S. D. 2006. GARD: a genetic algorithm for recombination 
detection. Bioinformatics, 22, 3096-8. 
 170 
 
KOSER, C. U., HOLDEN, M. T., ELLINGTON, M. J., CARTWRIGHT, E. J., 
BROWN, N. M., OGILVY-STUART, A. L., HSU, L. Y., 
CHEWAPREECHA, C., CROUCHER, N. J., HARRIS, S. R., SANDERS, 
M., ENRIGHT, M. C., DOUGAN, G., BENTLEY, S. D., PARKHILL, J., 
FRASER, L. J., BETLEY, J. R., SCHULZ-TRIEGLAFF, O. B., SMITH, G. 
P. & PEACOCK, S. J. 2012. Rapid whole-genome sequencing for 
investigation of a neonatal MRSA outbreak. N Engl J Med, 366, 2267-75. 
 
KUMARASAMY, K. K., TOLEMAN, M. A., WALSH, T. R., BAGARIA, J., 
BUTT, F., BALAKRISHNAN, R., CHAUDHARY, U., DOUMITH, M., 
GISKE, C. G., IRFAN, S., KRISHNAN, P., KUMAR, A. V., MAHARJAN, 
S., MUSHTAQ, S., NOORIE, T., PATERSON, D. L., PEARSON, A., 
PERRY, C., PIKE, R., RAO, B., RAY, U., SARMA, J. B., SHARMA, M., 
SHERIDAN, E., THIRUNARAYAN, M. A., TURTON, J., UPADHYAY, S., 
WARNER, M., WELFARE, W., LIVERMORE, D. M. & WOODFORD, N. 
2010. Emergence of a new antibiotic resistance mechanism in India, Pakistan, 
and the UK: a molecular, biological, and epidemiological study. Lancet Infect 
Dis, 10, 597-602. 
 
KWAN, T., LIU, J., DUBOW, M., GROS, P. & PELLETIER, J. 2005. The complete 
genomes and proteomes of 27 Staphylococcus aureus bacteriophages. Proc 
Natl Acad Sci U S A, 102, 5174-9. 
 
LARKIN, M. A., BLACKSHIELDS, G., BROWN, N. P., CHENNA, R., 
MCGETTIGAN, P. A., MCWILLIAM, H., VALENTIN, F., WALLACE, I. 
M., WILM, A., LOPEZ, R., THOMPSON, J. D., GIBSON, T. J. & 
HIGGINS, D. G. 2007. Clustal W and Clustal X version 2.0. Bioinformatics, 
23, 2947-8. 
 
LARSON, H. E., PRICE, A. B., HONOUR, P. & BORRIELLO, S. P. 1978. 




LAUTNER, M., SCHUNDER, E., HERRMANN, V. & HEUNER, K. 2013. 
Regulation, integrase-dependent excision, and horizontal transfer of genomic 
islands in Legionella pneumophila. J Bacteriol, 195, 1583-97. 
 
LEMEY, P., KOSAKOVSKY POND, S. L., DRUMMOND, A. J., PYBUS, O. G., 
SHAPIRO, B., BARROSO, H., TAVEIRA, N. & RAMBAUT, A. 2007. 
Synonymous substitution rates predict HIV disease progression as a result of 
underlying replication dynamics. PLoS Comput Biol, 3, e29. 
 
LEMEY, P., RAMBAUT, A., BEDFORD, T., FARIA, N. R., BIELEJEC, F., 
BAELE, G., RUSSELL, C. A., SMITH, D. J., PYBUS, O. G., 
BROCKMANN, D. & SUCHARD, M. A. 2012. The seasonal flight of 
influenza: a unified framework for spatiotemporal hypothesis testing. 16-16. 
 
LEMEY, P., RAMBAUT, A., DRUMMOND, A. J. & SUCHARD, M. A. 2009. 
Bayesian phylogeography finds its roots. PLoS Comput Biol, 5, e1000520. 
 
LESKI, T. A. & TOMASZ, A. 2005. Role of penicillin-binding protein 2 (PBP2) in 
the antibiotic susceptibility and cell wall cross-linking of Staphylococcus 
aureus: evidence for the cooperative functioning of PBP2, PBP4, and 
PBP2A. J Bacteriol, 187, 1815-24. 
 
LEVDIKOV, V. M., BLAGOVA, E., JOSEPH, P., SONENSHEIN, A. L. & 
WILKINSON, A. J. 2006. The structure of CodY, a GTP- and isoleucine-
responsive regulator of stationary phase and virulence in gram-positive 
bacteria. J Biol Chem, 281, 11366-73. 
 
LEWIS, T., LOMAN, N. J., BINGLE, L., JUMAA, P., WEINSTOCK, G. M., 
MORTIBOY, D. & PALLEN, M. J. 2010. High-throughput whole-genome 
sequencing to dissect the epidemiology of Acinetobacter baumannii isolates 
 172 
from a hospital outbreak. J Hosp Infect, 75, 37-41. 
 
LI, H. & DURBIN, R. 2009. Fast and accurate short read alignment with Burrows-
Wheeler transform. Bioinformatics, 25, 1754-60. 
 
LI, H. & DURBIN, R. 2010. Fast and accurate long-read alignment with Burrows-
Wheeler transform. Bioinformatics, 26, 589-95. 
 
LI, H., RUAN, J. & DURBIN, R. 2008. Mapping short DNA sequencing reads and 
calling variants using mapping quality scores. Genome Res, 18, 1851-8. 
 
LI, J. S., O'BRIEN, E. D. & GUEST, C. 2002. A review of national legionellosis 
surveillance in Australia, 1991 to 2000. Commun Dis Intell Q Rep, 26, 461-8. 
 
LIEBERMAN, T. D., MICHEL, J. B., AINGARAN, M., POTTER-BYNOE, G., 
ROUX, D., DAVIS, M. R., JR., SKURNIK, D., LEIBY, N., LIPUMA, J. J., 
GOLDBERG, J. B., MCADAM, A. J., PRIEBE, G. P. & KISHONY, R. 
2011. Parallel bacterial evolution within multiple patients identifies candidate 
pathogenicity genes. Nat Genet, 43, 1275-80. 
 




LINDSAY, J. A. 2013. Hospital-associated MRSA and antibiotic resistance-what 
have we learned from genomics? Int J Med Microbiol, 303, 318-23. 
 
LINDSAY, J. A. & HOLDEN, M. T. 2006. Understanding the rise of the superbug: 
investigation of the evolution and genomic variation of Staphylococcus 
aureus. Funct Integr Genomics, 6, 186-201. 
 
LIU, G. Y., ESSEX, A., BUCHANAN, J. T., DATTA, V., HOFFMAN, H. M., 
 173 
BASTIAN, J. F., FIERER, J. & NIZET, V. 2005. Staphylococcus aureus 
golden pigment impairs neutrophil killing and promotes virulence through its 
antioxidant activity. J Exp Med, 202, 209-15. 
 
LOMAN, N. J., CONSTANTINIDOU, C., CHAN, J. Z., HALACHEV, M., 
SERGEANT, M., PENN, C. W., ROBINSON, E. R. & PALLEN, M. J. 2012. 
High-throughput bacterial genome sequencing: an embarrassment of choice, a 
world of opportunity. Nat Rev Microbiol, 10, 599-606. 
 
LOMAN, N. J., CONSTANTINIDOU, C., CHRISTNER, M., ROHDE, H., CHAN, 
J. Z., QUICK, J., WEIR, J. C., QUINCE, C., SMITH, G. P., BETLEY, J. R., 
AEPFELBACHER, M. & PALLEN, M. J. 2013. A culture-independent 
sequence-based metagenomics approach to the investigation of an outbreak of 
Shiga-toxigenic Escherichia coli O104:H4. JAMA, 309, 1502-10. 
 
LOMAN, N. J., MISRA, R. V., DALLMAN, T. J., CONSTANTINIDOU, C., 
GHARBIA, S. E., WAIN, J. & PALLEN, M. J. 2012. Performance 
comparison of benchtop high-throughput sequencing platforms. Nat 
Biotechnol, 30, 434-9. 
 
LOMMA, M., GOMEZ VALERO, L., RUSNIOK, C. & BUCHRIESER, C. 2009. 
Legionella pneumophila - Host Interactions: Insights Gained from 
Comparative Genomics and Cell Biology. Genome Dyn, 6, 170-86. 
 
LOWDER, B. V., GUINANE, C. M., BEN ZAKOUR, N. L., WEINERT, L. A., 
CONWAY-MORRIS, A., CARTWRIGHT, R. A., SIMPSON, A. J., 
RAMBAUT, A., NUBEL, U. & FITZGERALD, J. R. 2009. Recent human-
to-poultry host jump, adaptation, and pandemic spread of Staphylococcus 
aureus. Proc Natl Acad Sci U S A, 106, 19545-50. 
 
LOWY, F. D. 1998. Staphylococcus aureus infections. N Engl J Med, 339, 520-32. 
 
 174 
LUCK, C., FRY, N. K., HELBIG, J. H., JARRAUD, S. & HARRISON, T. G. 2013. 
Typing methods for Legionella. Methods Mol Biol, 954, 119-48. 
 
LUO, Z. Q. & ISBERG, R. R. 2004. Multiple substrates of the Legionella 
pneumophila Dot/Icm system identified by interbacterial protein transfer. 
Proc Natl Acad Sci U S A, 101, 841-6. 
 
MA, X. X., ITO, T., KONDO, Y., CHO, M., YOSHIZAWA, Y., KANEKO, J., 
KATAI, A., HIGASHIIDE, M., LI, S. & HIRAMATSU, K. 2008. Two 
different Panton-Valentine leukocidin phage lineages predominate in Japan. J 
Clin Microbiol, 46, 3246-58. 
 
MA, X. X., ITO, T., TIENSASITORN, C., JAMKLANG, M., CHONGTRAKOOL, 
P., BOYLE-VAVRA, S., DAUM, R. S. & HIRAMATSU, K. 2002. Novel 
type of staphylococcal cassette chromosome mec identified in community-
acquired methicillin-resistant Staphylococcus aureus strains. Antimicrob 
Agents Chemother, 46, 1147-52. 
 
MAIDEN, M. C., BYGRAVES, J. A., FEIL, E., MORELLI, G., RUSSELL, J. E., 
URWIN, R., ZHANG, Q., ZHOU, J., ZURTH, K., CAUGANT, D. A., 
FEAVERS, I. M., ACHTMAN, M. & SPRATT, B. G. 1998. Multilocus 
sequence typing: a portable approach to the identification of clones within 
populations of pathogenic microorganisms. Proc Natl Acad Sci USA, 95, 
3140-5. 
 
MAINZ, J. G., NAEHRLICH, L., SCHIEN, M., KADING, M., SCHILLER, I., 
MAYR, S., SCHNEIDER, G., WIEDEMANN, B., WIEHLMANN, L., 
CRAMER, N., PFISTER, W., KAHL, B. C., BECK, J. F. & TUMMLER, B. 
2009. Concordant genotype of upper and lower airways P. aeruginosa and S. 
aureus isolates in cystic fibrosis. Thorax, 64, 535-40. 
 
MAJERCZYK, C. D., DUNMAN, P. M., LUONG, T. T., LEE, C. Y., SADYKOV, 
 175 
M. R., SOMERVILLE, G. A., BODI, K. & SONENSHEIN, A. L. 2010. 
Direct targets of CodY in Staphylococcus aureus. J Bacteriol, 192, 2861-77. 
 
MAREE, C. L., DAUM, R. S., BOYLE-VAVRA, S., MATAYOSHI, K. & 
MILLER, L. G. 2007. Community-associated methicillin-resistant 
Staphylococcus aureus isolates causing healthcare-associated infections. 
Emerg Infect Dis, 13, 236-42. 
 
MARPLES, R. R. & REITH, S. 1992. Methicillin-resistant Staphylococcus aureus in 
England and Wales. Commun Dis Rep CDR Wkly., 2, R25-9. 
 
MARSHALL, B. J. & WARREN, J. R. 1984. Unidentified curved bacilli in the 
stomach of patients with gastritis and peptic ulceration. Lancet, 1, 1311-5. 
 
MARSTON, B. J., LIPMAN, H. B. & BREIMAN, R. F. 1994. Surveillance for 
Legionnaires' disease. Risk factors for morbidity and mortality. Arch Intern 
Med, 154, 2417-22. 
 
MARTIN, M. 2011. Cutadapt removes adapter sequences from high-throughput 
sequencing reads. EMBnet.journal, 17, 10-12. 
 
MARTTINEN, P., HANAGE, W. P., CROUCHER, N. J., CONNOR, T. R., 
HARRIS, S. R., BENTLEY, S. D. & CORANDER, J. 2012. Detection of 
recombination events in bacterial genomes from large population samples. 
Nucleic Acids Res, 40, e6. 
 
MASTRO, T. D., FIELDS, B. S., BREIMAN, R. F., CAMPBELL, J., PLIKAYTIS, 
B. D. & SPIKA, J. S. 1991. Nosocomial Legionnaires' disease and use of 
medication nebulizers. J Infect Dis, 163, 667-71. 
 
MCADAM, P. R., HOLMES, A., TEMPLETON, K. E. & FITZGERALD, J. R. 
2011. Adaptive evolution of Staphylococcus aureus during chronic 
 176 
endobronchial infection of a cystic fibrosis patient. PLoS One, 6, e24301. 
 
MCADAM, P. R., TEMPLETON, K. E., EDWARDS, G. F., HOLDEN, M. T., 
FEIL, E. J., AANENSEN, D. M., BARGAWI, H. J., SPRATT, B. G., 
BENTLEY, S. D., PARKHILL, J., ENRIGHT, M. C., HOLMES, A., 
GIRVAN, E. K., GODFREY, P. A., FELDGARDEN, M., KEARNS, A. M., 
RAMBAUT, A., ROBINSON, D. A. & FITZGERALD, J. R. 2012. 
Molecular tracing of the emergence, adaptation, and transmission of hospital-
associated methicillin-resistant Staphylococcus aureus. Proc Natl Acad Sci U 
S A, 109, 9107-12. 
 
MCCARTHY, A. J. & LINDSAY, J. A. 2010. Genetic variation in Staphylococcus 
aureus surface and immune evasion genes is lineage associated: implications 
for vaccine design and host-pathogen interactions. BMC Microbiol, 10, 173. 
 
MCCORMICK, D., THORN, S., MILNE, D., EVANS, C., STEVENSON, J., 
LLANO, M., DONAGHY, M. & TEAM, I. M. 2012. Public health response 
to an outbreak of Legionnaires' disease in Edinburgh, United Kingdom, June 
2012. Euro Surveill, 17. 
 
MCDADE, J. E., SHEPARD, C. C., FRASER, D. W., TSAI, T. R., REDUS, M. A. 
& DOWDLE, W. R. 1977. Legionnaires' disease: isolation of a bacterium and 
demonstration of its role in other respiratory disease. N Engl J Med, 297, 
1197-203. 
 
MEIER, S., GOERKE, C., WOLZ, C., SEIDL, K., HOMEROVA, D., 
SCHULTHESS, B., KORMANEC, J., BERGER-BACHI, B. & BISCHOFF, 
M. 2007. sigmaB and the sigmaB-dependent arlRS and yabJ-spoVG loci 
affect capsule formation in Staphylococcus aureus. Infect Immun, 75, 4562-
71. 
 
METZKER, M. L. 2010. Sequencing technologies - the next generation. Nat Rev 
 177 
Genet, 11, 31-46. 
 
MIKHAIL, M., WANG, B., LEMEY, P., BECKTHOLD, B., VANDAMME, A. M., 
GILL, M. J. & SAKSENA, N. K. 2005. Role of viral evolutionary rate in 
HIV-1 disease progression in a linked cohort. Retrovirology, 2, 41. 
 
MOISAN, H., BROUILLETTE, E., JACOB, C. L., LANGLOIS-BEGIN, P., 
MICHAUD, S. & MALOUIN, F. 2006. Transcription of virulence factors in 
Staphylococcus aureus small-colony variants isolated from cystic fibrosis 
patients is influenced by SigB. J Bacteriol, 188, 64-76. 
 
MORRIS, G. K., PATTON, C. M., FEELEY, J. C., JOHNSON, S. E., GORMAN, 
G., MARTIN, W. T., SKALIY, P., MALLISON, G. F., POLITI, B. D. & 
MACKEL, D. C. 1979. Isolation of the Legionnaires' disease bacterium from 
environmental samples. Ann Intern Med, 90, 664-6. 
 
MOURVILLIER, B., TROUILLET, J. L., TIMSIT, J. F., BAUDOT, J., CHASTRE, 
J., REGNIER, B., GIBERT, C. & WOLFF, M. 2004. Infective endocarditis in 
the intensive care unit: clinical spectrum and prognostic factors in 228 
consecutive patients. Intensive Care Med, 30, 2046-52. 
 
MURCHAN, S., AUCKEN, H. M., O'NEILL G, L., GANNER, M. & COOKSON, 
B. D. 2004. Emergence, spread, and characterization of phage variants of 
epidemic methicillin-resistant Staphylococcus aureus 16 in England and 
Wales. J Clin Microbiol, 42, 5154-60. 
 
MUTREJA, A., KIM, D. W., THOMSON, N. R., CONNOR, T. R., LEE, J. H., 
KARIUKI, S., CROUCHER, N. J., CHOI, S. Y., HARRIS, S. R., LEBENS, 
M., NIYOGI, S. K., KIM, E. J., RAMAMURTHY, T., CHUN, J., WOOD, J. 
L., CLEMENS, J. D., CZERKINSKY, C., NAIR, G. B., HOLMGREN, J., 
PARKHILL, J. & DOUGAN, G. 2011. Evidence for several waves of global 
transmission in the seventh cholera pandemic. Nature, 477, 462-5. 
 178 
 
MWANGI, M. M., WU, S. W., ZHOU, Y., SIERADZKI, K., DE LENCASTRE, H., 
RICHARDSON, P., BRUCE, D., RUBIN, E., MYERS, E., SIGGIA, E. D. & 
TOMASZ, A. 2007. Tracking the in vivo evolution of multidrug resistance in 
Staphylococcus aureus by whole-genome sequencing. Proc Natl Acad Sci U 
S A, 104, 9451-6. 
 
NAGAEV, I., BJORKMAN, J., ANDERSSON, D. I. & HUGHES, D. 2001. 
Biological cost and compensatory evolution in fusidic acid-resistant 
Staphylococcus aureus. Mol Microbiol, 40, 433-9. 
 
NAGAI, H., KAGAN, J. C., ZHU, X., KAHN, R. A. & ROY, C. R. 2002. A 
bacterial guanine nucleotide exchange factor activates ARF on Legionella 
phagosomes. Science, 295, 679-82. 
 
NAHMIAS, A., SAKURAI, N., BLUMBERG, R., GOE GE, A. & SULZER, C. 
1961. The Staphylococcus 80/81 complex: epidemiological and laboratory 
observations. J Infect Dis, 109, 211-22. 
 
NCBI 2010. SRA Handbook, National Center for Biotechnology Information (US). 
 
NELSON, M. I., LEMEY, P., TAN, Y., VINCENT, A., LAM, T. T., DETMER, S., 
VIBOUD, C., SUCHARD, M. A., RAMBAUT, A., HOLMES, E. C. & 
GRAMER, M. 2011. Spatial dynamics of human-origin H1 influenza A virus 
in North American swine. PLoS Pathog, 7, e1002077. 
 
NGUYEN, T. M., ILEF, D., JARRAUD, S., ROUIL, L., CAMPESE, C., CHE, D., 
HAEGHEBAERT, S., GANIAYRE, F., MARCEL, F., ETIENNE, J. & 
DESENCLOS, J. C. 2006. A community-wide outbreak of Legionnaires 
disease linked to industrial cooling towers--how far can contaminated 
aerosols spread? J Infect Dis, 193, 102-11. 
 
 179 
NIENABER, J. J., SHARMA KUINKEL, B. K., CLARKE-PEARSON, M., 
LAMLERTTHON, S., PARK, L., RUDE, T. H., BARRIERE, S., WOODS, 
C. W., CHU, V. H., MARIN, M., BUKOVSKI, S., GARCIA, P., COREY, G. 
R., KORMAN, T., DOCO-LECOMPTE, T., MURDOCH, D. R., RELLER, 
L. B., FOWLER, V. G., JR. & INTERNATIONAL COLLABORATION ON 
ENDOCARDITIS-MICROBIOLOGY, I. 2011. Methicillin-susceptible 
Staphylococcus aureus endocarditis isolates are associated with clonal 
complex 30 genotype and a distinct repertoire of enterotoxins and adhesins. J 
Infect Dis, 204, 704-13. 
 
NOVICK, R. P. 2003. Mobile genetic elements and bacterial toxinoses: the 
superantigen-encoding pathogenicity islands of Staphylococcus aureus. 
Plasmid, 49, 93-105. 
 
NOVICK, R. P., CHRISTIE, G. E. & PENADES, J. R. 2010. The phage-related 
chromosomal islands of Gram-positive bacteria. Nat Rev Microbiol, 8, 541-
51. 
 
NOVICK, R. P. & SUBEDI, A. 2007. The SaPIs: mobile pathogenicity islands of 
Staphylococcus. Chem Immunol Allergy, 93, 42-57. 
 
NUBEL, U., DORDEL, J., KURT, K., STROMMENGER, B., WESTH, H., 
SHUKLA, S. K., ZEMLICKOVA, H., LEBLOIS, R., WIRTH, T., 
JOMBART, T., BALLOUX, F. & WITTE, W. 2010. A timescale for 
evolution, population expansion, and spatial spread of an emerging clone of 
methicillin-resistant Staphylococcus aureus. PLoS Pathog, 6, e1000855. 
 
OKASHA, S. 2012. Population Genetics. In: ZALTA, E. N. (ed.) Fall 2012 ed. 
 
OKORO, C. K., KINGSLEY, R. A., CONNOR, T. R., HARRIS, S. R., PARRY, C. 
M., AL-MASHHADANI, M. N., KARIUKI, S., MSEFULA, C. L., 
GORDON, M. A., DE PINNA, E., WAIN, J., HEYDERMAN, R. S., 
 180 
OBARO, S., ALONSO, P. L., MANDOMANDO, I., MACLENNAN, C. A., 
TAPIA, M. D., LEVINE, M. M., TENNANT, S. M., PARKHILL, J. & 
DOUGAN, G. 2012. Intracontinental spread of human invasive Salmonella 
Typhimurium pathovariants in sub-Saharan Africa. Nat Genet, 44, 1215-21. 
 
OLIVER, A. 2010. Mutators in cystic fibrosis chronic lung infection: Prevalence, 
mechanisms, and consequences for antimicrobial therapy. Int J Med 
Microbiol, 300, 563-72. 
 
OMRAN, A. R. 1971. The epidemiologic transition. A theory of the epidemiology of 
population change. Milbank Mem Fund Q, 49, 509-38. 
 
ORRISON, L. H., CHERRY, W. B. & MILAN, D. 1981. Isolation of Legionella 
pneumophilia from cooling tower water by filtration. Appl Environ 
Microbiol, 41, 1202-5. 
 
OSTERHOLM, M. T. & FORFANG, J. C. 1982. Toxic-shock syndrome in 
Minnesota: results of an active-passive surveillance system. J Infect Dis, 145, 
458-64. 
 
OU, C. Y., CIESIELSKI, C. A., MYERS, G., BANDEA, C. I., LUO, C. C., 
KORBER, B. T., MULLINS, J. I., SCHOCHETMAN, G., BERKELMAN, R. 
L., ECONOMOU, A. N. & ET AL. 1992. Molecular epidemiology of HIV 
transmission in a dental practice. Science, 256, 1165-71. 
 
PAGANI, I., LIOLIOS, K., JANSSON, J., CHEN, I. M., SMIRNOVA, T., 
NOSRAT, B., MARKOWITZ, V. M. & KYRPIDES, N. C. 2012. The 
Genomes OnLine Database (GOLD) v.4: status of genomic and metagenomic 
projects and their associated metadata. Nucleic Acids Res, 40, D571-9. 
 
PEACOCK, S. J., MOORE, C. E., JUSTICE, A., KANTZANOU, M., STORY, L., 
MACKIE, K., O'NEILL, G. & DAY, N. P. J. 2002. Virulent combinations of 
 181 
adhesin and toxin genes in natural populations of Staphylococcus aureus. 
Infect Immun, 70, 4987-96. 
 
PENTERMAN, J., NGUYEN, D., ANDERSON, E., STAUDINGER, B. J., 
GREENBERG, E. P., LAM, J. S. & SINGH, P. K. 2014. Rapid Evolution of 
Culture-Impaired Bacteria during Adaptation to Biofilm Growth. Cell Rep. 
 
PEREZ-ROTH, E., LORENZO-DIAZ, F., BATISTA, N., MORENO, A. & 
MENDEZ-ALVAREZ, S. 2004. Tracking methicillin-resistant 
Staphylococcus aureus clones during a 5-year period (1998 to 2002) in a 
Spanish hospital. J Clin Microbiol, 42, 4649-56. 
 
POHL, K., FRANCOIS, P., STENZ, L., SCHLINK, F., GEIGER, T., HERBERT, S., 
GOERKE, C., SCHRENZEL, J. & WOLZ, C. 2009. CodY in Staphylococcus 
aureus: a regulatory link between metabolism and virulence gene expression. 
J Bacteriol, 191, 2953-63. 
 
POPOVICH, K. J., WEINSTEIN, R. A. & HOTA, B. 2008. Are community-
associated methicillin-resistant Staphylococcus aureus (MRSA) strains 
replacing traditional nosocomial MRSA strains? Clin Infect Dis, 46, 787-94. 
 
POTTS, A., SINKA, K., LOVE, J., DONAGHY, M., MCDONALD, E., 
JOHNSTON, F., BLATCHFORD, O., LINDSAY, D., BROWN, A. & 
EDWARDS, G. 2011. Legionellosis in Scotland in 2009 and 2010. HPS 
Weekly Reports, 45, 389-394. 
 
POZZI, C., WATERS, E. M., RUDKIN, J. K., SCHAEFFER, C. R., LOHAN, A. J., 
TONG, P., LOFTUS, B. J., PIER, G. B., FEY, P. D., MASSEY, R. C. & 
O'GARA, J. P. 2012. Methicillin resistance alters the biofilm phenotype and 
attenuates virulence in Staphylococcus aureus device-associated infections. 
PLoS Pathog, 8, e1002626. 
 
 182 
PRÉVOST, G., POTTECHER, B., DAHLET, M., BIENTZ, M., MANTZ, J. M. & 
PIÉMONT, Y. 1991. Pulsed field gel electrophoresis as a new 
epidemiological tool for monitoring methicillin-resistant Staphylococcus 
aureus in an intensive care unit. J Hosp Infect, 17, 255-69. 
 
PRICE, L. B., STEGGER, M., HASMAN, H., AZIZ, M., LARSEN, J., 
ANDERSEN, P. S., PEARSON, T., WATERS, A. E., FOSTER, J. T., 
SCHUPP, J., GILLECE, J., DRIEBE, E., LIU, C. M., SPRINGER, B., 
ZDOVC, I., BATTISTI, A., FRANCO, A., ZMUDZKI, J., SCHWARZ, S., 
BUTAYE, P., JOUY, E., POMBA, C., PORRERO, M. C., RUIMY, R., 
SMITH, T. C., ROBINSON, D. A., WEESE, J. S., ARRIOLA, C. S., YU, F., 
LAURENT, F., KEIM, P., SKOV, R. & AARESTRUP, F. M. 2012. 
Staphylococcus aureus CC398: host adaptation and emergence of methicillin 
resistance in livestock. MBio, 3. 
 
PRIEST, N. K., RUDKIN, J. K., FEIL, E. J., VAN DEN ELSEN, J. M., CHEUNG, 
A., PEACOCK, S. J., LAABEI, M., LUCKS, D. A., RECKER, M. & 
MASSEY, R. C. 2012. From genotype to phenotype: can systems biology be 
used to predict Staphylococcus aureus virulence? Nat Rev Microbiol, 10, 
791-7. 
 
PRUNIER, A. L. & LECLERCQ, R. 2005. Role of mutS and mutL genes in 
hypermutability and recombination in Staphylococcus aureus. J Bacteriol, 
187, 3455-64. 
 
PRUNIER, A. L., MALBRUNY, B., LAURANS, M., BROUARD, J., DUHAMEL, 
J. F. & LECLERCQ, R. 2003. High rate of macrolide resistance in 
Staphylococcus aureus strains from patients with cystic fibrosis reveals high 
proportions of hypermutable strains. J Infect Dis, 187, 1709-16. 
 
QUECK, S. Y., KHAN, B. A., WANG, R., BACH, T. H., KRETSCHMER, D., 
CHEN, L., KREISWIRTH, B. N., PESCHEL, A., DELEO, F. R. & OTTO, 
 183 
M. 2009. Mobile genetic element-encoded cytolysin connects virulence to 
methicillin resistance in MRSA. PLoS Pathog, 5, e1000533. 
 
RASKO, D. A., WEBSTER, D. R., SAHL, J. W., BASHIR, A., BOISEN, N., 
SCHEUTZ, F., PAXINOS, E. E., SEBRA, R., CHIN, C. S., ILIOPOULOS, 
D., KLAMMER, A., PELUSO, P., LEE, L., KISLYUK, A. O., BULLARD, 
J., KASARSKIS, A., WANG, S., EID, J., RANK, D., REDMAN, J. C., 
STEYERT, S. R., FRIMODT-MOLLER, J., STRUVE, C., PETERSEN, A. 
M., KROGFELT, K. A., NATARO, J. P., SCHADT, E. E. & WALDOR, M. 
K. 2011. Origins of the E. coli strain causing an outbreak of hemolytic-
uremic syndrome in Germany. N Engl J Med, 365, 709-17. 
 
RATZOW, S., GAIA, V., HELBIG, J. H., FRY, N. K. & LUCK, P. C. 2007. 
Addition of neuA, the gene encoding N-acylneuraminate cytidylyl 
transferase, increases the discriminatory ability of the consensus sequence-
based scheme for typing Legionella pneumophila serogroup 1 strains. J Clin 
Microbiol, 45, 1965-8. 
 
RECSEI, P., KREISWIRTH, B., O'REILLY, M., SCHLIEVERT, P., GRUSS, A. & 
NOVICK, R. P. 1986. Regulation of exoprotein gene expression in 
Staphylococcus aureus by agr. MGG Molecular & General Genetics, 202, 
58-61. 
 
REGNERY, R. L., ANDERSON, B. E., CLARRIDGE, J. E., 3RD, RODRIGUEZ-
BARRADAS, M. C., JONES, D. C. & CARR, J. H. 1992. Characterization of 
a novel Rochalimaea species, R. henselae sp. nov., isolated from blood of a 
febrile, human immunodeficiency virus-positive patient. J Clin Microbiol, 30, 
265-74. 
 
REUTER, S., HARRISON, T. G., KOSER, C. U., ELLINGTON, M. J., SMITH, G. 
P., PARKHILL, J., PEACOCK, S. J., BENTLEY, S. D. & TOROK, M. E. 
2013. A pilot study of rapid whole-genome sequencing for the investigation 
 184 
of a Legionella outbreak. BMJ Open, 3, e002175. 
 
RIDDER-SCHAPHORN, S., RATJEN, F., DUBBERS, A., HABERLE, J., FALK, 
S., KUSTER, P., SCHUSTER, A., MELLIES, U., LOWE, B., REINTJES, R., 
PETERS, G. & KAHL, B. C. 2007. Nasal Staphylococcus aureus carriage is 
not a risk factor for lower-airway infection in young cystic fibrosis patients. J 
Clin Microbiol, 45, 2979-84. 
 
RIDENOUR, D. A., CIRILLO, S. L. G., FENG, S., SAMRAKANDI, M. M. & 
CIRILLO, J. D. 2003. Identification of a gene that affects the efficiency of 
host cell infection by Legionella pneumophila in a temperature-dependent 
fashion. Infect Immun, 71, 6256-63. 
 
RILEY, L. W., REMIS, R. S., HELGERSON, S. D., MCGEE, H. B., WELLS, J. G., 
DAVIS, B. R., HEBERT, R. J., OLCOTT, E. S., JOHNSON, L. M., 
HARGRETT, N. T., BLAKE, P. A. & COHEN, M. L. 1983. Hemorrhagic 
colitis associated with a rare Escherichia coli serotype. N Engl J Med, 308, 
681-5. 
 
RIORDAN, J., ROMMENS, J., KEREM, B., ALON, N., ROZMAHEL, R., 
GRZELCZAK, Z., ZIELENSKI, J., LOK, S., PLAVSIC, N., CHOU, J., 
DRUMM, M., IANNUZZI, M., COLLINS, F. & TSUI, L. 1989. 
Identification of the cystic fibrosis gene: cloning and characterization of 
complementary DNA. Science, 245, 1066-1073. 
 
ROBINSON, D. A. & ENRIGHT, M. C. 2004. Evolution of Staphylococcus aureus 
by large chromosomal replacements. J Bacteriol, 186, 1060-4. 
 
ROBINSON, D. A., KEARNS, A. M., HOLMES, A., MORRISON, D., 
GRUNDMANN, H., EDWARDS, G., O'BRIEN, F. G., TENOVER, F. C., 
MCDOUGAL, L. K., MONK, A. B. & ENRIGHT, M. C. 2005. Re-
emergence of early pandemic Staphylococcus aureus as a community-
 185 
acquired meticillin-resistant clone. Lancet, 365, 1256-8. 
 
ROBINSON, D. A., MONK, A. B., COOPER, J. E., FEIL, E. J. & ENRIGHT, M. C. 
2005. Evolutionary genetics of the accessory gene regulator (agr) locus in 
Staphylococcus aureus. J Bacteriol, 187, 8312-21. 
 
ROCHA, E. P., SMITH, J. M., HURST, L. D., HOLDEN, M. T., COOPER, J. E., 
SMITH, N. H. & FEIL, E. J. 2006. Comparisons of dN/dS are time dependent 
for closely related bacterial genomes. J Theor Biol, 239, 226-35. 
 
ROGERS, J., DOWSETT, A. B., DENNIS, P. J., LEE, J. V. & KEEVIL, C. W. 
1994. Influence of temperature and plumbing material selection on biofilm 
formation and growth of Legionella pneumophila in a model potable water 
system containing complex microbial flora. Appl Environ Microbiol, 60, 
1585-92. 
 
ROHDE, H., QIN, J., CUI, Y., LI, D., LOMAN, N. J., HENTSCHKE, M., CHEN, 
W., PU, F., PENG, Y., LI, J., XI, F., LI, S., LI, Y., ZHANG, Z., YANG, X., 
ZHAO, M., WANG, P., GUAN, Y., CEN, Z., ZHAO, X., CHRISTNER, M., 
KOBBE, R., LOOS, S., OH, J., YANG, L., DANCHIN, A., GAO, G. F., 
SONG, Y., LI, Y., YANG, H., WANG, J., XU, J., PALLEN, M. J., WANG, 
J., AEPFELBACHER, M., YANG, R. & CONSORTIUM, E. C. O. H. G. A. 
C.-S. 2011. Open-source genomic analysis of Shiga-toxin-producing E. coli 
O104:H4. N Engl J Med, 365, 718-24. 
 
ROMMENS, J. M., IANNUZZI, M. C., KEREM, B., DRUMM, M. L., MELMER, 
G., DEAN, M., ROZMAHEL, R., COLE, J. L., KENNEDY, D., HIDAKA, 
N. & ET AL. 1989. Identification of the cystic fibrosis gene: chromosome 
walking and jumping. Science, 245, 1059-65. 
 
ROSDAHL, V. T. & KNUDSEN, A. M. 1991. The decline of methicillin resistance 




ROSENDAL, K., JESSEN, O., BENTZON, M. W. & BÜLOW, P. 1977. Antibiotic 
policy and spread of Staphylococcus aureus strains in Danish hospitals, 1969-
1974. Acta pathologica et microbiologica Scandinavica. Section B, 
Microbiology, 85, 143-52. 
 
ROSSNEY, A. S., SHORE, A. C., MORGAN, P. M., FITZGIBBON, M. M., 
O'CONNELL, B. & COLEMAN, D. C. 2007. The emergence and 
importation of diverse genotypes of methicillin-resistant Staphylococcus 
aureus (MRSA) harboring the Panton-Valentine leukocidin gene (pvl) reveal 
that pvl is a poor marker for community-acquired MRSA strains in Ireland. J 
Clin Microbiol, 45, 2554-63. 
 
ROUNTREE, P. M. & ASHESHOV, E. H. 1961. Further Observations on Changes 
in the Phage-Typing Pattern of Phage Type 80/81 Staphylococci. J Gen 
Microbiol, 26, 111-122. 
 
ROWBOTHAM, T. J. 1980. Preliminary report on the pathogenicity of Legionella 
pneumophila for freshwater and soil amoebae. J Clin Microbiol, 33, 1179-83. 
 
RUDBECK, M., MOLBAK, K. & ULDUM, S. A. 2009. Dynamics of Legionella 
antibody levels during 1 year in a healthy population. Epidemiol Infect, 137, 
1013-8. 
 
RUDKIN, J. K., EDWARDS, A. M., BOWDEN, M. G., BROWN, E. L., POZZI, C., 
WATERS, E. M., CHAN, W. C., WILLIAMS, P., O'GARA, J. P. & 
MASSEY, R. C. 2012. Methicillin resistance reduces the virulence of 
healthcare-associated methicillin-resistant Staphylococcus aureus by 
interfering with the agr quorum sensing system. J Infect Dis, 205, 798-806. 
 
SADOSKY, A. B., WIATER, L. A. & SHUMAN, H. A. 1993. Identification of 
 187 
Legionella pneumophila genes required for growth within and killing of 
human macrophages. Infect Immun, 61, 5361-73. 
 
SAMPAIO, J. L. M., VIANA-NIERO, C., DE FREITAS, D., HÖFLING-LIMA, A. 
L. & LEÃO, S. C. 2006. Enterobacterial repetitive intergenic consensus PCR 
is a useful tool for typing Mycobacterium chelonae and Mycobacterium 
abscessus isolates. Diagn Microbiol Infect Dis., 55, 107-18. 
 
SANCHEZ, I., GARCIA-NUNEZ, M., RAGULL, S., SOPENA, N., PEDRO-
BOTET, M. L., REY-JOLY, C., SABRIA, M. & ESTEVE, M. 2008. 
Genotypic variability and persistence of Legionella pneumophila PFGE 
patterns in 34 cooling towers from two different areas. Environ Microbiol, 
10, 395-9. 
 
SASS, P., BERSCHEID, A., JANSEN, A., OEDENKOVEN, M., SZEKAT, C., 
STRITTMATTER, A., GOTTSCHALK, G. & BIERBAUM, G. 2012. 
Genome sequence of Staphylococcus aureus VC40, a vancomycin- and 
daptomycin-resistant strain, to study the genetics of development of 
resistance to currently applied last-resort antibiotics. J Bacteriol, 194, 2107-8. 
 
SCHLECH, W. F., 3RD, LAVIGNE, P. M., BORTOLUSSI, R. A., ALLEN, A. C., 
HALDANE, E. V., WORT, A. J., HIGHTOWER, A. W., JOHNSON, S. E., 
KING, S. H., NICHOLLS, E. S. & BROOME, C. V. 1983. Epidemic 
listeriosis--evidence for transmission by food. N Engl J Med, 308, 203-6. 
 
SCHOULS, L. M., SPALBURG, E. C., VAN LUIT, M., HUIJSDENS, X. W., 
PLUISTER, G. N., VAN SANTEN-VERHEUVEL, M. G., VAN DER 
HEIDE, H. G., GRUNDMANN, H., HECK, M. E. & DE NEELING, A. J. 
2009. Multiple-locus variable number tandem repeat analysis of 
Staphylococcus aureus: comparison with pulsed-field gel electrophoresis and 
spa-typing. PLoS One, 4, e5082. 
 
 188 
SCHROEDER, G. N., PETTY, N. K., MOUSNIER, A., HARDING, C. R., 
VOGRIN, A. J., WEE, B., FRY, N. K., HARRISON, T. G., NEWTON, H. J., 
THOMSON, N. R., BEATSON, S. A., DOUGAN, G., HARTLAND, E. L. & 
FRANKEL, G. 2010. Legionella pneumophila strain 130b possesses a unique 
combination of type IV secretion systems and novel Dot/Icm secretion 
system effector proteins. J Bacteriol, 192, 6001-16. 
 
SCHULTE, B., BIERBAUM, G., POHL, K., GOERKE, C. & WOLZ, C. 2013. 
Diversification of clonal complex 5 methicillin-resistant Staphylococcus 
aureus strains (Rhine-Hesse clone) within Germany. J Clin Microbiol, 51, 
212-6. 
 
SCICLUNA, E. A., SHORE, A. C., THURMER, A., EHRICHT, R., SLICKERS, P., 
BORG, M. A., COLEMAN, D. C. & MONECKE, S. 2010. Characterisation 
of MRSA from Malta and the description of a Maltese epidemic MRSA 
strain. Eur J Clin Microbiol Infect Dis, 29, 163-70. 
 
SEIDL, K., BISCHOFF, M. & BERGER-BACHI, B. 2008. CcpA mediates the 
catabolite repression of tst in Staphylococcus aureus. Infect Immun, 76, 5093-
9. 
 
SEIDL, K., STUCKI, M., RUEGG, M., GOERKE, C., WOLZ, C., HARRIS, L., 
BERGER-BACHI, B. & BISCHOFF, M. 2006. Staphylococcus aureus CcpA 
affects virulence determinant production and antibiotic resistance. Antimicrob 
Agents Chemother, 50, 1183-94. 
 
SETH-SMITH, H. M., HARRIS, S. R., SKILTON, R. J., RADEBE, F. M., 
GOLPARIAN, D., SHIPITSYNA, E., DUY, P. T., SCOTT, P., CUTCLIFFE, 
L. T., O'NEILL, C., PARMAR, S., PITT, R., BAKER, S., ISON, C. A., 
MARSH, P., JALAL, H., LEWIS, D. A., UNEMO, M., CLARKE, I. N., 
PARKHILL, J. & THOMSON, N. R. 2013. Whole-genome sequences of 
Chlamydia trachomatis directly from clinical samples without culture. 
 189 
Genome Res, 23, 855-66. 
 
SHANDS, K. N., SCHMID, G. P., DAN, B. B., BLUM, D., GUIDOTTI, R. J., 
HARGRETT, N. T., ANDERSON, R. L., HILL, D. L., BROOME, C. V., 
BAND, J. D. & FRASER, D. W. 1980. Toxic-shock syndrome in 
menstruating women: association with tampon use and Staphylococcus 
aureus and clinical features in 52 cases. N Engl J Med, 303, 1436-42. 
 
SHERWOOD, J., PARK, M., ROBBEN, P., WHITMAN, T. & ELLIS, M. W. 2013. 
USA300 methicillin-resistant Staphylococcus aureus emerging as a cause of 
bloodstream infections at military medical centers. Infect Control Hosp 
Epidemiol, 34, 393-9. 
 
SIEVERT, D. M., RUDRIK, J. T., PATEL, J. B., MCDONALD, L. C., WILKINS, 
M. J. & HAGEMAN, J. C. 2008. Vancomycin-resistant Staphylococcus 
aureus in the United States, 2002-2006. Clin Infect Dis, 46, 668-74. 
 
SMITH, E. E., BUCKLEY, D. G., WU, Z., SAENPHIMMACHAK, C., HOFFMAN, 
L. R., D'ARGENIO, D. A., MILLER, S. I., RAMSEY, B. W., SPEERT, D. 
P., MOSKOWITZ, S. M., BURNS, J. L., KAUL, R. & OLSON, M. V. 2006. 
Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic 
fibrosis patients. Proc Natl Acad Sci U S A, 103, 8487-92. 
 
SMYTH, E. T., MCILVENNY, G., ENSTONE, J. E., EMMERSON, A. M., 
HUMPHREYS, H., FITZPATRICK, F., DAVIES, E., NEWCOMBE, R. G., 
SPENCER, R. C. & HOSPITAL INFECTION SOCIETY PREVALENCE 
SURVEY STEERING, G. 2008. Four country healthcare associated infection 
prevalence survey 2006: overview of the results. J Hosp Infect, 69, 230-48. 
 
SODERQUIST, B., BERGLUND, C. & STRALIN, K. 2006. Community-acquired 
pneumonia and bacteremia caused by an unusual methicillin-resistant 
Staphylococcus aureus (MRSA) strain with sequence type 36, staphylococcal 
 190 
cassette chromosome mec type IV and Panton-Valentine leukocidin genes. 
Eur J Clin Microbiol Infect Dis, 25, 604-6. 
 
SOUZA, H. A., NOGUEIRA, K. S., MATOS, A. P., VIEIRA, R. P., RIEDI, C. A., 
ROSARIO, N. A., TELLES, F. Q. & COSTA, L. M. 2006. Early microbial 
colonization of cystic fibrosis patients identified by neonatal screening, with 
emphasis on Staphylococcus aureus. J Pediatr (Rio J), 82, 377-82. 
 
STAMATAKIS, A. 2006. RAxML-VI-HPC: maximum likelihood-based 
phylogenetic analyses with thousands of taxa and mixed models. 
Bioinformatics, 22, 2688-90. 
 
STEFANI, S., CHUNG, D. R., LINDSAY, J. A., FRIEDRICH, A. W., KEARNS, A. 
M., WESTH, H. & MACKENZIE, F. M. 2012. Meticillin-resistant 
Staphylococcus aureus (MRSA): global epidemiology and harmonisation of 
typing methods. Int J Antimicrob Agents, 39, 273-82. 
 
STEVENS, D. L., TANNER, M. H., WINSHIP, J., SWARTS, R., RIES, K. M., 
SCHLIEVERT, P. M. & KAPLAN, E. 1989. Severe group A streptococcal 
infections associated with a toxic shock-like syndrome and scarlet fever toxin 
A. N Engl J Med, 321, 1-7. 
 
STRYJEWSKI, M. E. & CHAMBERS, H. F. 2008. Skin and soft-tissue 
infections caused by community-acquired methicillin-resistant 
Staphylococcus aureus. Clin Infect Dis, 46 Suppl 5, S368-77. 
 
SUBEDI, A., UBEDA, C., ADHIKARI, R. P., PENADES, J. R. & NOVICK, R. P. 
2007. Sequence analysis reveals genetic exchanges and intraspecific spread 
of SaPI2, a pathogenicity island involved in menstrual toxic shock. 
Microbiology, 153, 3235-45. 
 
TANAKA, M., WANG, T., ONODERA, Y., UCHIDA, Y. & SATO, K. 2000. 
 191 
Mechanism of quinolone resistance in Staphylococcus aureus. J Infect 
Chemother, 6, 131-9. 
 
TATEDA, K., DENG, J. C., MOORE, T. A., NEWSTEAD, M. W., PAINE, R., 
3RD, KOBAYASHI, N., YAMAGUCHI, K. & STANDIFORD, T. J. 2003. 
Hyperoxia mediates acute lung injury and increased lethality in murine 
Legionella pneumonia: the role of apoptosis. J Immunol, 170, 4209-16. 
 
TENAILLON, O., SKURNIK, D., PICARD, B. & DENAMUR, E. 2010. The 
population genetics of commensal Escherichia coli. Nat Rev Microbiol, 8, 
207-17. 
 
THOMAS, D. L., MUNDY, L. M. & TUCKER, P. C. 1993. Hot tub legionellosis. 
Legionnaires' disease and Pontiac fever after a point-source exposure to 
Legionella pneumophila. Arch Intern Med, 153, 2597-9. 
 
THOMAS, J. C., GODFREY, P. A., FELDGARDEN, M. & ROBINSON, D. A. 
2012. Candidate targets of balancing selection in the genome of 
Staphylococcus aureus. Mol Biol Evol, 29, 1175-86. 
 
THUMANU, K., CHA, J., FISHER, J. F., PERRINS, R., MOBASHERY, S. & 
WHARTON, C. 2006. Discrete steps in sensing of beta-lactam antibiotics by 
the BlaR1 protein of the methicillin-resistant Staphylococcus aureus 
bacterium. Proc Natl Acad Sci U S A, 103, 10630-5. 
 
TIEMERSMA, E. W., BRONZWAER, S. L. A. M., LYYTIKÄINEN, O., 
DEGENER, J. E., SCHRIJNEMAKERS, P., BRUINSMA, N., MONEN, J., 
WITTE, W. & GRUNDMAN, H. 2004. Methicillin-resistant Staphylococcus 
aureus in Europe, 1999-2002. Emerg Infect Dis, 10, 1627-34. 
 
TONG, S. Y., SHARMA-KUINKEL, B. K., THADEN, J. T., WHITNEY, A. R., 
YANG, S. J., MISHRA, N. N., RUDE, T., LILLIEBRIDGE, R. A., SELIM, 
 192 
M. A., AHN, S. H., HOLT, D. C., GIFFARD, P. M., BAYER, A. S., 
DELEO, F. R. & FOWLER, V. G., JR. 2013. Virulence of endemic 
nonpigmented northern Australian Staphylococcus aureus clone (clonal 
complex 75, S. argenteus) is not augmented by staphyloxanthin. J Infect Dis, 
208, 520-7. 
 
TORMO-MAS, M. A., MIR, I., SHRESTHA, A., TALLENT, S. M., CAMPOY, S., 
LASA, I., BARBE, J., NOVICK, R. P., CHRISTIE, G. E. & PENADES, J. R. 
2010. Moonlighting bacteriophage proteins derepress staphylococcal 
pathogenicity islands. Nature, 465, 779-82. 
 
TORRES-SANGIAO, E., PEREZ-CASTRO, S., FERNANDEZ-NATAL, M. I., 
CISTERNA-CANCER, R., ZAPICO-GONZALEZ, M., FERNANDEZ-
PEREZ, B., OJEDA-FERNANDEZ, E., NEBREDA, T., GOZALO-
MARGUELLO, M., FUSTER-FOZ, C., ROIZ-MESONES, M. P., MIGUEL-
MARTIN, M. D., TORROBA, L., COIRA-NIETO, A., VASALLO-VIDAL, 
F., MENDEZ-LAGE, S., PRIETO-RODRIGUEZ, E., EIROS, J. M., 
TORRES, J. & BOU, G. 2012. Identification of international circulating 
lineages of meticillin-resistant Staphylococcus aureus in the north of Spain 
and their glycopeptide and linezolid susceptibility. J Med Microbiol, 61, 305-
7. 
 
TUCHSCHERR, L., MEDINA, E., HUSSAIN, M., VOLKER, W., HEITMANN, V., 
NIEMANN, S., HOLZINGER, D., ROTH, J., PROCTOR, R. A., BECKER, 
K., PETERS, G. & LOFFLER, B. 2011. Staphylococcus aureus phenotype 
switching: an effective bacterial strategy to escape host immune response and 
establish a chronic infection. EMBO Mol Med, 3, 129-41. 
 
UBUKATA, K., NONOGUCHI, R., MATSUHASHI, M. & KONNO, M. 1989. 
Expression and inducibility in Staphylococcus aureus of the mecA gene, 
which encodes a methicillin-resistant S. aureus - specific penicillin-binding 
protein. J Bacteriol, 171, 2882-5. 
 193 
 
VAN BELKUM, A., VAN LEEUWEN, W., KAUFMANN, M. E., COOKSON, B., 
FOREY, F., ETIENNE, J., GOERING, R., TENOVER, F., STEWARD, C., 
O'BRIEN, F., GRUBB, W., TASSIOS, P., LEGAKIS, N., MORVAN, A., EL 
SOLH, N., DE RYCK, R., STRUELENS, M., SALMENLINNA, S., 
VUOPIO-VARKILA, J., KOOISTRA, M., TALENS, A., WITTE, W. & 
VERBRUGH, H. 1998. Assessment of resolution and intercenter 
reproducibility of results of genotyping Staphylococcus aureus by pulsed-
field gel electrophoresis of SmaI macrorestriction fragments: a multicenter 
study. J Clin Microbiol, 36, 1653-9. 
 
VAN BELKUM, A., VERKAIK, N. J., DE VOGEL, C. P., BOELENS, H. A., 
VERVEER, J., NOUWEN, J. L., VERBRUGH, H. A. & WERTHEIM, H. F. 
2009. Reclassification of Staphylococcus aureus nasal carriage types. J Infect 
Dis, 199, 1820-6. 
VAN WAMEL, W. J., ROOIJAKKERS, S. H., RUYKEN, M., VAN KESSEL, K. P. 
& VAN STRIJP, J. A. 2006. The innate immune modulators staphylococcal 
complement inhibitor and chemotaxis inhibitory protein of Staphylococcus 
aureus are located on beta-hemolysin-converting bacteriophages. J Bacteriol, 
188, 1310-5. 
 
VICKERS, A. A., POTTER, N. J., FISHWICK, C. W., CHOPRA, I. & O'NEILL, A. 
J. 2009. Analysis of mutational resistance to trimethoprim in Staphylococcus 
aureus by genetic and structural modelling techniques. J Antimicrob 
Chemother, 63, 1112-7. 
 
VU-THIEN, H., HORMIGOS, K., CORBINEAU, G., FAUROUX, B., CORVOL, 
H., MOISSENET, D., VERGNAUD, G. & POURCEL, C. 2010. 
Longitudinal survey of Staphylococcus aureus in cystic fibrosis patients using 
a multiple-locus variable-number of tandem-repeats analysis method. BMC 
Microbiol, 10, 24. 
 
 194 
WARD, M., BOLAND, M., NICOLAY, N., MURPHY, H., MCELHINEY, J., 
COLLINS, C., LYNCH, M., MCCARTHY, M. & J, O. D. 2010. A cluster of 
Legionnaires' disease and associated Pontiac fever morbidity in office 
workers, Dublin, June-July 2008. J Environ Public Health, 2010, 463926. 
 
WATANABE, S., ITO, T., SASAKI, T., LI, S., UCHIYAMA, I., KISHII, K., 
KIKUCHI, K., SKOV, R. L. & HIRAMATSU, K. 2009. Genetic diversity of 
staphylocoagulase genes (coa): insight into the evolution of variable 
chromosomal virulence factors in Staphylococcus aureus. PLoS One, 4, 
e5714. 
 
WATTS, D. J. & STROGATZ, S. H. 1998. Collective dynamics of 'small-world' 
networks. Nature, 393, 440-2. 
 
WERTHEIM, H., MELLES, D., VOS, M., VANLEEUWEN, W., VANBELKUM, 
A., VERBRUGH, H. & NOUWEN, J. 2005. The role of nasal carriage in 
infections. Lancet Infect Dis, 5, 751-762. 
 
WERTHEIM, H. F., VOS, M. C., OTT, A., VAN BELKUM, A., VOSS, A., 
KLUYTMANS, J. A., VAN KEULEN, P. H., VANDENBROUCKE-
GRAULS, C. M., MEESTER, M. H. & VERBRUGH, H. A. 2004. Risk and 
outcome of nosocomial Staphylococcus aureus bacteraemia in nasal carriers 
versus non-carriers. Lancet, 364, 703-5. 
 
WHITE, P. S., GRAHAM, F. F., HARTE, D. J., BAKER, M. G., AMBROSE, C. D. 
& HUMPHREY, A. R. 2013. Epidemiological investigation of a 
Legionnaires' disease outbreak in Christchurch, New Zealand: the value of 
spatial methods for practical public health. Epidemiol Infect, 141, 789-99. 
 
WICHELHAUS, T. A., BODDINGHAUS, B., BESIER, S., SCHAFER, V., 
BRADE, V. & LUDWIG, A. 2002. Biological cost of rifampin resistance 
from the perspective of Staphylococcus aureus. Antimicrob Agents 
 195 
Chemother, 46, 3381-5. 
 
WILGENBUSCH, J. C. & SWOFFORD, D. 2003. Inferring evolutionary trees with 
PAUP*. Curr Protoc Bioinformatics, Chapter 6, Unit 6 4. 
 
WILSON, G. J., SEO, K. S., CARTWRIGHT, R. A., CONNELLEY, T., CHUANG-
SMITH, O. N., MERRIMAN, J. A., GUINANE, C. M., PARK, J. Y., 
BOHACH, G. A., SCHLIEVERT, P. M., MORRISON, W. I. & 
FITZGERALD, J. R. 2011. A novel core genome-encoded superantigen 
contributes to lethality of community-associated MRSA necrotizing 
pneumonia. PLoS Pathog, 7, e1002271. 
 
WIRTH, T., WANG, X., LINZ, B., NOVICK, R. P., LUM, J. K., BLASER, M., 
MORELLI, G., FALUSH, D. & ACHTMAN, M. 2004. Distinguishing 
human ethnic groups by means of sequences from Helicobacter pylori: 
lessons from Ladakh. Proc Natl Acad Sci U S A, 101, 4746-51. 
 
WONG, A. & KASSEN, R. 2011. Parallel evolution and local differentiation in 
quinolone resistance in Pseudomonas aeruginosa. Microbiology, 157, 937-
44. 
 
WYLLIE, D. H., WALKER, A. S., MILLER, R., MOORE, C., WILLIAMSON, S. 
R., SCHLACKOW, I., FINNEY, J. M., O'CONNOR, L., PETO, T. E. & 
CROOK, D. W. 2011. Decline of meticillin-resistant Staphylococcus aureus 
in Oxfordshire hospitals is strain-specific and preceded infection-control 
intensification. BMJ Open, 1, e000160. 
 
YOUNG, B. C., GOLUBCHIK, T., BATTY, E. M., FUNG, R., LARNER-
SVENSSON, H., VOTINTSEVA, A. A., MILLER, R. R., GODWIN, H., 
KNOX, K., EVERITT, R. G., IQBAL, Z., RIMMER, A. J., CULE, M., IP, C. 
L., DIDELOT, X., HARDING, R. M., DONNELLY, P., PETO, T. E., 
CROOK, D. W., BOWDEN, R. & WILSON, D. J. 2012. Evolutionary 
 196 
dynamics of Staphylococcus aureus during progression from carriage to 
disease. Proc Natl Acad Sci U S A, 109, 4550-5. 
 
ZDZIARSKI, J., BRZUSZKIEWICZ, E., WULLT, B., LIESEGANG, H., BIRAN, 
D., VOIGT, B., GRONBERG-HERNANDEZ, J., RAGNARSDOTTIR, B., 
HECKER, M., RON, E. Z., DANIEL, R., GOTTSCHALK, G., HACKER, J., 
SVANBORG, C. & DOBRINDT, U. 2010. Host imprints on bacterial 
genomes--rapid, divergent evolution in individual patients. PLoS Pathog, 6, 
e1001078. 
 
ZERBINO, D. R. & BIRNEY, E. 2008. Velvet: algorithms for de novo short read 
assembly using de Bruijn graphs. Genome Res, 18, 821-9. 
 
ZHANG, K., MCCLURE, J. A., ELSAYED, S., LOUIE, T. & CONLY, J. M. 2005. 
Novel multiplex PCR assay for characterization and concomitant subtyping 
of staphylococcal cassette chromosome mec types I to V in methicillin-
resistant Staphylococcus aureus. J Clin Microbiol, 43, 5026-33. 
 
ZUSMAN, T., YERUSHALMI, G. & SEGAL, G. 2003. Functional similarities 
between the icm/dot pathogenesis systems of Coxiella burnetii and Legionella 




Details of CC30 isolates used in this study 
Isolate ST Lineage Isolation Year Country Reference 
00_4016_R 30 - 2000 Scotland This study 
02_7796_N 30 - 2002 Scotland This study 
05T116 30 - 2005 Sweden Söderquist et al., 2006 
09_7338_H 30 - 2009 Scotland This study 
4022 30 - 1998 Cuba Robinson et al., 2005 
MSA3412 37 - 1980s USA Fitzgerald et al., 2001 
MSA2885 441 - 1974 Canada Fitzgerald et al., 2001 
55.2053_55 30 80/81 1955 England Robinson et al., 2005 
55.2798_55 30 80/81 1955 England Robinson et al., 2005 
55.3224_55 30 80/81 1955 England Robinson et al., 2005 
58.362_58 30 80/81 1958 USA Robinson et al., 2005 
58.424_58 30 80/81 1958 USA Robinson et al., 2005 
65.1322_65 30 80/81 1965 USA Robinson et al., 2005 
65.20_65 30 80/81 1965 USA Robinson et al., 2005 
66.1888_66 30 80/81 1966 USA Robinson et al., 2005 
68.397_68 30 80/81 1968 USA Robinson et al., 2005 
68.81_68 30 80/81 1968 USA Robinson et al., 2005 
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Isolate ST Lineage Isolation Year Country Reference 
69.172_69 30 80/81 1969 USA Robinson et al., 2005 
69.412_69 30 80/81 1969 USA Robinson et al., 2005 
A017934_97 30 80/81 1997 Sweden Robinson et al., 2005 
e1410_62 30 80/81 1962 Denmark Robinson et al., 2005 
M1015_62 30 80/81 1962 Australia Robinson et al., 2005 
M1016_62 30 80/81 1962 Australia Robinson et al., 2005 
M876_61 30 80/81 1961 Australia Robinson et al., 2005 
M899_61 30 80/81 1961 Australia Robinson et al., 2005 
1227_07.08 36 EMRSA-16 2007 Scotland This study 
1696_07.08 36 EMRSA-16 2007 Scotland This study 
1712_07.08 36 EMRSA-16 2007 Scotland This study 
1791_03.08 36 EMRSA-16 2003 Scotland This study 
2449_07.17 36 EMRSA-16 2007 Scotland This study 
2483_97.75 36 EMRSA-16 1997 Scotland This study 
2496_07.17 36 EMRSA-16 2007 Scotland This study 
2589_07.17 36 EMRSA-16 2007 Scotland This study 
2880_07.25 36 EMRSA-16 2007 Scotland This study 
3366_99 36 EMRSA-16 1999 Ireland Shore et al., 2005 
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Isolate ST Lineage Isolation Year Country Reference 
3841_07.33 36 EMRSA-16 2007 Scotland This study 
5806_98.83 36 EMRSA-16 1998 Scotland This study 
6636_07.67 36 EMRSA-16 2007 Scotland This study 
6659_07.67 36 EMRSA-16 2007 Scotland This study 
7206_07.75 36 EMRSA-16 2007 Scotland This study 
75916_95 36 EMRSA-16 1995 Finland Robinson et al., 2005 
9570_06.92 36 EMRSA-16 2006 Scotland This study 
DEN4415_01 36 EMRSA-16 2001 Denmark Faria et al., 2005 
HAR24_93 36 EMRSA-16 1993 UK Harmony Collection 
HU275_02 36 EMRSA-16 2002 Hungary Conceicao et al., 2007 
MRSA252_97 36 EMRSA-16 1997 UK Holden et al., 2004 
sa1_98.92 36 EMRSA-16 1998 England This study 
sa10_07.75 36 EMRSA-16 2007 Scotland This study 
sa11_07.42 36 EMRSA-16 2007 Scotland This study 
sa12_07.67 36 EMRSA-16 2007 Scotland This study 
sa13_07.33 36 EMRSA-16 2007 Scotland This study 
sa14_06.50 36 EMRSA-16 2006 Scotland This study 
sa15_08.25 36 EMRSA-16 2008 England This study 
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Isolate ST Lineage Isolation Year Country Reference 
sa16_06.75 36 EMRSA-16 2006 England This study 
sa17_06.50 36 EMRSA-16 2006 Scotland This study 
sa18_07.50 36 EMRSA-16 2007 England This study 
sa19_06.00 36 EMRSA-16 2005 England This study 
sa2_97.00 36 EMRSA-16 1997 England This study 
sa20_07.83 36 EMRSA-16 2007 England This study 
sa21_03.00 36 EMRSA-16 2003 England This study 
sa22_07.42 36 EMRSA-16 2007 England This study 
sa23_07.50 36 EMRSA-16 2007 England This study 
sa24_07.50 36 EMRSA-16 2007 England This study 
sa25_99.67 36 EMRSA-16 1999 England This study 
sa26_00.25 36 EMRSA-16 2000 England This study 
sa27_00.33 36 EMRSA-16 2000 England This study 
sa28_02.42 36 EMRSA-16 2002 England This study 
sa29_99.17 36 EMRSA-16 1999 England This study 
sa3_97.92 36 EMRSA-16 1997 England This study 
sa30_07.75 36 EMRSA-16 2007 England This study 
sa31_02.00 36 EMRSA-16 2002 England This study 
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Isolate ST Lineage Isolation Year Country Reference 
sa32_07.42 36 EMRSA-16 2007 Scotland This study 
sa33_98.92 36 EMRSA-16 1998 England This study 
sa34_06.83 36 EMRSA-16 2006 Scotland This study 
sa35_07.50 36 EMRSA-16 2007 Scotland This study 
sa36_06.25 36 EMRSA-16 2006 Scotland This study 
sa37_07.33 36 EMRSA-16 2007 England This study 
sa38_05.83 36 EMRSA-16 2005 Scotland This study 
sa4_97.67 36 EMRSA-16 1997 England This study 
sa5_95.00 36 EMRSA-16 1995 Finland This study 
sa6_93.00 36 EMRSA-16 1993 England This study 
sa7_02.00 36 EMRSA-16 2002 England This study 
sa8_02.00 36 EMRSA-16 2002 England This study 
sa9_07.67 36 EMRSA-16 2007 Scotland This study 
7G_02 500 EMRSA-16 2002 USA This study 
PS12 500 EMRSA-16 - USA This study 
MSA3407 36 EMRSA16 1980s USA Fitzgerald et al., 2001 
02_7346_J 30 Other epidemic CC30 2002 Scotland This study 
04_2707_R 30 Other epidemic CC30 2004 Scotland This study 
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Isolate ST Lineage Isolation Year Country Reference 
05_6324_F 30 Other epidemic CC30 2005 Scotland This study 
06_5394_X 30 Other epidemic CC30 2006 Scotland This study 
08_8403_F 30 Other epidemic CC30 2008 Scotland This study 
09_6122_D 30 Other epidemic CC30 2009 Scotland This study 
10_1316_Z 30 Other epidemic CC30 2010 Scotland This study 
10_6346_K 30 Other epidemic CC30 2010 Scotland This study 
11_3148_R 30 Other epidemic CC30 2011 Scotland This study 
11_3669_V 30 Other epidemic CC30 2011 Scotland This study 
11_4342 30 Other epidemic CC30 2011 Scotland This study 
11_4425 30 Other epidemic CC30 2011 Scotland This study 
11_5419_S 30 Other epidemic CC30 2011 Scotland This study 
4030 30 Other epidemic CC30 - Cuba Robinson et al., 2005 
BTN1260 30 Other epidemic CC30 1999 England Robinson et al., 2005 
C101 30 Other epidemic CC30 1997 England Robinson et al., 2005 
ED83_83.92 30 Other epidemic CC30 1983 France Branger et al., 1996 
ED84_84.83 30 Other epidemic CC30 1984 France Branger et al., 1996 
ED86_86.08 30 Other epidemic CC30 1986 France Branger et al., 1996 
MN8_80 30 Other epidemic CC30 1980 USA Altemeier et al., 1982 
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Isolate ST Lineage Isolation Year Country Reference 
MSA1205 30 Other epidemic CC30 - USA Fitzgerald et al., 2001 
MSA1832 30 Other epidemic CC30 1968 USA Fitzgerald et al., 2001 
MSA2346 30 Other epidemic CC30 - Sweden Fitzgerald et al., 2001 
MSA2754 30 Other epidemic CC30 - Canada Fitzgerald et al., 2001 
MSA3095 30 Other epidemic CC30 1987 Canada Fitzgerald et al., 2001 
MSA537 30 Other epidemic CC30 1985 USA Fitzgerald et al., 2001 
PS10 30 Other epidemic CC30 - USA This study 
PS11 30 Other epidemic CC30 - USA This study 
PS13 30 Other epidemic CC30 - USA This study 
PS14 30 Other epidemic CC30 - USA This study 
PS17 30 Other epidemic CC30 - USA This study 
PS2 30 Other epidemic CC30 - USA This study 
PS20 30 Other epidemic CC30 - USA This study 
PS4 30 Other epidemic CC30 - USA This study 
PS5 30 Other epidemic CC30 - USA This study 
PS6 30 Other epidemic CC30 - USA This study 
PS7 30 Other epidemic CC30 - USA This study 
PS8 30 Other epidemic CC30 - USA This study 
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Isolate ST Lineage Isolation Year Country Reference 
PS9 30 Other epidemic CC30 - USA This study 
WW2703_97 30 Other epidemic CC30 1997 Germany Robinson et al., 2005 
WW2707_97 30 Other epidemic CC30 1997 Germany Robinson et al., 2005 
MSA1836 442 Other epidemic CC30 1972 USA Fitzgerald et al., 2001 
02_7810_P novel ST30 slv Other epidemic CC30 2002 Scotland This study 
03_7601_Q novel ST30 slv Other epidemic CC30 2003 Scotland This study 
03_9652_M novel ST30 slv Other epidemic CC30 2003 Scotland This study 
05_8345_P novel ST30 slv Other epidemic CC30 2005 Scotland This study 
09_1004_N novel ST30 slv Other epidemic CC30 2009 Scotland This study 
PS18 novel ST30 slv Other epidemic CC30 - USA This study 
08_8403_F 30 Southwest Pacific 2008 Scotland This study 
09_6292_C 30 Southwest Pacific 2009 Scotland This study 
11_1491_D 30 Southwest Pacific 2011 Scotland This study 
11_2558_B 30 Southwest Pacific 2011 Scotland This study 
11_3775_X 30 Southwest Pacific 2011 Scotland This study 
11_3902_X 30 Southwest Pacific 2011 Scotland This study 
11_4527_D 30 Southwest Pacific 2011 Scotland This study 
11_5404_G 30 Southwest Pacific 2011 Scotland This study 
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Isolate ST Lineage Isolation Year Country Reference 
11_5558_L 30 Southwest Pacific 2011 Scotland This study 
11_5717_J 30 Southwest Pacific 2011 Scotland This study 
1973_07.17 30 Southwest Pacific 2007 Scotland This study 
7997_01 30 Southwest Pacific 2001 Scotland Robinson et al., 2005 
TCH_00.58 30 Southwest Pacific 2000 USA Human Microbiome Project 
WBG_99 30 Southwest Pacific 1999 Australia Robinson et al., 2005 
02_6340_B 39 ST39 2002 Scotland This study 
02_7657_Q 39 ST39 2002 Scotland This study 
MSA1827 39 ST39 1964 USA Fitzgerald et al., 2001 
MSA2335 39 ST39 - Sweden Fitzgerald et al., 2001 
PS16 39 ST39 - USA This study 







Bayesian phylogeny of original CC30 dataset with nodes labelled with 
posterior support, and tips labelled with isolate names.  Scale bar 
represents unit time in years. 
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